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THE	  SPLICEOSOME	  RECYCLING	  FACTOR,	  SART3,	  REGULATES	  H2B	  DEUBIQUITINATION	  
BY	  USP15	  
	  
	   In	  eukaryotes	  plasticity	  of	  chromatin	  architecture	  is	  paramount	  to	  allow	  proper	  
regulation	  of	  processes	  such	  as	  transcription	  regulation,	  DNA	  repair,	  and	  DNA	  replication.	  
Modulation	  of	  chromatin	  dynamics	  is	  primarily	  achieved	  via	  signaling	  to	  chromatin	  
modifiers	  and	  remodelers	  though	  a	  complex	  code	  of	  histone	  post-­‐translational	  
modifications	  (PTMs).	  These	  PTMs	  include	  methylation,	  acetylation,	  phosphorylation,	  and	  
ubiquitination.	  	  In	  comparison	  to	  other	  histone	  PTMs,	  attachment	  of	  the	  8.5	  kDa	  ubiquitin	  
(Ub)	  protein	  stands	  out	  due	  to	  its	  considerable	  size.	  The	  majority	  of	  histone	  
monoubiquitination	  occurs	  on	  histones	  H2A	  and	  H2B	  (at	  lysine	  residues	  119	  and	  120,	  
respectively),	  and	  these	  modifications	  have	  roles	  in	  the	  regulation	  of	  many	  cellular	  
processes	  including	  transcription,	  pre-­‐mRNA	  processing,	  and	  DNA	  damage	  repair.	  	  
	   To	  uncover	  the	  mechanisms	  underlying	  various	  functions	  associated	  with	  
ubiquitinated	  histones,	  we	  generated	  non-­‐hydrolyzable	  Ub-­‐histone	  mimics	  and	  assembled	  
them	  into	  H2A/H2B	  dimers	  or	  nucleosomes.	  Quantitative	  mass	  spectrometry	  was	  
employed	  to	  identify	  proteins	  that	  bound	  to	  unmodified	  or	  modified	  histone	  dimers	  and	  
mononucleosomes.	  We	  also	  found	  that,	  within	  the	  context	  of	  a	  mononucleosome,	  Ub,	  when	  
attached	  to	  H2B,	  partially	  obscures	  the	  H2A/H2B	  acidic	  patch.	  	  
Among	  the	  proteins	  that	  were	  identified,	  a	  deubiquitinating	  enzyme	  (DUB),	  Usp15,	  
exhibited	  high	  affinity	  and	  specificity	  towards	  ubiquitinated	  histone	  dimers.	  Further	  




deubiquitinates	  Ub-­‐containing	  histone	  octamers	  versus	  Ub-­‐containing	  mononucleosomes.	  
Usp15	  associates	  with	  the	  U4/U6	  spliceosome	  recycling	  factor,	  SART3,	  which	  we	  found	  also	  
bound	  to	  histones.	  These	  interactions	  result	  in	  more	  efficient	  histone	  deubiquitination	  by	  
Usp15.	  In	  cells,	  depletion	  of	  SART3	  results	  in	  elevated	  ubH2B	  levels	  that	  we	  show	  is	  due	  to	  
a	  decreased	  rate	  in	  H2B	  deubiquitination.	  These	  observations	  indicate	  SART3	  may	  play	  a	  
role	  in	  regulating	  ubH2B	  dynamics	  as	  a	  possible	  mechanism	  by	  which	  regulate	  alternative	  
splicing	  and	  transcription.	  
Depletion	  of	  SART3	  also	  alters	  transcriptional	  and	  alternative	  splicing	  patterns.	  By	  
chromatin	  immunoprecipitation,	  we	  confirmed	  that	  SART3	  localizes	  to	  at	  least	  a	  subset	  of	  
genes	  whose	  transcription	  decreased	  upon	  SART3	  depletion.	  Future	  studies	  will	  be	  
designed	  to	  elucidate	  the	  mechanism	  by	  which	  Usp15,	  SART3,	  and	  ubH2B	  work	  together	  to	  
regulate	  transcription	  and	  alternative	  splicing.	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CHAPTER	  1:	  INTRODUCTION	  
	  
	  
In	  eukaryotes,	  the	  state	  of	  chromatin	  dictates	  all	  processes	  that	  require	  access	  to	  
DNA,	  such	  as	  transcription,	  replication,	  and	  DNA	  repair.	  DNA	  accessibility	  is	  regulated,	  in	  
part,	  by	  numerous	  post-­‐translational	  modifications	  (PTMs)	  that	  occur	  on	  histones	  
including:	  acetylation,	  methylation,	  phosphorylation,	  SUMOylation,	  and	  ubiquitination	  (Tan	  
et	  al.,	  2011).	  	  
Ubiquitin	  (Ub)	  is	  a	  protein	  of	  76	  amino	  acids	  with	  a	  well-­‐folded,	  highly	  stable	  
structure.	  It	  is	  attached	  to	  other	  proteins	  through	  the	  formation	  of	  an	  isopeptide	  linkage	  
between	  the	  C-­‐terminal	  carboxylate	  of	  Ub	  and	  a	  lysine	  side	  chain	  of	  the	  substrate	  protein.	  
Although	  all	  four	  core	  histones	  and	  linker	  histone	  H1	  have	  been	  reported	  to	  undergo	  
ubiquitination	  at	  various	  positions,	  the	  predominant	  forms	  of	  ubiquitinated	  histones	  in	  
humans	  are	  H2A	  ubiquitinated	  at	  K119	  and	  H2B	  ubiquitinated	  at	  K120	  (ubH2A	  and	  ubH2B,	  
respectively)	  (Kim	  et	  al.,	  2011;	  Osley,	  2006).	  MonoUb	  attachment	  to	  histones	  H2A	  and	  H2B	  
serves	  as	  signals	  in	  the	  regulation	  of	  gene	  expression,	  pre-­‐mRNA	  splicing,	  and	  DNA	  repair	  
processes.	  Dynamic	  conjugation	  and	  deconjugation	  of	  Ub	  is	  imperative	  as	  Ub	  histone-­‐
regulated	  processes	  must	  be	  tightly	  regulated.	  Deubiquitinating	  enzymes	  (DUBs)	  perform	  
Ub	  deconjugation.	  My	  thesis	  will	  focus	  on	  the	  generation	  and	  application	  of	  ubiquitinated	  
histone	  mimics,	  characterization	  of	  a	  histone	  DUB,	  Usp15,	  and	  its	  relationship	  with	  the	  
spliceosome	  recycling	  factor,	  SART3,	  and	  transcription.	  
	  
1.1	  Ubiquitin	  conjugation	  
	   Ub	  conjugation	  is	  accomplished	  through	  a	  coordinated	  effort	  between	  a	  cascade	  of	  






dependent	  process,	  Ub	  is	  activated	  and	  reacts	  with	  the	  active	  site	  cysteine	  residue	  on	  the	  
Ub-­‐activating	  enzyme	  (E1)	  to	  form	  an	  E1-­‐Ub	  thiolester.	  Next,	  Ub	  is	  transferred	  from	  the	  E1	  
to	  the	  Ub	  conjugating	  enzyme	  (E2)	  active	  site	  cysteine.	  The	  transfer	  of	  Ub	  to	  a	  substrate	  is	  
modulated	  through	  the	  activity	  of	  the	  Ub	  ligase	  (E3).	  The	  E3	  is	  confers	  the	  ubiquitination	  
substrate	  specificity	  and	  the	  mechanism	  of	  action	  differs	  between	  classes	  of	  E3s.	  Most	  E3	  
enzymes	  fall	  into	  the	  Really	  Important	  New	  Gene	  (RING)	  family.	  RING	  family	  ligases	  bind	  
both	  the	  E2-­‐Ub	  and	  the	  substrate	  to	  act	  as	  a	  bridging	  factor	  whereby	  Ub	  is	  transferred	  from	  
the	  E2	  to	  the	  substrate.	  The	  alternative	  mechanism	  of	  Ub	  ligation	  is	  carried	  out	  by	  the	  
Homologous	  to	  E6AP	  Carboxy	  Terminus	  (HECT)	  family	  of	  E3	  ligases.	  In	  this	  case,	  the	  HECT	  
family	  E3	  ligase	  also	  interacts	  with	  both	  the	  E2-­‐Ub	  and	  the	  substrate;	  but	  rather	  than	  a	  
direct	  transfer	  of	  Ub	  from	  the	  E2	  to	  the	  substrate,	  the	  transference	  of	  Ub	  to	  the	  active	  site	  
cysteine	  on	  the	  E3	  is	  required	  prior	  to	  the	  final	  step	  of	  Ub	  conjugation	  to	  the	  substrate.	  	  
	   Ub	  is	  conjugated	  through	  the	  C-­‐terminal	  carboxylate	  of	  Ub	  and	  the	  lysine	  side	  chain	  
of	  the	  substrate	  protein,	  resulting	  in	  an	  isopeptide	  linkage.	  Because	  Ub	  itself	  encodes	  seven	  
lysine	  residues	  (at	  positions	  6,	  11,	  27,	  29,	  33,	  48,	  and	  63),	  in	  addition	  to	  lysine	  residues	  on	  
other	  proteins,	  Ub	  may	  also	  serve	  as	  a	  target	  for	  Ub	  conjugation.	  In	  some	  cases,	  the	  target	  
protein	  is	  first	  monoubiquitinated	  by	  the	  conjugation	  of	  a	  single	  Ub.	  Subsequently,	  Ub	  
ligases	  can	  form	  chains	  of	  Ub	  by	  conjugating	  additional	  molecules	  onto	  the	  first	  (proximal)	  
Ub,	  forming	  poly-­‐Ub	  chains.	  Poly-­‐Ub	  chains	  may	  be	  formed	  via	  linkages	  through	  a	  single	  
lysine	  residue	  or	  by	  linkages	  through	  multiple	  different	  lysine	  residues	  within	  the	  same	  
chain	  (branched	  or	  mixed	  chains),	  thus	  increasing	  the	  complexity	  of	  the	  Ub	  signal	  (Ye	  and	  
Rape,	  2009).	  The	  type	  of	  Ub	  chain	  that	  is	  formed	  is	  dictated	  by	  the	  E3,	  as	  certain	  Ub	  ligases	  
specifically	  ligate	  the	  proximal	  Ub	  to	  the	  target	  protein	  or	  extend	  Ub	  chains	  through	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particular	  linkage	  types.	  Notably,	  there	  is	  an	  additional	  class	  of	  enzymes,	  E4s,	  which	  
function	  to	  extend	  poly-­‐Ub	  chains	  (Hoppe,	  2005).	  
	   The	  type	  of	  Ub	  linkage	  influences	  the	  fate	  of	  an	  ubiquitinated	  protein.	  
Monoubiquitination	  of	  substrates	  is	  typically	  involved	  in	  cellular	  localization	  or	  protein-­‐
protein	  interactions	  while	  Lys-­‐11	  and	  Lys-­‐48	  linkages	  predominantly	  target	  proteins	  for	  
proteosomal	  degradation.	  Adding	  to	  the	  complexity	  of	  signaling	  via	  ubiquitination,	  many	  
Ub-­‐like	  proteins	  (UBLs)	  have	  been	  identified	  such	  as	  Nedd8,	  Small	  Ub-­‐like	  Modifier	  
(SUMO),	  Hub1,	  Ufm1,	  Atg8,	  and	  ISG15	  (van	  der	  Veen	  and	  Ploegh,	  2012).	  These	  UBLs	  use	  
conjugation	  machinery	  that	  is	  distinct	  from	  the	  Ub	  conjugation	  enzymes.	  Nedd8	  is	  closest	  
in	  homology	  to	  Ub	  (58%	  sequence	  identity)	  and	  often	  modifies	  Ub	  ligase	  components	  to	  
enhance	  Ub	  conjugation.	  SUMOylated	  proteins	  are	  typically	  not	  targeted	  for	  degradation,	  
but	  are	  involved	  in	  a	  variety	  of	  pathways	  including	  cell	  cycle	  and	  transcriptional	  regulation.	  
In	  summary,	  multiple	  E2s	  and	  E3s,	  various	  Ub	  linkage	  types,	  and	  UBLs	  all	  contribute	  to	  the	  
diversity	  of	  signaling	  achieved	  by	  the	  ubiquitination	  pathway.	  
	   	  	  
1.2	  Ubiquitin	  deconjugation	  
	   Ubiquitination	  is	  a	  reversible	  process	  carried	  out	  by	  a	  particular	  type	  of	  proteases:	  
deubiquitinating	  enzymes	  (DUBs)	  (Ventii	  and	  Wilkinson,	  2008).	  Ub	  deconjugation	  is	  
critical	  in	  many	  processes.	  For	  example,	  substrates	  that	  are	  targeted	  for	  proteosomal	  
degradation	  via	  poly-­‐Ub	  chains	  are	  often	  deubiquitinated	  by	  proteasome-­‐associated	  DUBs	  
prior	  to	  degradation,	  thus	  allowing	  the	  Ub	  to	  be	  recycled	  and	  conjugated	  onto	  a	  new	  
substrate.	  Additionally,	  proteins	  are	  often	  ubiquitinated	  during	  cellular	  processes	  such	  as	  
transcription,	  cell	  cycle	  checkpoints,	  and	  autophagy;	  precise	  control	  of	  these	  processes	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must	  be	  regulated	  by	  both	  ubiquitination	  and	  deubiquitination.	  DUBs	  have	  also	  been	  
reported	  to	  deubiquitinate	  E3s	  that	  undergo	  auto-­‐ubiquitination,	  thereby	  increasing	  the	  
half-­‐life	  of	  the	  Ub	  ligase	  by	  preventing	  Ub-­‐mediated	  proteosomal	  degradation	  of	  the	  E3	  
(Eletr	  and	  Wilkinson,	  2014).	  
	   Approximately	  79	  DUBs	  are	  encoded	  by	  the	  genome	  and	  are	  classified	  into	  five	  
families:	  1)	  Ub	  Specific	  Proteases	  (USP/UBP),	  2)	  Ub	  C-­‐terminal	  Hydrolases	  (UCH),	  3)	  
Ovarian	  Tumors	  (OTU),	  4)	  Josephin	  domains	  (MJD),	  and	  5)	  JAMM	  domain	  zinc-­‐dependent	  
metalloproteses.	  Notably,	  the	  USP/UBP	  family	  represents	  the	  largest	  group	  of	  DUBs	  as	  over	  
50	  enzymes	  fall	  into	  this	  category.	  These	  DUBs	  are	  cysteine	  proteases	  characterized	  by	  the	  
presence	  of	  both	  a	  highly	  conserved	  USP-­‐fold	  and	  three	  catalytic	  residues	  contained	  within	  
the	  Cys-­‐	  and	  His-­‐box	  motifs	  (Amerik	  and	  Hochstrasser,	  2004).	  Mutation	  of	  any	  of	  these	  
catalytic	  residues	  renders	  the	  DUB	  inactive.	  
	   The	  number	  of	  DUBs	  is	  small	  when	  compared	  to	  that	  of	  ubiquitinated	  proteins	  
present	  in	  the	  cell.	  Therefore,	  regulation	  of	  DUBs	  must	  be	  achieved	  through	  multiple	  
mechanisms	  to	  attain	  specificity.	  These	  points	  of	  regulation	  include	  subcellular	  localization,	  
changes	  in	  expression,	  and	  PTMs.	  DUBs	  also	  achieve	  specificity	  by	  making	  direct	  contacts	  
with	  both	  Ub	  and	  its	  substrate.	  For	  example,	  structural	  studies	  have	  shown	  Usp7	  makes	  
direct	  contacts	  with	  its	  substrate	  and	  Ub,	  indicating	  recognition	  of	  both	  Ub	  and	  the	  specific	  
substrate	  are	  important	  for	  Ub	  hydrolysis	  (Hu	  et	  al.,	  2006).	  Additionally,	  in	  vitro	  studies	  
showed	  Usp15	  binds	  ubiquitinated	  histones	  with	  higher	  affinity	  than	  it	  binds	  Ub	  or	  
histones	  alone	  (Long	  et	  al.,	  2014).	  Finally,	  many	  DUBs	  are	  associated	  with	  larger	  complexes	  
through	  which	  regulation	  is	  mediated.	  In	  the	  case	  of	  Uch37,	  multiple	  mechanisms	  of	  
regulation	  are	  employed	  to	  prevent	  promiscuous	  DUB	  activity.	  In	  one	  case,	  Uch37	  is	  
	  
	  6	  
recruited	  to	  the	  proteasome	  where	  auto-­‐inhibition	  is	  relieved	  through	  an	  interaction	  with	  
the	  proteosomal	  subunit	  protein,	  Rpn13	  (Yao	  et	  al.,	  2006).	  In	  another	  mode	  of	  regulation,	  
Uch37	  is	  a	  component	  of	  the	  chromatin	  remodeling	  INO80	  complex	  where	  its	  activity	  is	  
repressed	  by	  the	  NFRKB	  subunit	  (Yao	  et	  al.,	  2008).	  Thus,	  DUBs	  may	  utilize	  multiple	  mode	  
of	  regulation	  to	  enhance	  substrate	  specificity.	  
	  
1.3	  Histone	  post-­‐translational	  modifications	  
In	  each	  human	  diploid	  cell,	  there	  are	  approximately	  6	  billion	  base	  pairs	  of	  DNA,	  
which,	  if	  extended,	  would	  measure	  2	  meters	  in	  length.	  Paradoxically,	  this	  large	  amount	  of	  
DNA	  needs	  to	  be	  compacted	  into	  the	  nucleus,	  which	  has	  an	  average	  diameter	  of	  6	  μm;	  
therefore,	  a	  compaction	  of	  approximately	  300,000-­‐fold	  must	  occur	  to	  fit	  the	  DNA	  into	  the	  
nucleus	  (Annunziato,	  2013).	  This	  enigma	  is	  overcome	  through	  a	  mechanism	  of	  compaction	  
whereby	  DNA	  is	  coiled	  around	  a	  set	  of	  histone	  proteins.	  This	  reaction	  is	  made	  favorable,	  in	  
part,	  due	  to	  electrostatic	  interactions	  between	  negatively	  charged	  phosphate	  backbone	  of	  
DNA	  and	  the	  positively	  charged	  histones.	  The	  compacted	  DNA	  is	  comprised	  of	  repeating	  
units	  of	  nucleosome	  core	  particles	  (NCPs).	  NCPs	  are	  made-­‐up	  of	  146	  base	  pairs	  of	  DNA	  
wrapped	  around	  the	  core	  histone	  octamer,	  which	  contains	  of	  2	  copies	  each	  of	  histones	  H2A,	  
H2B,	  H3,	  and	  H4	  (Luger	  et	  al.,	  1997).	  Each	  nucleosome	  core	  particle	  is	  joined	  by	  ~20-­‐90	  
base	  pairs	  of	  linker	  DNA,	  giving	  the	  appearance	  of	  “beads	  on	  a	  string”	  when	  analyzed	  by	  
electron	  microscopy	  (Bei	  et	  al.,	  1983).	  Further	  compaction	  is	  accomplished	  via	  deposition	  




Within	  the	  cell,	  the	  machineries	  involved	  in	  processes	  such	  as	  DNA	  replication,	  DNA	  
damage	  repair,	  and	  transcription	  require:	  1)	  targeting	  to	  specific	  chromatin	  regions	  and/or	  
2)	  direct	  access	  to	  decondensed	  chromatin	  for	  functionality.	  Therefore,	  chromatin	  
signaling,	  compaction,	  and	  decompaction	  must	  occur	  in	  a	  highly	  regulated	  manner	  to	  
facilitate	  these	  processes.	  Much	  of	  this	  regulation	  comes	  in	  the	  form	  of	  histone	  PTMs.	  While	  
histones	  contain	  a	  globular	  histone-­‐fold	  domain,	  many	  of	  the	  PTMs	  occur	  within	  the	  more	  
accessible,	  unstructured	  tail	  regions.	  These	  modifications	  include	  ubiquitination,	  
acetylation,	  methylation,	  SUMOylation,	  phosphorylation,	  citrullation,	  and	  ADP-­‐ribosylation	  
(Arnaudo	  and	  Garcia,	  2013).	  Preliminarily,	  a	  “histone	  code”	  was	  hypothesized	  whereby	  a	  
particular	  combination	  of	  PTMs	  rigorously	  dictates	  the	  downstream	  affect	  (i.e.	  activation	  or	  
repression	  of	  transcription)	  (Strahl	  and	  Allis,	  2000).	  While	  it’s	  true	  that	  specific	  patterns	  of	  
histone	  PTMs	  participate	  in	  organizing	  particular	  regions	  of	  chromatin,	  emerging	  studies	  
suggest	  the	  regulation	  of	  DNA	  processes	  by	  histone	  PTMs	  may	  involve	  more	  variables	  than	  
was	  originally	  postulated.	  
Histone	  PTMs	  convey	  changes	  in	  chromatin	  through	  two	  major	  mechanisms.	  First,	  
the	  modifications	  themselves	  can	  directly	  affect	  the	  stability	  of	  the	  nucleosome.	  For	  
example,	  acetylation	  of	  lysine	  residues	  on	  histone	  tails	  can	  neutralize	  the	  positively-­‐
charged	  of	  the	  histone	  tail,	  effectively	  decreasing	  the	  affinity	  between	  the	  DNA	  and	  histone	  
octamers	  (Hong	  et	  al.,	  1993).	  In	  another	  case,	  conjugation	  of	  a	  bulky	  Ub	  moiety	  to	  H2B	  
(ubH2B)	  is	  antagonistic	  to	  chromatin	  compaction	  of	  nucleosomal	  arrays	  in	  vitro	  (Fierz	  et	  
al.,	  2010).	  Furthermore,	  Fierz	  et	  al.	  showed	  that	  when	  nucleosomal	  arrays	  contained	  both	  
acetylated	  H4	  at	  Lys16	  and	  ubiquitinated	  H2B	  (ubH2B),	  H4	  acetylation	  predominantly	  
exerted	  the	  adverse	  effect	  on	  internucleosomal	  interactions	  while	  the	  combination	  of	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modifications	  worked	  synergistically	  to	  prevent	  oligomerization	  (intramolecular	  
interactions)	  of	  nucleosomal	  arrays	  (Fierz	  et	  al.,	  2010).	  These	  data	  demonstrate	  how	  
histone	  PTMs	  can	  work	  independently	  or	  synergistically	  to	  modulate	  the	  chromatin	  state	  
through	  different	  mechanisms.	  	  
The	  second	  major	  method	  by	  which	  histone	  PTMs	  can	  affect	  downstream	  processes	  
is	  through	  recruitment	  of	  effector	  proteins	  (Bottomley,	  2004).	  Certain	  effector	  proteins	  
“read”	  these	  PTMs	  using	  domains	  that	  interact	  with	  specific	  histone	  modifications.	  For	  
example,	  bromodomain-­‐containing	  proteins	  are	  recruited	  to	  chromatin	  through	  
interactions	  with	  lysine-­‐acetylated	  histone	  tails	  (Dhalluin	  et	  al.,	  1999;	  Kanno	  et	  al.,	  2004).	  
In	  another	  case,	  many	  chromodomain-­‐containing	  proteins	  are	  recruited	  to	  particular	  
chromatin	  regions	  through	  binding	  of	  methylated	  histones	  (Jacobs	  and	  Khorasanizadeh,	  
2002;	  Nielsen	  et	  al.,	  2002).	  These	  effector	  proteins	  have	  a	  wide	  array	  of	  functions	  by	  which	  
chromatin-­‐mediated	  processes	  are	  executed	  including	  perpetuation	  of	  additional	  histone	  
PTMs	  and	  recruitment	  of	  additional	  factors	  such	  as	  histone	  chaperones	  or	  DNA	  damage	  
repair	  machinery.	  Notably,	  this	  is	  a	  relatively	  simplistic	  overview	  about	  the	  mechanism	  of	  
histone	  PTMs	  modulation	  of	  chromatin	  dynamics	  as	  many	  additional	  factors	  are	  involved	  
in	  regulating	  these	  dynamic	  processes.	  	  
	  
1.4	  Histone	  ubiquitination	  
	   Among	  the	  various	  types	  of	  histone	  PTMs,	  histone	  ubiquitination	  is	  particularly	  
striking,	  as	  the	  modification	  size	  (~8.5	  kDa)	  is	  substantially	  large	  when	  compared	  with	  
other	  PTMs	  such	  as	  acetylation	  or	  methylation	  (Figure	  1.2).	  In	  mammalian	  cells,	  all	  four	  






residues,	  and	  these	  modifications	  play	  roles	  in	  several	  specific	  processes	  (Table	  1.1).	  In	  
addition,	  linker	  histone	  H1	  was	  also	  demonstrated	  to	  be	  ubiquitinated	  in	  Drosophila	  
embryos,	  resulting	  in	  transactivation	  of	  a	  subset	  of	  genes	  (Pham	  and	  Sauer,	  2000).	  	  
	   Histone	  H2A	  was	  the	  first	  ubiquitinated	  protein	  to	  be	  identified	  (Goldknopf	  et	  al.,	  
1975)	  and	  was	  later	  realized	  to	  be	  one	  of	  the	  most	  abundant	  ubiquitinated	  proteins	  in	  the	  
nucleus.	  While	  monoubiquitinated	  H2A	  (ubH2A)	  has	  not	  been	  described	  in	  S.	  cerevisiae,	  
approximately	  5-­‐15%	  of	  total	  H2A	  in	  metazoans	  is	  monoubiquitinated	  at	  Lys119	  (Hatch	  et	  
al.,	  1983;	  Wu	  et	  al.,	  1981;	  Wunsch	  et	  al.,	  1987).	  Although	  only	  one	  E2	  (UbcH5)	  has	  been	  
identified	  to	  play	  a	  role	  in	  H2A	  monoubiquitination,	  multiple	  E3	  enzymes	  coordinate	  Ub	  
conjugation	  to	  H2A	  (Chen	  et	  al.,	  2002).	  These	  include	  RING1A/RING1B/BMI1,	  2A-­‐HUB,	  and	  
BRCA1/BARD1,	  all	  of	  which	  fall	  into	  the	  RING	  family	  of	  Ub	  ligases	  (Cao	  et	  al.,	  2005;	  Chen	  et	  
al.,	  2002;	  Gearhart	  et	  al.,	  2006;	  Zhou	  et	  al.,	  2008;	  Zhu	  et	  al.,	  2011).	  Recently	  reports	  have	  
identified	  Lys13	  and	  Lys15	  as	  additional	  sites	  of	  H2A	  monoubiquitination	  although	  this	  
modification	  seems	  to	  be	  less	  abundant	  than	  ubiquitination	  at	  Lys119	  (Gatti	  et	  al.,	  2012;	  
Mattiroli	  et	  al.,	  2012).	  
	   	  Monoubiquitination	  of	  H2B	  (ubH2B)	  at	  Lys120	  (Lys123	  in	  yeast)	  is	  fairly	  abundant	  
and	  has	  broad	  functional	  roles	  within	  the	  cell.	  Approximately	  1-­‐2%	  of	  total	  H2B	  is	  
ubiquitinated	  (Wu	  et	  al.,	  1981),	  and	  this	  is	  primarily	  mediated	  through	  the	  RING	  family	  Ub	  
ligase	  heterodimer	  RNF20/RNF40	  (orthologous	  to	  Bre1	  in	  yeast).	  This	  E3	  ligase	  cooperates	  
with	  the	  E2,	  RAD6A/B	  (Rad6	  in	  yeast),	  to	  modify	  H2B	  (Kao	  et	  al.,	  2004;	  Kim	  et	  al.,	  2005;	  
Robzyk	  et	  al.,	  2000).	  Additional	  sites	  of	  H2B	  monoubiquitination	  include	  Lys34	  and	  Lys125,	  
although	  these	  are	  much	  less	  abundant	  than	  modification	  at	  K120	  (Table	  1.1)	  (Minsky	  and	  
Oren,	  2004;	  Wu	  et	  al.,	  2011).	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Table	  1.1.	  Histone	  monoubiquitination	  at	  different	  sites	  are	  associated	  with	  different	  
functions.	  
Histone	  
(human)	   MonoUb	  Sites	   Associated	  Functions	   References	  
H2A	   13,	  15	   DNA	  damage	  response	  
Mattrioli	  et	  al.,	  
2012;	  Gatti	  et	  al.,	  
2012	  
H2A	   119	  
Transcription	  silencing	  and	  DNA	  
damage	  response.	  Corresponding	  
positions	  in	  H2A.X,	  H2A.Z,	  and	  
MacroH2A1.2	  have	  been	  reported	  to	  




and	  Wright	  et	  al.,	  
2012	  
H2B	   34	   Transcription	  activation	   Wu	  et	  al.,	  2011	  




and	  Wright	  et	  al.,	  
2012	  
H2B	   125	   Transcription	  repression	   Minsky	  and	  Oren,	  2004	  
H3	   23	   Maintenance	  of	  DNA	  methylation	  during	  DNA	  replication	  
Nishiyama	  et	  al.,	  
2013	  
H4	   31	   Transcription	  activation	   Kim	  et	  al.,	  2013	  
H4	   91	   DNA	  damage	  response	   Yan	  et	  al.,	  2009	  
	  
1.5	  Histone	  deubiquitination	  
	   Many	  H2A	  and	  H2B	  DUBs	  have	  been	  identified.	  Whereas	  some	  DUBs	  deubiquitinate	  
both	  H2A	  and	  H2B,	  others	  specifically	  deubiquitinate	  either	  H2A	  or	  H2B	  (Table	  1.2).	  
Characterizing	  enzymatic	  properties	  of	  histone	  DUBs	  has	  proven	  difficult	  as	  a	  obtaining	  a	  
purified,	  ubiquitinated	  substrate	  is	  problematic.	  Using	  recombinantly	  expressed	  and	  
purified	  E1,	  E2	  (RAD6A/B),	  and	  E3	  (RNF20/RNF40)	  along	  with	  Ub	  and	  H2B	  in	  an	  in	  vitro	  
ubiquitination	  assay	  to	  obtain	  ubiquitinated	  histones	  are	  problematic	  for	  two	  reasons.	  
First,	  the	  yield	  of	  ubiquitinated	  product	  is	  extremely	  low	  (less	  than	  5%).	  Second,	  the	  E3	  
ligase	  exhibits	  promiscuity	  as	  reaction	  products	  contain	  the	  Ub	  modification	  at	  sites	  other	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Table	  1.2.	  Histone	  deubiquitinating	  enzymes	  have	  different	  substrate	  specificities.	  
Substrate	  specificities	  for	  histone	  DUBs	  are	  discussed	  in	  section	  1.5	  and	  references	  are	  
listed	  therein.	  
	  
than	  Lys120	  (Kim	  and	  Roeder,	  2011).	  Another	  strategy	  used	  to	  obtain	  ubiquitinated	  
histones	  is	  by	  purification	  from	  tissue	  culture	  cells	  (Joo	  et	  al.,	  2007;	  Lee	  et	  al.,	  2005).	  This	  
Ub-­‐histone	  substrate	  is	  less	  than	  ideal	  as	  purified	  histones	  are	  heterogeneous	  due	  to	  a	  
variety	  of	  naturally	  occurring	  PTMs.	  These	  additional	  PTMs	  could	  affect	  the	  efficiency	  or	  
specificity	  of	  deubiquitination,	  thus	  convoluting	  in	  vitro	  deubiquitination	  assay	  results.	  In	  
fact,	  we	  know	  that	  the	  H2A-­‐specific	  DUB,	  2A-­‐DUB,	  more	  effectively	  deubiquitinates	  ubH2A-­‐
containing	  chromatin	  that	  also	  contain	  high	  levels	  of	  H3	  and	  H4	  acetylation	  when	  
compared	  to	  chromatin	  with	  unperturbed	  acetylation	  levels	  (Zhu	  et	  al.,	  2007).	  The	  Brik	  
group	  has	  combined	  protein	  ligation	  and	  peptide	  synthesis	  to	  generate	  a	  native	  ubH2B	  at	  
H2BK120,	  H2BK34,	  and	  H2AK119	  (T.Y.	  and	  A.B.,	  unpublished	  results)	  (Long	  et	  al.,	  2014;	  
Siman	  et	  al.,	  2013).	  In	  addition	  to	  the	  highly	  specialized	  and	  technically	  challenging	  method	  
employed,	  the	  yield	  of	  ubiquitinated	  histone	  is	  extremely	  low.	  These	  obstacles	  make	  it	  
DUB	   Organism	   Substrate	   Nucleosomal	  substrate	  
Free	  histone	  
substrate	  	  
Usp16	  (Ubp-­‐M)	   Human	   H2A	   +	   -­‐	  
Usp21	   Human	   H2A	   +	   -­‐	  
2A-­‐DUB	   Human	   H2A	   +	   n.d.	  
BAP1	   Human/Drosophila	   H2A	   +	   n.d.	  
Ubp8	   Yeast	   H2B	   +	   -­‐	  
Ubp10	   Yeast	   H2B	   n.d.	   n.d.	  
Usp7	  (HAUSP)	   Human	   H2B	   n.d.	   +	  
Usp44	   Human	   H2B	   n.d.	   n.d.	  
Usp49	   Human	   H2B	   +	   -­‐	  
Usp3	   Human	   H2A	  &	  H2B	   n.d.	   n.d.	  
Usp4/Usp15	   Human	   H2A	  &	  H2B	   ?	   ?	  
Usp12/Usp46	   Xenopus	   H2A	  &	  H2B	   +	   -­‐	  
Usp22	   Human	   H2A	  &	  H2B	   +	   +	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especially	  challenging	  to	  systematically	  identify	  and	  study	  histone	  DUBs.	  In	  addition	  to	  
analyzing	  DUB	  substrate	  specificity	  in	  vitro,	  DUB	  activity	  is	  often	  assayed	  using	  in	  vivo	  
techniques.	  Typically,	  the	  histone	  DUB	  is	  either	  depleted	  or	  overexpressed	  and	  changes	  in	  
ubH2A	  and	  ubH2B	  levels	  are	  assayed	  by	  western	  blotting	  for	  ubH2A	  or	  ubH2B.	  
H2A-­‐specific	  DUBs	  include	  Usp16,	  Usp21,	  2A-­‐DUB,	  and	  BAP1	  (Joo	  et	  al.,	  2007;	  
Nakagawa	  et	  al.,	  2008;	  Scheuermann	  et	  al.,	  2010;	  Shanbhag	  et	  al.,	  2010;	  Zhu	  et	  al.,	  2007).	  In	  
each	  case,	  perturbation	  of	  the	  cellular	  levels	  of	  each	  DUB	  resulted	  in	  changes	  in	  ubH2A	  
levels,	  and	  not	  ubH2B	  levels.	  With	  the	  exception	  of	  BAP1,	  free	  histone	  or	  nucleosomal	  
substrates	  isolated	  form	  cellular	  extracts	  were	  used	  to	  assay	  deubiquitinating	  activity	  in	  
vitro.	  (Scheuermann	  et	  al.	  used	  the	  E1,	  E2,	  E3	  conjugating	  system	  to	  ubiquitinate	  H2A,	  
which	  was	  then	  used	  in	  a	  nucleosomal	  substrate	  context	  to	  analyze	  Bap1-­‐mediated	  histone	  
deubiquitination.)	  In	  the	  case	  of	  Usp16	  and	  Usp21,	  both	  DUBs	  deubiquitinated	  a	  ubH2A-­‐
containing	  nucleosomal	  substrate	  but	  could	  not	  hydrolyze	  Ub	  from	  free	  histones	  (Joo	  et	  al.,	  
2007;	  Nakagawa	  et	  al.,	  2008).	  These	  data	  indicate	  one	  mode	  of	  histone	  DUB	  regulation	  may	  
involve	  recognition	  of	  the	  ubiquitinated	  histones	  within	  a	  certain	  context	  (i.e.	  nucleosomal	  
vs.	  free	  histones).	  
In	  yeast,	  both	  Ubp8	  and	  Ubp10	  have	  been	  characterized	  as	  H2B-­‐specific	  DUBs	  
(Daniel	  et	  al.,	  2004;	  Emre	  et	  al.,	  2005;	  Henry	  et	  al.,	  2003).	  Ubp8	  is	  part	  of	  the	  Spt-­‐Ada-­‐Gcn5-­‐
Acetyltransferase	  (SAGA)	  complex,	  an	  important	  transcriptional	  co-­‐activator.	  Within	  the	  
SAGA	  complex,	  Ubp8	  and	  three	  additional	  proteins	  (Sgf11,	  Sus1,	  and	  Sgf73)	  make-­‐up	  a	  
smaller	  functional	  unit	  called	  the	  DUB	  module	  (SAGADUB)	  (Kohler	  et	  al.,	  2010).	  In	  vitro	  and	  
in	  vivo	  studies	  have	  shown	  Ubp8	  can	  only	  deubiquitinate	  H2B	  within	  the	  context	  of	  the	  
DUB	  module.	  (Daniel	  et	  al.,	  2004;	  Henry	  et	  al.,	  2003;	  Lee	  et	  al.,	  2005).	  While	  Ubp10	  also	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deubiquitinates	  H2B	  in	  vitro	  and	  in	  vivo,	  data	  suggest	  Ubp8	  and	  Ubp10	  act	  on	  different	  
subsets	  of	  ubH2B	  in	  the	  cell.	  This	  was	  demonstrated	  by	  the	  fact	  that	  a	  Δubp8Δubp10	  yeast	  
strain	  results	  in	  a	  more	  dramatic	  increase	  in	  ubH2B	  when	  compared	  to	  deletion	  of	  either	  
Ubp8	  or	  Ubp10	  alone	  (Emre	  et	  al.,	  2005).	  Furthermore,	  Ubp8	  and	  Ubp10	  localize	  to	  distinct	  
DNA	  loci,	  supporting	  the	  hypothesis	  that	  multiple	  histone	  DUBs	  exist	  to	  fine	  tune	  the	  
regulation	  of	  histone	  deubiquitination	  through	  mechanisms	  such	  as	  localization	  and	  
substrate	  specificity.	  
Other	  H2B-­‐specific	  DUBs	  include	  Usp7	  (HAUSP),	  Usp44,	  and	  Usp49	  (Fuchs	  et	  al.,	  
2012;	  van	  der	  Knaap	  et	  al.,	  2005;	  Zhang	  et	  al.,	  2013).	  Proper	  temporal	  regulation	  of	  H2B	  
deubiquitination	  by	  Usp7	  and	  Usp44	  are	  required	  for	  proper	  development.	  Specifically,	  in	  
Drosophila,	  Usp7	  is	  critical	  in	  silencing	  homeotic	  genes	  (van	  der	  Knaap	  et	  al.,	  2005)	  while	  in	  
human	  and	  mouse	  embryonic	  stem	  cells	  (ESCs),	  diminished	  Usp44	  levels	  correspond	  with	  
an	  increase	  in	  ubH2B	  levels.	  Perturbation	  of	  ubH2B	  homeostasis	  results	  in	  ESC	  
differentiation	  defects	  (Fuchs	  et	  al.,	  2012).	  On	  the	  other	  hand,	  Usp49	  perturbation	  has	  
incremental	  effects	  upon	  gene	  expression	  but	  has	  been	  identified	  as	  playing	  a	  major	  role	  in	  
the	  regulation	  of	  differential	  splicing	  (Zhang	  et	  al.,	  2013).	  
In	  addition	  to	  H2A	  and	  H2B-­‐specific	  histone	  DUBs,	  multiple	  DUBs	  have	  been	  
characterized	  that	  deubiquitinate	  both	  H2A	  and	  H2B	  including	  Usp3,	  Usp12/Usp46,	  and	  
Usp22	  (Joo	  et	  al.,	  2011;	  Nicassio	  et	  al.,	  2007).	  Deubiquitination	  of	  histones	  by	  Usp3	  is	  
required	  for	  progression	  through	  S	  phase	  and	  genome	  stability	  (Nicassio	  et	  al.,	  2007).	  
Usp12/Usp46	  regulate	  ubH2B	  levels	  at	  specific	  promoters	  during	  Xenopus	  development	  
(Joo	  et	  al.,	  2011).	  Like	  its	  yeast	  ortholog	  Ubp8,	  Usp22	  is	  a	  component	  of	  the	  SAGADUB	  in	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humans	  and	  has	  been	  shown	  to	  play	  a	  role	  in	  transcription	  activation,	  cell	  cycle	  
progression,	  and	  mRNA	  export	  (Kohler	  et	  al.,	  2008;	  Zhang	  et	  al.,	  2008;	  Zhao	  et	  al.,	  2008).	  
	  
1.6	  Usp15	  
Usp15	  is	  one	  of	  the	  most	  recent	  members	  of	  the	  histone	  DUB	  family	  (Long	  et	  al.,	  
2014).	  It	  is	  classified	  as	  a	  USP/UBP	  DUB	  and	  contains	  an	  N-­‐terminal	  Domain	  present	  in	  Ub	  
Specific	  Proteases	  (DUSP)	  domain,	  two	  Ub-­‐Like	  (UBL)	  domains,	  and	  three	  residues	  that	  
function	  as	  the	  catalytic	  triad.	  Usp15	  is	  part	  of	  a	  subfamily	  comprised	  of	  Usp4	  (61%	  
sequence	  identity)	  and	  Usp11	  (32%	  sequence	  identity),	  which	  are	  characterized	  by	  the	  
presence	  of	  both	  a	  DUSP	  domain	  and	  UBL	  domains	  (collectively	  called	  DU).	  Additionally,	  
Usp15	  contains	  a	  Zn	  finger	  necessary	  for	  deconjugating	  poly-­‐Ub	  chains	  (Hetfeld	  et	  al.,	  
2005).	  	  
Although	  the	  structure	  of	  full-­‐length	  Usp15	  has	  not	  yet	  been	  solved,	  NMR	  and	  
crystal	  structures	  of	  particular	  domains	  has	  revealed	  specific	  intra-­‐	  and	  inter-­‐molecular	  
interactions.	  The	  N-­‐terminal	  DU	  domain	  of	  Usp15	  and	  Usp4	  interact	  in	  tandem	  and	  the	  UBL	  
domain	  is	  unlikely	  to	  play	  a	  role	  in	  regulation	  through	  an	  auto-­‐inhibition	  mechanism	  
(Harper	  et	  al.,	  2011).	  In	  agreement	  with	  Harper	  et	  al.	  (2011),	  a	  recent	  study	  showed	  that	  
neither	  the	  N-­‐terminal	  or	  C-­‐terminal	  UBL	  domains	  had	  an	  auto-­‐inhibitory	  effect	  on	  Usp11	  
(Harper	  et	  al.,	  2014).	  
Unlike	  Usp15,	  Usp4	  has	  a	  deep	  hydrophobic	  pocket	  within	  the	  DUSP	  domain	  that	  
could	  contribute	  to	  differences	  in	  substrate	  specificity	  between	  Usp4	  and	  Usp15	  (Harper	  et	  
al.,	  2011).	  Despite	  this	  difference,	  there	  is	  a	  large	  overlap	  of	  Usp4/Usp15	  interacting	  
proteins	  (Sowa	  et	  al.,	  2009).	  Usp4	  shuttles	  between	  the	  nucleus	  and	  cytoplasm	  using	  NES	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and	  NLS	  signals	  recognized	  by	  importin	  α/β	  (Soboleva	  et	  al.,	  2005).	  Although	  NLS	  and	  NES	  
sequences	  have	  not	  been	  explicitly	  characterized,	  immunofluorescence	  staining	  shows	  
Usp15	  localizes	  to	  both	  the	  nucleus	  and	  cytoplasm	  (Long	  et	  al.,	  2014).	  In	  accordance,	  both	  
cytoplasmic-­‐	  and	  nuclear-­‐localized	  substrates	  have	  been	  identified	  for	  Usp15.	  
Like	  many	  other	  DUBs,	  Usp15	  can	  function	  alone	  or	  as	  part	  of	  a	  larger	  complex.	  
Usp15	  is	  part	  of	  the	  large	  COP9	  signalosome	  (CSN)	  complex.	  The	  CSN	  is	  comprised	  of	  8	  
subunits	  and	  is	  significantly	  similar	  to	  the	  26S	  proteasome	  lid	  in	  both	  sequence	  and	  
structure	  (Hetfeld	  et	  al.,	  2005).	  The	  large	  CSN	  participates	  in	  a	  wide	  array	  of	  processes,	  
including	  deneddylation	  of	  the	  cullin	  family	  of	  Ub	  ligases.	  Within	  the	  context	  of	  the	  CSN	  
complex,	  Usp15	  deubiquitinates	  and	  stabilizes	  the	  cullin	  Ub	  ligase,	  Rbx1	  (Emre	  et	  al.,	  
2005).	  Usp15	  also	  stabilizes	  other	  E3	  Ub	  ligases,	  including	  Keap1	  and	  RNF40	  (Long	  et	  al.,	  
2014;	  Villeneuve	  et	  al.,	  2013).	  
Other	  substrates	  of	  Usp15	  include	  factors	  involved	  in	  the	  immune	  response	  such	  as	  
Tripartite	  Motif	  protein	  25	  (TRIM25)	  and	  cell	  growth	  like	  TGF-­‐β	  type	  I	  receptor	  (TβRI)	  
(Eichhorn	  et	  al.,	  2012a;	  Pauli	  et	  al.,	  2014).	  Usp15	  is	  also	  involved	  in	  the	  regulation	  of	  
transcription	  through	  deubiquitination	  and	  stabilization	  of	  transcription	  factors	  such	  as	  
RE1	  Silencing	  Transcription	  factor	  (REST)	  and	  SMAD	  proteins	  (Faronato	  et	  al.,	  2013;	  Inui	  et	  
al.,	  2011).	  	  
Recently,	  Usp15	  was	  described	  as	  a	  histone	  DUB	  (Long	  et	  al.,	  2014).	  Unlike	  Usp22,	  
Usp15	  preferentially	  deubiquitinates	  ubH2B-­‐containing	  histone	  octamer	  rather	  than	  
ubH2B-­‐containing	  mononucleosomes.	  These	  results	  could	  have	  further	  implications	  in	  




1.7	  The	  role	  of	  ubH2A	  in	  transcription	  and	  DNA	  damage	  repair	  
As	  previously	  mentioned,	  ubH2A	  is	  not	  present	  in	  yeast	  but	  exists	  in	  metazoans.	  
Primarily,	  ubH2A	  is	  vital	  for	  transcriptional	  repression	  and	  DNA	  damage	  repair.	  Strikingly,	  
ubH2A	  is	  localized	  to	  transcriptionally	  silent	  regions	  of	  chromatin,	  such	  as	  the	  telomeres	  
and	  the	  inactivated	  X	  chromosome	  (Fang	  et	  al.,	  2004).	  Correspondingly,	  H2A	  Ub	  ligases	  are	  
associated	  with	  repressive	  complexes	  such	  as	  the	  Polycomb	  Repressive	  Complex	  1	  (PRC1),	  
which	  is	  targeted	  to	  regions	  of	  chromatin	  bearing	  H3K27me3	  (a	  modification	  antagonistic	  
to	  transcription	  initiation)	  (Cao	  et	  al.,	  2005;	  Wang	  et	  al.,	  2004).	  UbH2A-­‐mediated	  
transcriptional	  repression	  is	  refereed	  through	  multiple	  mechanisms.	  First,	  ubH2A	  
facilitates	  the	  compaction	  of	  chromatin	  through	  the	  recruitment	  of	  the	  linker	  histone	  H1	  
(Zhu	  et	  al.,	  2007).	  Within	  the	  context	  of	  a	  nucleosome,	  the	  C-­‐terminal	  tail	  of	  H2A,	  where	  
monoUb	  attaches,	  is	  predicted	  to	  juxtapose	  the	  globular	  domain	  of	  H1,	  perhaps	  facilitating	  
deposition	  of	  H1	  through	  direct	  interactions	  (Luger	  et	  al.,	  1997).	  Indeed,	  in	  vitro	  studies	  
showed	  ubH2A-­‐containing	  nucleosomes	  enhanced	  binding	  of	  H1	  to	  linker	  DNA	  when	  
compared	  to	  nucleosomes	  containing	  unmodified	  H2A	  (Jason	  et	  al.,	  2005).	  	  
A	  second	  method	  by	  which	  ubH2A	  represses	  transcription	  is	  through	  the	  inhibition	  
of	  Facilitates	  Chromatin	  Transcription	  (FACT)	  recruitment	  (Zhou	  et	  al.,	  2008).	  FACT	  is	  an	  
H2A/H2B	  histone	  chaperone	  comprised	  of	  two	  subunits:	  Spt16	  and	  SSRP1	  (Winkler	  et	  al.,	  
2011).	  FACT	  plays	  a	  critical	  role	  in	  chromatin	  reorganization	  in	  processes	  such	  as	  
transcription,	  DNA	  damage	  repair,	  and	  DNA	  replication	  where	  chromatin	  remodeling	  is	  
paramount.	  Because	  FACT	  recruitment	  is	  essential	  for	  transcription	  elongation	  through	  a	  
chromatin	  template,	  it’s	  not	  surprising	  that	  ubH2A-­‐mediated	  inhibition	  of	  FACT	  
recruitment	  results	  in	  transcriptional	  repression	  (Orphanides	  et	  al.,	  1999).	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UbH2A	  is	  required	  for	  signaling	  in	  the	  nucleotide	  excision	  repair	  (NER)	  pathway,	  
although	  the	  role	  of	  ubH2A	  at	  sites	  of	  DNA	  damage	  is	  somewhat	  controversial.	  One	  theory	  
suggests	  that	  ubH2A	  signals	  to	  recruit	  DNA	  damage	  repair	  machinery	  during	  nucleotide	  
excision	  repair	  (NER)	  (Bergink	  et	  al.,	  2006).	  Another	  theory	  stems	  from	  studies	  
demonstrating	  that	  ubH2A	  is	  recruited	  to	  sites	  of	  DNA	  damage	  by	  the	  histone	  chaperone,	  
CAF-­‐1,	  and	  the	  modified	  ubH2A	  persists	  for	  a	  substantial	  amount	  of	  time	  after	  UV	  
irradiation,	  suggesting	  ubH2A	  marks	  sites	  of	  prior	  DNA	  damage	  repair	  (Zhu	  et	  al.,	  2009).	  
Additionally,	  the	  histone	  variants	  H2A.X	  and	  H2A.Z	  are	  monoubiquitinated	  at	  the	  residue	  
equivalent	  to	  Lys119	  in	  H2A,	  and	  this	  modification	  is	  also	  associated	  with	  transcriptional	  
silencing	  and	  DNA	  damage	  repair.	  	  
	  
1.8	  The	  role	  of	  ubH2B	  in	  transcription	  
Unlike	  ubH2A,	  ubH2B	  is	  typically	  associated	  with	  activation	  of	  transcription.	  The	  
mechanism	  of	  ubH2B-­‐regulated	  transcription	  is	  highly	  debated	  as	  ubH2B	  has	  also	  been	  
described	  to	  have	  a	  role	  in	  transcriptional	  repression.	  Presented	  below	  is	  a	  description	  of	  
some	  of	  the	  most	  critical	  studies	  used	  to	  decipher	  the	  mechanism	  of	  ubH2B-­‐regulated	  
transcription.	  
Nucleosome	  stability	  vs.	  nucleosome	  instability—Many	  approaches	  have	  been	  used	  to	  
answer	  the	  question	  of	  whether	  ubH2B	  promotes	  nucleosome	  stability	  or	  nucleosome	  
instability.	  Because	  ubH2B	  promotes	  transcription	  elongation	  and	  the	  core	  histones	  are	  
removed	  during	  transcription	  to	  facilitate	  RNAPII	  processivity,	  some	  hypothesized	  
conjugation	  of	  a	  bulky	  Ub	  moiety	  may	  contribute	  to	  nucleosome	  instability	  (Schwabish	  and	  
Struhl,	  2004;	  Weake	  and	  Workman,	  2008).	  In	  vitro	  studies	  showed	  ubH2B	  had	  only	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moderate	  effects	  on	  mononucleosome	  stability	  when	  compared	  to	  mononucleosomes	  
containing	  unmodified	  H2B	  (Fierz	  et	  al.,	  2012b).	  In	  a	  more	  complex	  in	  vitro	  system,	  
nucleosomal	  arrays	  showed	  ubH2B	  prevented	  inter-­‐	  and	  intra-­‐nucleosomal	  interactions	  
while	  conjugation	  of	  a	  Ub-­‐like	  protein,	  Hub1,	  to	  H2B	  had	  no	  effect	  on	  chromatin	  
compaction	  (Fierz	  et	  al.,	  2010).	  These	  data	  suggest	  the	  mechanism	  of	  Ub-­‐mediated	  
chromatin	  decompaction	  cannot	  simply	  be	  attributed	  to	  the	  bulkiness	  of	  Ub.	  	  
Alternatively,	  another	  study	  analyzed	  the	  role	  of	  ubH2B	  on	  nucleosome	  stability	  in	  
vivo	  and	  concluded	  that	  ubH2B	  stabilized	  nucleosomes	  (Chandrasekharan	  et	  al.,	  2009).	  In	  
agreement	  with	  Fierz	  et	  al.,	  Ub	  did	  not	  affect	  transcription	  by	  acting	  as	  a	  “wedge”	  to	  
destabilize	  chromatin	  because	  conjugation	  of	  another	  Ub-­‐like	  protein,	  SUMO,	  did	  not	  affect	  
chromatin	  stability.	  Chandrasekharan	  and	  colleagues	  found	  ubH2B	  was	  increased	  in	  both	  
ORFs	  of	  actively	  transcribed	  genes	  and	  promoters	  of	  transcriptionally	  repressed	  genes.	  It	  
was	  suggested	  that	  ubH2B	  plays	  a	  role	  in	  elongation	  of	  active	  genes	  by	  acting	  as	  a	  
“platform”	  to	  bind	  elongation	  factors	  and	  regulates	  transcription	  initiation	  by	  stabilizing	  
nucleosomes	  at	  promoters.	  Currently,	  the	  predominantly	  accepted	  model	  is	  ubH2B	  acts	  as	  
a	  platform	  to	  recruit	  specific	  ubH2B-­‐interacting	  proteins	  (Shema-­‐Yaacoby	  et	  al.,	  2013).	  
	   Transcription	  activation:	  elongation—Several	  lines	  of	  evidence	  point	  to	  ubH2B	  as	  a	  
point	  of	  regulation	  for	  transcription	  elongation.	  Initially,	  Rad6	  and	  Bre1	  (RAD6A/B	  and	  
RNF20/RNF40	  in	  humans)	  were	  identified	  as	  localizing	  to	  promoters	  of	  actively	  
transcribed	  genes	  (Henry	  et	  al.,	  2003;	  Wood	  et	  al.,	  2003a).	  Further	  evidence	  for	  a	  positive	  
role	  for	  ubH2B	  in	  elongation	  was	  that	  the	  H2B	  ubiquitination	  machinery	  travels	  along	  with	  
RNAPII	  upon	  transcription	  activation,	  and	  this	  is	  accompanied	  by	  an	  increase	  in	  ubH2B	  in	  
ORFs	  (Xiao	  et	  al.,	  2005).	  Abolishment	  of	  Ser5	  phosphorylation	  of	  the	  RNAPII	  C-­‐terminal	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domain	  (CTD),	  a	  mark	  seen	  in	  early	  elongation,	  abrogates	  H2B	  ubiquitination.	  The	  role	  for	  
ubH2B	  in	  transcription	  elongation	  was	  further	  emphasized	  as	  perturbation	  of	  ubH2B	  levels	  
during	  ESC	  differentiation	  most	  notably	  affected	  transcript	  levels	  of	  relatively	  long	  genes	  
where	  effective	  elongation	  processivity	  is	  particularly	  critical	  (Fuchs	  et	  al.,	  2012).	  	  
	   Processive	  elongation	  via	  ubH2B	  is	  mediated	  by	  several	  different	  factors.	  In	  vitro	  
and	  in	  vivo,	  recruitment	  of	  the	  H2B	  ubiquitination	  machinery	  to	  promoters	  is	  not	  sufficient	  
to	  obtain	  ubH2B	  (Pavri	  et	  al.,	  2006;	  Wood	  et	  al.,	  2003b;	  Xiao	  et	  al.,	  2005).	  Rather,	  
elongation	  factors	  such	  FACT	  and	  the	  Polymerase	  Associated	  Factor	  (PAF)	  complex	  are	  
additionally	  required	  for	  H2B	  ubiquitination.	  Additionally,	  in	  vitro	  transcription	  assays	  
using	  purified	  factors	  showed	  ubH2B,	  FACT,	  and	  the	  PAF	  complex	  are	  absolutely	  required	  
for	  the	  elongation	  phase	  of	  transcription	  (Pavri	  et	  al.,	  2006).	  Mechanistically,	  ubH2B	  likely	  
recruits	  the	  histone	  chaperones	  FACT	  and	  SWI/SNF,	  which	  then	  promote	  transcription	  
elongation	  via	  chromatin	  remodeling	  (Pavri	  et	  al.,	  2006;	  Shema-­‐Yaacoby	  et	  al.,	  2013).	  In	  
addition	  to	  nucleosome	  disassembly,	  ubH2B	  and	  FACT	  are	  required	  for	  nucleosome	  
reassembly	  in	  the	  wake	  of	  elongating	  RNAPII	  (Fleming	  et	  al.,	  2008;	  Pavri	  et	  al.,	  2006).	  In	  
vivo,	  ubH2B	  is	  required	  for	  nucleosome	  reassembly	  in	  ORFs	  (Chandrasekharan	  et	  al.,	  
2009).	  Abolishment	  of	  either	  FACT	  or	  ubH2B	  results	  in	  transcription	  initiation	  from	  cryptic	  
starts	  sites	  and	  an	  increased	  RNAPII	  elongation	  rate,	  and	  this	  is	  attributed	  to	  poor	  
reassembly	  of	  nucleosomes	  (Fleming	  et	  al.,	  2008;	  Kaplan	  et	  al.,	  2003).	  Reciprocally,	  
transcription	  elongation	  stimulates	  H2B	  ubiquitination	  in	  that	  phosphorylation	  of	  the	  
RNAPII	  CTD	  Ser5	  by	  Cdk9	  (Bur1/Bur2	  in	  yeast)	  promotes	  H2B	  ubiquitination	  (Laribee	  et	  
al.,	  2005;	  Shchebet	  et	  al.,	  2012;	  Wood	  et	  al.,	  2005).	  Furthermore,	  H2B	  ubiquitination	  and	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Cdk9	  seem	  to	  work	  in	  a	  positive	  feedback	  loop	  as	  ubH2B	  enhances	  Cdk9	  recruitment	  and	  
Cdk9	  promotes	  H2B	  ubiquitination	  (Sanso	  et	  al.,	  2012).	  	  
	   Transcription	  activation:	  methylation-­‐dependent	  vs.	  -­‐independent	  elongation:	  
Another	  mechanism	  by	  which	  ubH2B	  promotes	  transcriptional	  elongation	  is	  through	  
recruitment	  of	  histone	  methyltransferases.	  Histone	  H3	  methylation	  at	  specific	  sites	  are	  
associated	  with	  active	  transcription	  (H3K4me	  and	  H3K79me)	  while	  methylation	  at	  other	  
sites	  are	  associated	  with	  repressed	  transcription	  (H3K9me	  and	  H3K27me).	  Initially,	  it	  was	  
described	  that	  ubH2B	  mediated	  elongation	  by	  promoting	  H3K79	  trimethylation	  
(H3K79me3)	  by	  the	  methyltransferase,	  Dot1	  (DOT1L	  in	  mammals)	  (Ng	  et	  al.,	  2002).	  Others	  
showed	  ubH2B	  is	  required	  for	  H3K4me3	  and	  H3K79me3	  by	  the	  Set1	  and	  Dot1	  
methyltransferases,	  respectively	  (Wood	  et	  al.,	  2003b).	  Histone	  methylation	  by	  these	  
complexes	  is	  mediated	  through	  both	  direct	  interactions	  between	  ubH2B	  and	  the	  
methyltransferase	  and	  by	  ubH2B-­‐mediated	  stimulation	  of	  methyltransferase	  activity	  (Lee	  
et	  al.,	  2007).	  	  
In	  contrast,	  there	  are	  reported	  instances	  where	  ubH2B	  stimulates	  elongation	  
independent	  of	  histone	  methylation.	  Specifically,	  ubH2B	  depletion	  displayed	  defects	  in	  
RNAPII	  elongation,	  independent	  of	  H3	  methylation	  status.	  Reciprocally,	  H3	  methlylation	  in	  
the	  absence	  of	  ubH2B	  isn’t	  sufficient	  to	  promote	  proper	  transcriptional	  elongation	  (Shukla	  
and	  Bhaumik,	  2007).	  Together,	  these	  data	  suggest	  ubH2B	  may	  promote	  elongation	  via	  
histone	  methylation	  on	  a	  subset	  of	  genes	  while,	  in	  other	  cases,	  ubH2B	  uses	  alternative	  
methods	  to	  promote	  transcription	  activation.	  
Transcription	  repression:	  Although	  ubH2B	  promotes	  transcriptional	  elongation	  via	  
multiple	  mechanisms,	  instances	  of	  ubH2B-­‐mediated	  transcriptional	  repression	  have	  also	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been	  reported.	  Depletion	  of	  one	  subunit	  of	  the	  H2B	  E3	  ligase,	  RNF20,	  causes	  a	  global	  
decrease	  in	  ubH2B.	  Microarray	  expression	  analysis	  of	  RNF20-­‐depleted	  cells	  showed	  that	  
while	  the	  majority	  of	  transcripts	  were	  unaffected	  by	  RNF20	  depletion,	  a	  subset	  of	  genes	  
was	  repressed	  (Shema	  et	  al.,	  2008).	  Interestingly,	  despite	  the	  decrease	  in	  transcript	  levels,	  
RNAPII	  levels	  within	  the	  coding	  regions	  was	  high,	  suggesting	  a	  defect	  in	  elongation.	  
Correspondingly,	  a	  subset	  of	  genes	  was	  activated	  upon	  RNF20	  knockdown	  (ubH2B	  was	  
antagonistic	  to	  transcription),	  indicating	  dual	  roles	  for	  ubH2B	  in	  transcription.	  	  
In	  another	  study,	  Shema	  et	  al.	  showed	  ubH2B	  inhibits	  recruitment	  of	  TFIIS,	  a	  factor	  
primarily	  responsible	  for	  promoting	  elongation	  from	  stalled	  RNAPII	  complexes	  (Shema	  et	  
al.,	  2011).	  Just	  as	  the	  H2B	  ubiquitination	  machinery	  associates	  with	  elongating	  RNAPII,	  
USP22	  (Ubp8	  in	  yeast),	  a	  component	  of	  SAGADUB,	  is	  a	  histone	  DUB	  that	  also	  travels	  along	  
with	  RNAPII	  during	  elongation.	  In	  fact,	  in	  vivo	  studies	  have	  shown	  that,	  in	  addition	  to	  H2B	  
ubiquitination,	  deubiquitination	  of	  H2B	  is	  also	  required	  for	  proper	  elongation	  (Emre	  et	  al.,	  
2005).	  Specifically,	  Ubp8	  is	  required	  for	  recruitment	  of	  the	  RNAPII	  Ser2	  kinase,	  Ctk1	  
(CTDK1	  in	  metazoans),	  which	  is	  a	  mark	  associated	  with	  transcription	  initiation	  (Wyce	  et	  
al.,	  2007).	  Together,	  these	  data	  suggest	  that,	  in	  addition	  to	  promoting	  elongation,	  ubH2B	  
may	  induce	  RNAPII	  pausing	  and	  serve	  as	  a	  “checkpoint”	  before	  initiation	  of	  progressive	  
elongation.	  Together,	  these	  data	  suggest	  that	  dynamic	  ubiquitination	  and	  deubiquitination	  
of	  H2B	  is	  required	  for	  productive	  elongation.	  
	  
1.9	  The	  role	  of	  ubH2B	  in	  DNA	  damage	  repair	  and	  DNA	  replication	  
	   Although	  ubH2A	  has	  been	  most	  strongly	  associated	  with	  DNA	  damage	  repair,	  
ubH2B	  also	  plays	  a	  role	  in	  this	  pathway.	  Upon	  induction	  of	  DNA	  double	  strand	  breaks	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(DSBs),	  RNF20/RNF40	  ubiquitinates	  H2B	  and	  this	  monoubiquitination	  is	  required	  for	  
repair	  through	  both	  the	  nonhomologous	  end	  joining	  (NHEJ)	  and	  homologous	  
recombination	  repair	  (HRR)	  pathways	  (Moyal	  et	  al.,	  2011;	  Nakamura	  et	  al.,	  2011).	  	  
A	  role	  for	  ubH2B	  has	  also	  been	  described	  during	  DNA	  replication.	  UbH2B	  and	  
RNF20/RNF40	  are	  localized	  to	  origins	  of	  replication.	  While	  ubH2B	  is	  not	  required	  for	  
initiation	  of	  replication,	  it	  is	  required	  for	  replication	  processivity	  and	  subsequent	  S-­‐phase	  
progression.	  As	  previously	  mentioned,	  ubH2B	  cooperates	  with	  FACT	  to	  reassemble	  
nucleosomes	  in	  the	  wake	  of	  elongating	  RNAPII.	  Similarly,	  ubH2B	  is	  required	  for	  FACT	  
recruitment	  and	  deposition	  of	  nucleosomes	  on	  newly	  synthesized	  DNA	  (Trujillo	  and	  Osley,	  
2012).	  
	  
1.10	  The	  role	  of	  ubH2B	  in	  mRNA	  splicing,	  processing,	  and	  export	  
	   One	  of	  the	  earlier	  reports	  of	  ubH2B’s	  involvement	  in	  mRNA	  processing	  came	  when	  
Narita	  et	  al.	  found	  that	  knockdown	  of	  CDK9	  or	  RNF20/RNF40	  resulted	  in	  an	  increase	  in	  
polyadenylated	  histone	  mRNAs	  (Narita	  et	  al.,	  2007).	  Additional	  studies	  identified	  
enrichment	  of	  RNF20/RNF40	  and	  ubH2B	  at	  the	  3’	  end	  cleavage	  site	  of	  the	  HIST1H2BD	  gene	  
and	  depletion	  of	  CDK9	  impaired	  recruitment	  of	  splicing	  factors	  to	  this	  site	  (Pirngruber	  et	  
al.,	  2009b).	  Others	  showed	  inhibition	  of	  H2B	  ubiquitination	  resulted	  in	  an	  accumulation	  of	  
polyadenylated	  mRNAs	  in	  the	  nucleus	  and	  this	  was	  caused	  by	  defects	  in	  mRNA	  processing	  
and	  export	  (Vitaliano-­‐Prunier	  et	  al.,	  2012).	  Roles	  for	  H2B	  deubiquitination	  in	  mRNA	  export	  
have	  also	  been	  suggested	  as	  Sgf73	  (Ataxin7	  in	  mammals),	  a	  component	  of	  SAGADUB	  is	  
involved	  in	  recruitment	  of	  mRNA	  export	  machinery	  (Kohler	  et	  al.,	  2008).	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Schor	  et	  al.	  demonstrated	  chromatin	  structure	  plays	  a	  role	  in	  regulating	  binding	  of	  
splicing	  factors.	  This	  group	  showed	  perturbation	  of	  chromatin	  structure	  through	  various	  
methods	  (such	  as	  histone	  hyperacetylation,	  chromatin	  decompaction,	  and	  inhibition	  of	  
transcription)	  inhibited	  proper	  recruitment	  of	  splicing	  factors	  to	  nascent	  RNA	  (Schor	  et	  al.,	  
2012).	  A	  role	  of	  ubH2B	  in	  pre-­‐mRNA	  splicing	  in	  yeast	  was	  highlighted	  upon	  the	  discovery	  
that	  combining	  a	  strain	  where	  H2B	  could	  not	  be	  ubiquitinated	  (htb-­‐K123R)	  with	  deletion	  of	  
components	  of	  the	  U2	  snRNP	  resulted	  in	  lethality	  (Shieh	  et	  al.,	  2011).	  Further	  studies	  
showed	  ubH2B	  (but	  not	  H3K4me3	  or	  H3K79me3)	  recruits	  early	  splicing	  factors	  such	  as	  U1	  
and	  U2	  snRNPs	  onto	  nascent	  RNA	  (Herissant	  et	  al.,	  2014).	  ChIP-­‐seq	  analysis	  showed	  ubH2B	  
levels	  are	  increased	  at	  intron/exon	  boundaries	  of	  highly	  expressed	  genes	  and	  high	  levels	  of	  
ubH2B	  is	  correlated	  with	  exon	  skipping	  (Jung	  et	  al.,	  2012).	  Relatedly,	  knockdown	  of	  Usp49	  
resulted	  in	  an	  increase	  in	  ubH2B	  and,	  correspondingly,	  an	  increase	  in	  alternative	  splicing.	  
This	  was	  accompanied	  by	  a	  reduction	  in	  splicing	  factors	  binding	  to	  nascent	  RNA	  and	  
chromatin	  and	  a	  concomitant	  decrease	  in	  splicing	  efficiency	  (Zhang	  et	  al.,	  2013).	  Possible	  
mechanisms	  for	  ubH2B-­‐medated	  regulation	  of	  pre-­‐mRNA	  splicing	  are	  discussed	  in	  Chapter	  
5.	  
	  
1.11	  Pre-­‐mRNA	  splicing	  
	   In	  higher	  eukaryotes,	  a	  large	  number	  of	  transcribed	  genes	  contain	  exons	  and	  
introns.	  To	  ultimately	  obtain	  a	  functional	  protein,	  introns	  from	  nascent	  RNAs	  must	  be	  
removed.	  Additionally,	  inclusion	  or	  exclusion	  of	  exons	  in	  alternative	  splicing	  increases	  the	  




A	  complex	  network	  of	  proteins	  and	  catalytic	  RNAs,	  called	  snRNPs,	  modulate	  splicing	  
(Wahl	  et	  al.,	  2009).	  As	  the	  nascent	  RNA	  emerges	  from	  the	  elongating	  RNAPII,	  it	  is	  bound	  by	  
Serine-­‐Arginine	  (SR)	  proteins.	  SR	  proteins	  typically	  contain	  a	  RS	  (Arg-­‐Ser	  repeat)	  domain	  
and	  multiple	  RNA-­‐recognition	  motifs	  (RRMs),	  which	  mediate	  interactions	  between	  RNA	  
and	  SR	  proteins.	  In	  general,	  the	  splicing	  machinery	  forms	  four	  distinct	  complexes	  to	  
execute	  removal	  of	  introns	  or	  alternative	  exons:	  complexes	  E,	  A,	  B,	  and	  C	  (Figure	  1.3)	  (Chen	  
and	  Manley,	  2009).	  Intron/exon	  regions	  typically	  encode	  four	  RNA	  sequence	  elements	  that	  
are	  recognized	  by	  the	  splicing	  machinery:	  5’	  splice	  site,	  branch	  point	  sequence	  (BPS),	  
polypyrimidine	  tract	  (PPT),	  and	  the	  3’	  splice	  site.	  Initially,	  the	  U1	  snRNP	  binds	  the	  5’	  splice	  
site	  while	  the	  splicing	  factor	  1	  (SF1)	  recognizes	  the	  branch	  point.	  The	  U2AF	  snRNP	  
interacts	  with	  both	  the	  PPT	  and	  3’	  splice	  site	  to	  complete	  the	  formation	  of	  Complex	  E.	  
Progression	  into	  Complex	  A	  is	  mediated	  by	  displacement	  of	  SF1	  followed	  by	  the	  U2	  snRNP	  
binding	  to	  the	  BPS.	  Next,	  the	  U4/U6.U5	  tri-­‐snRNP	  is	  recruited	  to	  the	  emerging	  
splicesosome	  to	  form	  Complex	  B.	  Upon	  catalytic	  activation,	  the	  spliceosome	  undergoes	  
rearrangements	  where	  the	  interaction	  between	  U6	  and	  U4	  is	  destabilized	  and	  while	  U2	  and	  
U6	  undergo	  base	  pairing.	  The	  U2,	  U5,	  and	  U6	  snRNPs	  form	  the	  catalytic	  splicing	  unit	  
(Complex	  C).	  Following	  catalysis,	  U2,	  U5,	  and	  U6	  are	  released	  from	  the	  spliced	  RNA.	  The	  
lariat	  intron	  is	  degraded	  by	  nucleases	  while	  the	  pre-­‐mRNA	  is	  destined	  for	  further	  
processing	  and	  export.	  	  
	   The	  work	  presented	  herein	  will	  focus	  on	  the	  identification	  of	  unmodified	  and	  
ubiquitinated	  histone	  binding	  proteins.	  Additionally,	  the	  functional	  relationship	  between	  
SART3	  and	  Usp15	  with	  regards	  to	  histone	  deubiquitination	  is	  explored.	  These	  studies	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provide	  further	  insight	  into	  the	  mechanisms	  by	  which	  histone	  ubiquitination	  and	  






CHAPTER	  2:	  GENERATION	  OF	  NONHYDROLYZABLE	  UBIQUITIN-­‐HISTONE	  MIMICS	  
	  
	  
1Histone	  proteins	  undergo	  various	  types	  of	  post-­‐translational	  modifications	  (PTMs)	  to	  
regulate	  dynamic	  processes	  in	  the	  cell,	  including	  transcription	  and	  DNA	  damage	  repair.	  One	  
type	  of	  histone	  PTM	  is	  the	  attachment	  of	  a	  small	  protein,	  ubiquitin	  (Ub).	  In	  eukaryotic	  
organisms,	  a	  single	  Ub	  is	  attached	  to	  specific	  lysine	  residues	  of	  histones	  H2A	  and	  H2B	  in	  a	  
modification	  that,	  unlike	  many	  other	  forms	  of	  ubiquitination	  in	  the	  cell,	  does	  not	  signal	  
degradation.	  Instead,	  both	  attachment	  and	  removal	  of	  a	  single	  Ub	  (monoUb)	  to	  histones	  has	  
been	  shown	  to	  affect	  gene	  transcription,	  pre-­‐mRNA	  splicing,	  and	  DNA	  damage	  repair,	  but	  
the	  mechanistic	  details	  by	  which	  histone	  ubiquitination	  governs	  these	  processes	  is	  not	  well	  
understood.	  In	  an	  effort	  to	  identify	  “readers”	  of	  Ub-­‐histones,	  we	  developed	  a	  
straightforward	  crosslinking	  strategy	  to	  generate	  nonhydrolyzable	  Ub-­‐histone	  mimics.	  
These	  mimics	  were	  assembled	  into	  Ub-­‐histone-­‐containing	  dimers	  or	  nucleosomes.	  We	  
demonstrate	  that	  they	  can	  be	  used	  in	  pulldown	  assays	  to	  identify	  proteins	  that	  differentiate	  
unmodified	  and	  ubiquitinated	  histones.	  Additionally,	  Ub-­‐histone	  mimics	  were	  used	  to	  




Histones	  undergo	  a	  variety	  of	  post-­‐translational	  modifications,	  including	  
phosphorylation,	  acetylation,	  methylation,	  citrullation,	  and	  ubiquitination	  (Kouzarides,	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  This	  chapter	  is	  related	  to	  Long,	  L.,	  Furgason,	  M.,	  and	  Yao,	  T.	  (2014)	  Generation	  of	  
nonhydrolyzable	  ubiquitin-­‐histone	  mimics.	  Methods.	  (Submitted	  for	  review	  in	  April	  2014).	  
Figure	  2.1	  is	  included	  in	  the	  submitted	  manuscript.	  Furgason,	  M.	  developed	  the	  Ub-­‐histone	  




2007;	  Patel	  and	  Wang,	  2013).	  Addition	  and	  removal	  of	  these	  modifications	  is	  crucial	  for	  the	  
proper	  regulation	  of	  many	  cellular	  processes	  including	  DNA	  damage	  repair,	  DNA	  
replication,	  and	  transcription.	  Although	  many	  of	  these	  modifications	  have	  been	  correlated	  
with	  specific	  events	  in	  the	  cell,	  in	  many	  cases,	  the	  mechanisms	  by	  which	  these	  
modifications	  are	  modulated	  remain	  elusive.	  One	  approach	  used	  to	  untangle	  these	  detailed	  
mechanisms	  is	  to	  identify	  proteins	  that	  preferentially	  bind	  either	  the	  modified	  histone	  or	  
the	  unmodified	  histone,	  in	  effect,	  identifying	  modulators	  of	  histone	  modification-­‐driven	  
events.	  Typically,	  biotinylated	  synthetic	  histone	  peptides	  that	  have	  been	  methylated,	  
acetylated,	  or	  phosphorylated	  at	  specific	  residues	  are	  incubated	  with	  nuclear	  extract	  and	  
bound	  proteins	  are	  identified	  using	  LC-­‐MS/MS.	  	  
In	  metazoans,	  both	  histone	  H2A	  and	  H2B	  are	  monoubiquitinated	  at	  specific	  lysine	  
residues	  (K119	  and	  K120,	  respectively)	  (Osley,	  2006).	  Whereas	  H2A	  ubiquitination	  is	  
associated	  with	  transcriptional	  repression	  and	  silencing,	  H2B	  ubiquitination	  is	  associated	  
with	  actively	  transcribed	  regions	  and	  has	  multiple	  roles	  in	  initiation,	  elongation	  and	  mRNA	  
processing	  (reviewed	  in	  (Weake	  and	  Workman,	  2008;	  Wright	  et	  al.,	  2012)).	  Both	  H2A	  and	  
H2B	  ubiquitination	  have	  also	  been	  implicated	  in	  DNA	  double	  strand	  break	  (DSB)	  repair	  
(Pinder	  et	  al.,	  2013).	  Additionally,	  H2B	  ubiquitination	  has	  been	  reported	  to	  enhance	  
nucleosome	  assembly	  during	  DNA	  replication	  in	  yeast	  (Trujillo	  and	  Osley,	  2012).	  Despite	  
accumulating	  evidence	  of	  the	  functional	  significance	  of	  histone	  ubiquitination,	  surprisingly	  
little	  is	  known	  about	  how	  the	  modification	  elicits	  specific	  functions.	  This	  is	  in	  part	  due	  to	  
difficulty	  in	  obtaining	  chemically-­‐defined	  Ub-­‐histone	  conjugates	  for	  in	  vitro	  studies.	  
The	  identification	  of	  ubH2A	  and	  ubH2B	  effectors	  through	  pull-­‐down	  studies	  has	  
proven	  problematic	  as	  obtaining	  large	  amounts	  highly	  purified	  monoubiquitinated	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histones	  is	  difficult.	  First,	  purification	  of	  ubiquitinated	  histones	  from	  cell	  extracts	  results	  in	  
isolation	  of	  a	  heterogenous	  population	  of	  histones,	  which	  in	  addition	  to	  monoubiquitinated	  
H2A	  and	  H2B,	  contain	  a	  variety	  of	  naturally	  occurring	  PTMs.	  Secondly,	  preparing	  
ubiquitinated	  histones	  using	  the	  E1,	  E2,	  and	  E3	  system	  in	  vitro	  results	  in	  a	  low	  yield	  of	  
ubiquitinated	  histones,	  making	  biochemical	  studies	  with	  these	  substrates	  difficult	  (Kim	  et	  
al.,	  2009;	  Kim	  and	  Roeder,	  2011).	  This	  is	  further	  complicated	  by	  the	  fact	  that	  the	  product	  
formed	  by	  ubiquitination	  with	  the	  native	  enzymes	  results	  in	  the	  additional	  conjugation	  of	  
Ub	  at	  sites	  other	  than	  H2BK120	  (Kim	  and	  Roeder,	  2011).	  Hydrolyzable	  forms	  of	  ubH2A	  and	  
ubH2B	  have	  been	  synthesized	  using	  both	  protein	  ligation	  and	  peptide	  synthesis,	  but	  these	  
methods	  are	  cumbersome	  and	  technically	  challenging	  (Fierz	  et	  al.,	  2012b;	  Haj-­‐Yahya	  et	  al.,	  
2012;	  Kumar	  et	  al.,	  2011;	  Long	  et	  al.,	  2014;	  McGinty	  et	  al.,	  2008).	  To	  overcome	  these	  
obstacles,	  we	  have	  developed	  a	  strategy	  to	  synthesize	  a	  nonhydrolyzable	  ubiquitinated	  
histone	  mimic	  that	  we	  can	  purify	  in	  large	  amounts	  to	  homogeneity	  and	  is	  impervious	  to	  
deubiquitination	  in	  the	  presence	  of	  cellular	  extracts.	  Here	  we	  describe	  in	  detail	  the	  method	  
of	  producing	  these	  ub-­‐histone	  mimics	  and	  offer	  examples	  of	  using	  these	  mimics	  to	  
understand	  how	  the	  Ub	  modification	  modulates	  chromatin	  structure	  and	  function.	  	  
	  
2.2	  Experimental	  Procedures	  
2.2.1	  Generation	  of	  ubiquitinated	  histone	  mimics	  
Expression	  and	  purification	  of	  recombinant	  proteins—A	  6xHis	  tag	  was	  inserted	  at	  the	  
N-­‐terminus	  of	  Ub	  to	  facilitate	  purification	  of	  Ub-­‐histone	  crosslinked	  products.	  To	  express	  
His6-­‐Ub(G76C),	  BL21(DE3)	  E.	  coli	  bearing	  the	  expression	  plasmid	  were	  grown	  to	  log	  phase	  
and	  expression	  was	  induced	  with	  0.4	  mM	  IPTG	  at	  37	  °C	  for	  3	  h.	  Cell	  lysis	  (Protocol	  9)	  and	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batch	  purification	  under	  native	  conditions	  using	  Ni-­‐NTA	  agarose	  (Protocol	  12)	  were	  
performed	  according	  to	  the	  manufacturer’s	  protocol	  (QIAGEN,	  2003).	  	  The	  only	  
modification	  was	  that	  all	  buffers	  were	  supplemented	  with	  5	  mM	  β-­‐mercaptoethanol	  (βME).	  
Eluates	  were	  then	  dialyzed	  against	  10	  mM	  Tris,	  pH	  8.0,	  50	  mM	  NaCl,	  0.2	  mM	  EDTA,	  10	  mM	  
βME	  at	  4	  °C	  overnight.	  To	  remove	  minor	  impurities,	  dialyzed	  eluates	  were	  passed	  through	  
Q	  Sepharose	  Fast	  Flow	  resin	  (GE	  Healthcare).	  His6-­‐Ub(G76C)	  remained	  in	  the	  flow-­‐
through,	  which	  was	  dialyzed	  exhaustively	  against	  1	  mM	  HOAc	  before	  lyophilization.	  The	  
use	  of	  1	  mM	  HOAc	  in	  the	  final	  step	  prior	  to	  lyophilization	  helps	  to	  prevent	  oxidation	  of	  
cysteine	  thiols.	  Typically,	  200	  mg	  of	  purified	  proteins	  were	  obtained	  from	  4-­‐liter	  cultures.	  	  
Site-­‐directed	  mutagenesis	  was	  used	  to	  introduce	  the	  K119C	  mutation	  in	  human	  
H2A.	  Mutant	  histones	  were	  expressed	  and	  purified	  according	  to	  Dyer	  et	  al.	  (Dyer	  et	  al.,	  
2004)	  with	  the	  modification	  that	  they	  were	  dialyzed	  in	  1	  mM	  HOAc	  before	  lyophilization.	  
	   Crosslinking—Lyophilized	  His6-­‐Ub(G76C)	  or	  H2A(K119C)	  was	  resuspended	  in	  10	  
mM	  HOAc,	  7	  M	  urea	  at	  ~10	  mg/mL,	  as	  the	  crosslinking	  reaction	  is	  more	  efficient	  when	  the	  
reactants	  are	  at	  high	  concentrations.	  As	  a	  quality	  control	  step,	  Ellman’s	  reagent	  (5,5'-­‐dithio-­‐
bis-­‐(2-­‐nitrobenzoic	  acid),	  also	  known	  as	  DTNB)	  was	  used	  to	  determine	  the	  percentage	  of	  
cysteines	  in	  the	  reduced	  state	  for	  each	  batch	  of	  purified	  protein.	  Briefly,	  an	  aliquot	  of	  
dissolved	  His6-­‐Ub(G76C)	  or	  H2A(K119C)	  is	  diluted	  in	  stock	  buffer	  (100	  mM	  NaPi,	  pH	  7.5,	  1	  
mM	  EDTA)	  to	  a	  final	  concentration	  of	  25	  mM.	  1	  mL	  of	  the	  diluted	  protein	  is	  then	  mixed	  
with	  0.5	  mL	  of	  0.4	  mM	  DTNB	  at	  room	  temperature	  for	  30	  min.	  A	  yellow	  color	  will	  develop	  
and	  absorbance	  at	  412	  nm	  is	  measured	  to	  determine	  the	  sulfhydryl	  concentration	  using	  an	  
extinction	  coefficient	  of	  14150	  M-­‐1cm-­‐1.	  Subsequently,	  sulfhydryl	  concentrations	  are	  used	  in	  
place	  of	  protein	  concentrations	  to	  reflect	  true	  concentrations	  of	  the	  reactants.	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   Pilot-­‐scale	  crosslinking	  reactions	  were	  performed	  with	  varying	  Ub:histone	  ratios	  to	  
determine	  the	  optimal	  condition	  with	  each	  protein	  preparation	  (Figure	  2.1B).	  We	  found	  
that	  a	  Ub:histone	  molar	  ratio	  of	  1:2	  usually	  gave	  the	  highest	  yield.	  A	  typical	  crosslinking	  
reaction	  is	  performed	  as	  follows:	  
(1) Mix	  dissolved	  His6-­‐Ub(G76C)	  and	  H2A(K119C)	  at	  1:2	  molar	  ratio	  (i.e.,	  in	  terms	  of	  
reduced-­‐cysteine	  concentrations)	  in	  50	  mM	  sodium	  tetraborate,	  pH	  8.5,	  6	  M	  urea.	  	  
(2) Add	  1	  M	  TCEP	  (tris(2-­‐carboxyethyl)phosphine)	  stock	  (adjusted	  to	  neutral	  pH)	  to	  
reach	  5	  mM	  final	  concentration	  and	  incubate	  at	  room	  temperature	  for	  30	  min.	  	  
(3) Freshly	  prepare	  0.1	  M	  1,3-­‐dichloroacetone	  in	  N,N’-­‐dimethylformamide.	  Add	  an	  
amount	  of	  crosslinker	  equal	  to	  one-­‐half	  of	  the	  total	  sulfhydryl	  groups	  in	  the	  reaction.	  
After	  incubation	  on	  ice	  for	  30	  min,	  the	  reaction	  is	  stopped	  with	  the	  addition	  of	  5	  mM	  
βME.	  	  
The	  resulting	  products	  contain	  a	  mixture	  of	  unreacted	  Ub	  and	  H2A,	  Ub*Ub,	  ub*H2A	  and	  
H2A*H2A;	  these	  are	  separated	  in	  the	  subsequent	  purification	  steps.	  	  
	   Purification	  of	  the	  Ub-­‐histone	  mimic—Unreacted	  histones	  are	  removed	  by	  nickel	  
affinity	  purification.	  The	  crosslinking	  reaction	  was	  diluted	  1:10	  in	  denaturing	  binding	  
buffer	  (50	  mM	  NaPi,	  pH	  8,	  300	  mM	  NaCl,	  6	  M	  urea,	  10	  mM	  imidazole,	  5	  mM	  βME)	  and	  
incubated	  with	  Ni-­‐NTA	  agarose	  at	  4	  °C	  for	  1	  h.	  After	  extensive	  washes	  with	  the	  binding	  
buffer,	  bound	  proteins	  were	  eluted	  with	  the	  binding	  buffer	  supplemented	  with	  250	  mM	  
imidazole	  (Figure	  2.1C).	  Eluates	  will	  contain	  Ub,	  Ub*Ub	  and	  ub*H2A.	  The	  presence	  of	  Ub	  
and	  Ub*Ub	  will	  not	  interfere	  with	  subsequent	  refolding	  of	  histone	  dimers	  or	  octamers.	  The	  
mixture	  can	  be	  dialyzed	  into	  water	  and	  lyophilized	  for	  long-­‐term	  storage.	  Alternatively,	  it	  
can	  be	  directly	  used	  in	  the	  subsequent	  refolding	  steps	  without	  change	  of	  buffer.	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   Reconstitution	  of	  histone	  dimers	  or	  octamers	  containing	  Ub-­‐histone	  mimics—
Reconstitution	  of	  histone	  dimers	  or	  octamers	  was	  done	  as	  described	  by	  Dyer	  et	  al.	  (Dyer	  et	  
al.,	  2004).	  Lyophilized	  proteins	  were	  resuspended	  in	  unfolding	  buffer	  (6	  M	  guanidinium	  
hydrochloride,	  20	  mM	  Tris,	  pH	  7.5,	  5	  mM	  DTT)	  and	  allowed	  to	  unfold	  for	  at	  least	  30	  min	  
prior	  to	  determining	  protein	  concentration	  by	  measuring	  the	  absorbance	  at	  276	  nm.	  As	  the	  
eluates	  from	  the	  nickel	  affinity	  purification	  contain	  a	  mixture	  of	  Ub-­‐containing	  species,	  the	  
concentration	  of	  ub*H2A	  was	  estimated	  by	  SDS-­‐PAGE	  and	  Coomassie	  staining.	  For	  dimer	  
reconstitution,	  ub*H2A	  and	  H2B	  were	  mixed	  at	  equal	  molar	  ratio.	  Slight	  excess	  of	  H2B	  can	  
be	  used	  to	  ensure	  all	  ub*H2A	  is	  incorporated	  into	  the	  dimer.	  For	  octamer	  reconstitution,	  
ub*H2A,	  H2B,	  H3	  and	  H4	  were	  mixed	  at	  equal	  molar	  ratio.	  Total	  protein	  concentration	  
should	  be	  ~	  2	  mg/mL.	  These	  mixtures	  were	  then	  dialyzed	  into	  refolding	  buffer	  (10	  mM	  
Tris,	  pH	  7.5,	  2	  M	  NaCl,	  1	  mM	  EDTA,	  5	  mM	  βME).	  	  
After	  refolding,	  histone	  dimers	  or	  octamers	  were	  purified	  by	  gel	  filtration	  on	  a	  
Superdex	  75	  or	  Superdex	  200	  column,	  respectively	  (Dyer	  et	  al.,	  2004).	  Typically,	  excess	  
histones	  will	  elute	  as	  aggregates	  in	  the	  void	  volume,	  whereas	  the	  much	  smaller	  Ub	  and	  
Ub*Ub	  will	  elute	  later	  (Figure	  2.1D).	  Purified	  dimers	  or	  octamers	  are	  concentrated	  to	  ~	  3.5	  
mg/mL	  with	  Amicon	  Ultra	  Centrifugal	  filters.	  Octamers	  were	  supplemented	  with	  glycerol	  
to	  20%	  v/v	  and	  stored	  at	  -­‐80	  °C	  in	  small	  aliquots.	  
	   	  
2.2.2	  Assembly	  of	  mononucleosomes	  
Purification	  of	  147	  bp	  DNA—The	  147	  bp	  fragment	  containing	  the	  601	  nucleosome	  
positioning	  sequence	  was	  purified	  as	  previously	  described	  (Dyer	  et	  al.,	  2004).	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Amplification	  and	  purification	  of	  biotinylated	  183	  bp	  DNA—The	  biotinylated	  183	  bp	  
DNA	  fragment	  containing	  the	  147	  bp	  601	  positioning	  sequence	  was	  amplified	  by	  PCR	  
(Forward	  primer:	  5’-­‐GCTGTTCAATACATGCACAGGATGTATATATC-­‐3’,	  Reverse	  primer:	  5’-­‐
Biotin-­‐TACACGTACTAGAAGCTTCCCTGGAGAATCCCGGTGC-­‐3’).	  1	  ng	  of	  pGEM	  601	  was	  used	  
as	  the	  DNA	  template	  in	  a	  PCR	  mixture	  containing	  450	  nM	  of	  each	  forward	  and	  reverse	  
primers,	  200	  μM	  dNTPs,	  5	  uL	  DMSO,	  1x	  Dream	  Taq	  buffer,	  and	  0.5	  μL	  Dream	  Taq	  in	  a	  final	  
volume	  of	  100	  μL.	  The	  amplification	  cycle	  was	  as	  follows:	  
1) 4	  minutes	  at	  94	  °C	  
2) 30	  seconds	  at	  94	  °C	  
3) 30	  seconds	  at	  61	  °C	  
4) 40	  seconds	  at	  72	  °C	  
• Repeat	  steps	  2-­‐4	  for	  40	  cycles	  
5) 10	  minutes	  at	  72	  °C	  
6) Hold	  at	  10	  °C	  
PCR	  products	  were	  purified	  on	  a	  Mono	  Q	  column	  using	  a	  0.46-­‐0.82	  M	  linear	  gradient	  
of	  NaCl	  over	  20	  column	  volumes	  in	  a	  buffer	  of	  20	  mM	  Tris,	  pH	  7.5,	  and	  0.1	  mM	  EDTA.	  The	  
desired	  biotinylated	  183	  bp	  (B-­‐183mer)	  eluted	  from	  the	  column	  at	  approximately	  71%	  B	  
(0.74	  M	  NaCl)	  (Figure	  2.5B).	  Elution	  fractions	  were	  pooled	  and	  2.5	  times	  of	  100%	  EtOH	  
(v/v)	  was	  added	  to	  the	  elutions	  and	  incubated	  at	  -­‐20	  °C	  for	  at	  least	  1	  hour.	  The	  solution	  
was	  then	  transferred	  to	  1.7	  mL	  eppie	  tubes.	  Glycogen	  was	  added	  at	  20	  μg/mL	  prior	  to	  
centrifugation	  at	  14,000	  xg	  at	  4	  °C	  for	  30	  minutes.	  DNA	  pellets	  were	  washed	  twice	  with	  
70%	  EtOH,	  air	  dried,	  and	  resuspended	  in	  TE	  buffer	  (10	  mM	  Tris,	  pH	  8.0,	  0.1	  mM	  EDTA).	  We	  
obtained	  a	  yield	  of	  approximately	  285	  μg	  of	  B-­‐183mer	  from	  50	  PCR	  reactions.	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Assembly	  of	  mononucleosomes	  containing	  unmodified	  histones	  and	  Ub-­‐histone	  
mimics—Histone	  octamers	  containing	  ub*H2A	  (at	  K119)	  or	  ub*H2B	  (at	  K120)	  were	  
assembled	  into	  mononucleosomes	  by	  salt	  dilution	  (McGinty	  et	  al.,	  2008).	  Dilution	  buffers	  
were	  supplemented	  with	  0.1	  mg/mL	  BSA.	  For	  nucleosomes	  assembled	  using	  the	  B-­‐183mer	  
DNA	  fragment,	  reactions	  were	  diluted	  in	  dilution	  buffer	  #1	  (10	  mM	  Tris,	  pH	  7.6,	  1	  mM	  
EDTA)	  only	  until	  the	  final	  NaCl	  concentration	  was	  250	  mM	  (final	  volume	  of	  80	  μL	  per	  
reconstitution).	  DNA	  and	  histone	  octamers	  were	  mixed	  at	  an	  initial	  concentration	  of	  1.5	  
μM.	  (For	  assembly	  of	  nucleosomes	  with	  the	  147	  bp	  DNA,	  an	  initial	  concentration	  of	  1.15	  uM	  
of	  DNA	  and	  octamer	  was	  used.)	  Mononucleosomes	  were	  assembled	  at	  DNA:octamer	  ratios	  
of	  1:1,	  1:1.2,	  1:1.4,	  and	  1:1.6	  to	  determine	  the	  ideal	  DNA:octamer	  ratio.	  Nucleosomes	  were	  
separated	  on	  a	  6%	  TBE	  gel	  and	  visualized	  by	  EtBr	  staining.	  	  
Immobilization	  of	  B-­‐183mer	  nucleosomes	  to	  magnetic	  strepavitdin	  beads—124.5	  μg	  
of	  Dynabeads	  (Dynabeads®	  MyOneTM	  Streptavidin	  T1,	  Invitrogen)	  were	  washed	  once	  with	  
50	  μL	  of	  1x	  B&W	  buffer	  (5	  mM	  Tris,	  pH	  7.5,	  0.5	  mM	  EDTA,	  1	  M	  NaCl)	  and	  twice	  with	  50	  μL	  
of	  nucleosome	  reconstitution	  buffer	  containing	  250	  mM	  NaCl	  (10	  mM	  Tris,	  pH	  7.6,	  1	  mM	  
EDTA).	  Assuming	  90%	  of	  DNA	  in	  a	  single	  reconstitution	  reaction	  formed	  nucleosomes,	  1.63	  
μg	  of	  nucleosomal	  DNA	  was	  added	  to	  the	  beads	  (70	  μL	  of	  an	  80	  uL	  nucleosome	  
reconstitution	  reaction)	  and	  was	  incubated	  at	  25	  °C	  for	  30	  minutes	  in	  a	  Thermomixer	  at	  
1200	  rpm.	  The	  unbound	  fraction	  was	  removed	  and	  the	  bound	  fraction	  was	  washed	  twice	  
with	  70	  μL	  of	  reconstitution	  buffer	  containing	  250	  mM	  NaCl.	  (Dynabeads	  were	  immobilized	  
by	  a	  brief	  centrifugation	  and	  a	  30	  second	  incubation	  on	  magnetic	  eppendorf	  tube	  stands.)	  
To	  analyze	  the	  fraction	  of	  DNA	  bound	  to	  beads,	  5	  uL	  of	  0.1%	  SDS,	  10	  mM	  EDTA	  was	  added	  
to	  5	  μL	  of	  the	  input,	  bound,	  and	  unbound	  fractions.	  Samples	  were	  boiled	  for	  5	  minutes,	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separated	  on	  a	  2%	  agarose	  gel,	  and	  visualized	  by	  EtBr	  staining.	  Typically,	  approximately	  
70-­‐85%	  of	  biotinylated	  nucleosomes	  were	  seen	  in	  the	  bound	  fraction	  (Figure	  2.5D).	  
	  
2.2.3	  Generation	  of	  isotope-­‐labeled	  nuclear	  extracts	  
SILAC	  media—SILAC	  media	  with	  light	  isotope-­‐	  or	  heavy	  isotope-­‐containing	  lysine	  
and	  arginine	  were	  made	  as	  previously	  described	  (Ong	  and	  Mann,	  2006).	  Briefly,	  DMEM	  
containing	  10%	  of	  dialyzed	  FBS,	  100	  units/mL	  pen/strep	  (Life	  Technologies),	  100	  mg/L	  
lysine,	  and	  84	  mg/L	  arginine	  was	  filter	  sterilized	  using	  22	  μm	  filter	  (Millipore	  SCGPS05RE).	  
DMEM	  was	  kept	  at	  4	  °C	  for	  long-­‐term	  storage.	  
Trial	  incorporation	  of	  heavy	  isotope-­‐labeled	  amino	  acids—HeLa	  cells	  were	  plated	  in	  
two	  6	  cm	  dishes	  in	  either	  light	  isotope-­‐	  or	  heavy	  isotope-­‐containing	  media	  (abbreviated	  
light	  and	  heavy).	  Cells	  were	  allowed	  to	  undergo	  approximately	  8	  generations	  before	  
harvesting	  in	  1xPBS,	  1%	  NP-­‐40,	  2	  mM	  EDTA,	  0.1%	  SDS,	  and	  PIC	  (protease	  inhibitor	  
cocktail:	  1	  mM	  PMSF,	  1	  mg/mL	  pepstatin,	  1	  mg/mL	  leupeptin,	  1	  mg/mL	  aprotinin)	  and	  
lysing	  on	  ice	  for	  30	  minutes.	  Lysates	  were	  centrifuged	  at	  14,000	  xg	  at	  4	  °C	  for	  10	  minutes	  
and	  protein	  concentration	  was	  measure	  using	  BCA	  protein	  assay	  kit.	  20	  μg	  of	  light	  isotope-­‐	  
and	  heavy	  isotope-­‐labeled	  lysates	  were	  separated	  on	  a	  12.5%	  SDS-­‐PAGE	  gel	  and	  stained	  
with	  Coomassie.	  To	  maintain	  a	  keratin-­‐free	  environment,	  glass	  plates	  were	  soaked	  in	  a	  
0.5%	  SDS	  solution	  before	  pouring	  the	  SDS-­‐PAGE	  gels.	  Five	  bands	  present	  in	  both	  the	  light	  
and	  heavy	  lysates	  were	  excised	  and	  processed	  according	  to	  the	  CSU	  Proteomics	  Facility	  
trypsin	  in-­‐gel	  digestion	  protocol.	  Samples	  were	  analyzed	  by	  MALDI-­‐TOF	  to	  determine	  the	  
percent	  of	  heavy	  isotope	  incorporation.	  Identifying	  corresponding	  peptides	  in	  the	  light	  and	  
heavy	  extracts	  and	  verifying	  the	  absence	  of	  an	  unlabeled	  peptide	  in	  the	  heavy	  spectra	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determined	  percent	  incorporation	  of	  the	  heavy	  amino	  acids.	  Over	  50	  peptides	  were	  
analyzed	  to	  determine	  that	  100%	  of	  the	  analyzed	  peptides	  incorporated	  the	  heavy	  isotope-­‐
labeled	  amino	  acids.	  
Large-­‐scale	  incorporation	  of	  heavy	  isotopes—HeLa	  cells	  were	  plated	  in	  two	  6	  cm	  
dishes,	  gradually	  expanded	  into	  42	  x	  15	  cm	  dishes,	  and	  grown	  to	  confluency.	  Nuclear	  
extract	  was	  purified	  as	  previously	  described	  (Abmayr	  et	  al.,	  2006).	  Approximately	  10	  mL	  of	  
nuclear	  extract	  was	  obtained	  at	  either	  5.00	  mg/mL	  (light	  isotope-­‐labeled	  extract)	  or	  3.37	  
mg/mL	  (heavy	  isotope-­‐labeled	  extract).	  
	  
2.2.4	  Pulldown	  assays	  with	  Ub-­‐histone	  mimics	  
	   Histone	  dimer	  pulldown—Flag-­‐tagged	  histone	  dimers	  were	  prepared	  as	  described	  
above.	  These	  include:	  Flag-­‐H2A/H2B,	  H2A/Flag-­‐H2B,	  ub*H2A/Flag-­‐H2B,	  and	  Flag-­‐
H2A/ub*H2B.	  Typically,	  20	  μg	  histone	  dimers	  or	  7	  μg	  Flag-­‐Ub	  (BostonBiochem)	  in	  
refolding	  buffer	  was	  diluted	  to	  150	  μl	  to	  adjust	  salt	  concentration	  to	  300	  mM	  NaCl	  and	  then	  
incubated	  with	  20	  μl	  anti-­‐Flag	  M2	  affinity	  gel	  (Sigma	  A2220)	  at	  4	  °C	  for	  at	  least	  2	  h.	  
Unbound	  proteins	  were	  removed	  and	  the	  agarose	  beads	  were	  washed	  twice	  with	  high-­‐salt	  
binding	  buffer	  (10	  mM	  Hepes,	  pH	  7.9,	  470	  mM	  NaCl,	  10	  mM	  KCl,	  1.5	  mM	  MgCl2,	  0.2%	  Triton	  
X-­‐100,	  10%	  glycerol).	  	  
	   HeLa	  nuclear	  extract	  was	  prepared	  from	  HeLa	  S3	  cells	  as	  previously	  described	  
(Abmayr	  et	  al.,	  2006).	  It	  was	  then	  diluted	  to	  2.5	  mg/mL	  with	  high-­‐salt	  binding	  buffer.	  
Additional	  NaCl	  was	  added	  to	  reach	  the	  final	  concentration	  of	  470	  mM.	  To	  remove	  
contaminating	  proteases,	  DNA,	  and	  RNA,	  nuclear	  extract	  was	  routinely	  supplemented	  with	  
0.5	  mM	  PMSF,	  1	  μg/mL	  pepstatin,	  1	  μg/mL	  leupeptin,	  20	  μg/mL	  DNase	  I	  and	  20	  μg/mL	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RNase	  A,	  and	  then	  incubated	  at	  room	  temperature	  for	  30	  min	  and	  centrifuged	  at	  18,000	  x	  g	  
for	  30	  min	  at	  4	  °C	  to	  remove	  precipitates.	  
Typically,	  500	  μg	  nuclear	  extract	  was	  added	  to	  each	  pulldown	  reaction;	  tubes	  were	  
incubated	  for	  3	  h	  at	  4	  °C	  with	  rotation.	  Unbound	  proteins	  were	  removed	  and	  the	  agarose	  
beads	  were	  washed	  3-­‐times	  with	  200	  μL	  high-­‐salt	  binding	  buffer.	  Bound	  proteins	  were	  
eluted	  by	  incubation	  with	  3xFlag	  peptide	  (Sigma)	  at	  0.2	  mg/mL	  in	  binding	  buffer	  at	  4	  °C	  for	  
30	  min.	  The	  elution	  step	  was	  repeated	  and	  eluates	  were	  pooled.	  Fractions	  of	  the	  eluates	  (5-­‐
10%)	  were	  analyzed	  by	  SDS-­‐PAGE	  and	  silver	  staining.	  The	  rest	  of	  the	  eluates	  were	  subject	  
to	  LC-­‐MS/MS	  to	  identify	  the	  bound	  proteins.	  	  
SILAC	  Nucleosome	  Affinity	  Purification	  (SNAP)—Nucleosome	  pulldown	  experiments	  
were	  performed	  using	  the	  conditions	  in	  Bartke	  et	  al.	  as	  a	  guideline	  (Bartke	  et	  al.,	  2010).	  
Initial	  pulldown	  experiments	  were	  performed	  using	  1/12	  the	  amount	  of	  nucleosome	  
material	  used	  by	  Bartke	  et	  al.	  so	  reactions	  were	  scaled	  down	  accordingly.	  Nucleosomes	  
were	  bound	  to	  Dynabeads	  as	  described	  above.	  Each	  reaction	  was	  incubated	  with	  41.7	  µg	  of	  
light	  isotope-­‐	  or	  heavy	  isotope-­‐labeled	  extract	  in	  a	  final	  volume	  of	  85	  μL	  in	  SNAP	  binding	  
buffer	  (20	  mM	  Hepes,	  pH	  7.9,	  150	  mM	  NaCl,	  0.2	  mM	  EDTA,	  20%	  glycerol,	  0.1%	  NP-­‐40,	  1	  
mM	  DTT,	  and	  PIC)	  while	  rocking	  at	  4	  °C	  for	  4	  hours.	  Reactions	  included	  unmodified	  
nucleosomes	  (wt)	  +	  light	  extract	  (wt-­‐L),	  wt	  +	  heavy	  extract	  (wt-­‐H),	  ub*H2A-­‐L,	  ub*H2A-­‐H,	  
ub*H2B-­‐L,	  and	  ub*H2B-­‐H.	  Note	  that	  wt	  nucleosome-­‐containing	  reactions	  were	  duplicated	  
because	  they	  will	  be	  compared	  with	  both	  ub*H2A	  and	  ub*H2B-­‐containing	  reactions	  
downstream.	  After	  incubation	  with	  the	  extracts,	  beads	  were	  	  washed	  3	  times	  for	  5	  minutes	  
each	  at	  4	  °C	  in	  85	  μL	  binding	  buffer.	  Samples	  were	  eluted	  by	  the	  addition	  of	  20	  μL	  of	  0.1%	  
SDS,	  10	  mM	  EDTA	  at	  37	  °C	  for	  5	  minutes.	  12%	  of	  the	  elution	  was	  separated	  by	  SDS-­‐PAGE	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on	  a	  4-­‐18%	  gradient	  gel.	  Proteins	  were	  stained	  using	  SYPRO	  Ruby	  and	  imaged	  on	  the	  
Typhoon	  imager.	  
Densitometry	  measurements	  with	  Image	  Quant	  software	  were	  used	  to	  quantitate	  3	  
bands	  that	  are	  presumably	  DNA-­‐binding	  proteins	  in	  the	  elutions.	  We	  used	  the	  quantity	  of	  
these	  proteins	  to	  normalize	  between	  pulldown	  reactions	  assuming	  that	  these	  proteins	  
(most	  likely	  PARP1,	  Ku70	  and	  Ku80)	  bind	  to	  different	  nucleosomes	  with	  equal	  affinity.	  
Marker	  intensities	  were	  also	  used	  in	  normalization	  to	  account	  for	  differences	  in	  staining	  
efficiency	  between	  gels.	  Based	  on	  these	  quantitations,	  equal	  amounts	  of	  eluted	  proteins	  
from	  different	  pulldowns	  were	  mixed	  in	  a	  1:1	  ratio	  in	  a	  final	  volume	  of	  <50	  μL	  prior	  to	  
analysis	  by	  trypsin	  digest	  and	  quantitative	  LC-­‐MS/MS.	  (Note:	  Initially	  the	  concentration	  of	  
the	  light	  extract	  was	  underestimated.	  Pull-­‐downs	  using	  heavy	  extract	  were	  repeated	  to	  
generate	  a	  higher	  yield	  of	  bound	  proteins.)	  
	   Nucleosome	  pulldown	  using	  unlabeled	  nuclear	  extract—Pulldowns	  using	  unlabeled	  
nuclear	  extract	  were	  performed	  as	  described	  in	  the	  SNAP	  protocol.	  Bound	  fractions	  were	  
separated	  by	  SDS-­‐PAGE	  and	  visualized	  by	  either	  silver	  staining	  or	  western	  blotting.	  
	  
2.2.5	  Nucleosome	  gel	  shift	  assays	  
	   Unmodified	  and	  ub*H2A-­‐	  or	  ub*H2B-­‐containing	  nucleosomes	  were	  assembled	  as	  
previously	  described	  using	  the	  147	  bp	  601	  nucleosome	  positioning	  sequence.	  Nucleosomes	  
were	  concentrated	  to	  approximately	  150	  nM	  with	  Amicon	  Ultra	  0.5	  mL	  (50K	  cutoff)	  
concentrators.	  Nucleosome	  concentrations	  were	  determined	  by	  running	  various	  dilutions	  
of	  a	  known	  concentration	  of	  DNA	  alongside	  the	  reconstituted	  nucleosomes	  on	  a	  6%	  TBE	  
gel.	  DNA	  and	  nucleosomes	  were	  visualized	  by	  EtBr	  staining	  and	  imaged	  on	  the	  Typhoon	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imager.	  Densitometry	  measurements	  using	  Image	  Quant	  was	  used	  to	  generate	  a	  standard	  
curve	  according	  to	  the	  DNA	  dilutions,	  and	  nucleosome	  concentrations	  were	  calculated	  
based	  on	  this	  standard	  curve.	  
	   Gel	  shift	  assays	  were	  performed	  at	  a	  final	  NaCl	  concentration	  of	  300	  mM	  in	  reaction	  
buffer	  (10	  mM	  Tris,	  pH	  7.6,	  1	  mM	  EDTA,	  0.05%	  NP-­‐40,	  10%	  glycerol,	  0.1	  mg/mL	  BSA,	  1	  mM	  
DTT).	  All	  reactions	  contained	  452	  pmol	  of	  nucleosomes	  and	  GST-­‐LANA	  1-­‐23	  was	  titrated	  
from	  251	  nM	  to	  20	  μM.	  GST	  was	  used	  as	  a	  negative	  control	  at	  a	  concentration	  of	  20	  μM.	  
Final	  reaction	  volumes	  of	  3	  μL	  were	  incubated	  on	  ice	  for	  2	  hours;	  then	  1	  μL	  of	  20%	  sucrose	  
was	  added	  to	  each	  reaction	  prior	  to	  separation	  on	  a	  6%	  TBE	  gel	  and	  imaging	  as	  previously	  
described.	  To	  calculate	  the	  apparent	  Kd	  (Kdapp),	  the	  percentage	  of	  GST-­‐LANA	  peptide-­‐
bound	  nucleosomes	  were	  calculated	  according	  to	  densitometry	  measurements	  and	  the	  
data	  were	  analyzed	  using	  a	  Hill	  coefficient	  nonlinear	  regression	  fit	  where	  y=Bmax	  *	  
(Xn/(Xn+Kdn)).	  
	  
2.2.6	  Differential	  scanning	  calorimetry	  
	   Unmodified	  and	  ub*histone	  dimers	  were	  extensively	  dialyzed	  into	  10	  mM	  sodium	  
phosphate,	  pH	  7.6,	  1	  mM	  EDTA,	  pH	  8.0,	  300	  mM	  NaCl.	  All	  buffers	  and	  protein-­‐containing	  
samples	  were	  degassed	  prior	  to	  analysis	  by	  differential	  scanning	  calorimetry	  (DSC).	  To	  
ensure	  the	  dialysis	  buffer	  was	  stable	  during	  the	  DSC	  heating	  and	  cooling	  cycles,	  a	  heating	  
and	  cooling	  program	  from	  0	  °C	  to	  90	  °C	  was	  performed	  and	  compared	  to	  a	  water	  reference	  
sample.	  Next,	  3	  buffer-­‐to-­‐buffer	  cycles	  were	  run	  to	  obtain	  a	  baseline	  curve.	  Histone	  dimers	  
were	  diluted	  to	  a	  range	  from	  0.2	  to	  0.4	  mg/mL	  in	  dialysis	  buffer	  and	  scans	  from	  37	  °C	  to	  75	  
°C	  were	  performed.	  Duplicate	  samples	  were	  analyzed	  for	  both	  unmodified	  and	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ubiquitinated	  histone	  dimers.	  The	  buffer	  baseline	  curve	  was	  subtracted	  from	  each	  scan	  and	  
thermodynamic	  properties	  were	  extrapolated	  from	  the	  resulting	  curves.	  
	  
2.3	  Results	  
2.3.1	  Characterization	  of	  histone	  dimer	  thermodynamic	  properties	  
Because	  ubH2A	  and	  ubH2B	  have	  functionally	  different	  roles,	  we	  proposed	  that	  
identification	  of	  ubiquitinated	  histone	  “readers”	  or	  “effectors”	  would	  give	  some	  insight	  as	  
to	  how	  H2A	  and	  H2B	  monoubiquitination	  mechanistically	  signals	  in	  particular	  cellular	  
pathways.	  To	  identify	  histone-­‐binding	  proteins,	  we	  used	  unmodified	  or	  ubiquitinated	  
histones	  in	  pulldown	  assays.	  Obtaining	  large	  amounts	  of	  Ub-­‐histone	  is	  necessary	  for	  this	  
type	  of	  biochemical	  study,	  which	  is	  somewhat	  problematic	  as	  generating	  ubH2B	  using	  the	  
ubiquitination	  cascade	  enzymes	  (E1,	  E2,	  E3)	  results	  in	  a	  very	  low	  yield	  of	  ubiquitinated	  
product.	  Furthermore,	  ubiquitination	  at	  sites	  other	  than	  Lys120	  was	  observed	  when	  using	  
this	  system	  to	  obtain	  ubH2B	  (Kim	  and	  Roeder,	  2011).	  Ubiquitinated	  histones	  can	  be	  
isolated	  from	  cellular	  extracts,	  but	  the	  isolated	  histones,	  in	  addition	  to	  monoUb,	  contain	  a	  
heterogeneous	  mixture	  of	  other	  PTMs.	  To	  circumvent	  these	  difficulties,	  we	  generated	  
nonhydrolyzable	  Ub-­‐histone	  mimics	  using	  a	  strategy	  derived	  from	  a	  method	  previously	  
employed	  to	  generate	  di-­‐Ub	  (Yin	  et	  al.,	  2000a)	  and	  ubiquitinated	  PCNA	  (Carlile	  et	  al.,	  2009)	  
analogs.	  This	  method	  takes	  advantage	  of	  a	  highly	  reactive	  bifunctional	  thiol	  crosslinker,	  
1,3-­‐dichloroacetone.	  Since	  neither	  Ub	  nor	  H2A	  contain	  naturally	  occurring	  cysteine	  
residues,	  we	  can	  implement	  site-­‐specific	  crosslinking	  by	  introducing	  cysteine	  at	  the	  C-­‐
terminus	  of	  Ub	  (G76C)	  and	  the	  native	  ubiquitination	  site	  of	  human	  H2A	  (K119C)	  or	  
H2B(K120C).	  Compared	  to	  a	  native	  Ub-­‐protein	  isopeptide	  linkage,	  the	  crosslinked	  product	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contains	  an	  additional	  carboxylate	  group	  and	  is	  one	  C-­‐C	  bond	  longer	  (Figure	  2.1A).	  The	  
crosslinked	  ub*H2A	  and	  ub*H2B	  mimics	  (*	  denotes	  the	  crosslink)	  were	  further	  assembled	  
into	  H2A/H2B	  dimers	  (Figure	  2.1D).	  	  	  
One	  way	  that	  Ub	  modification	  can	  affect	  chromatin	  function	  is	  to	  perturb	  its	  
structure.	  To	  investigate	  whether	  Ub	  attached	  to	  either	  H2A	  or	  H2B	  affects	  the	  stability	  of	  
H2A/H2B	  dimer,	  we	  analyzed	  the	  thermodynamic	  properties	  of	  H2A/H2B,	  ub*H2A/H2B,	  
and	  H2A/ub*H2B	  using	  differential	  scanning	  calorimetry	  (DSC).	  DSC	  can	  be	  used	  to	  
measure	  enthalpic	  properties	  of	  proteins	  and	  protein	  complexes	  by	  measuring	  the	  amount	  
of	  heat	  required	  to	  denature	  the	  protein.	  Typically,	  protein	  structures	  that	  are	  stabilized	  by	  
an	  increased	  number	  of	  intramolecular	  interactions	  exhibit	  a	  higher	  Tm	  than	  those	  that	  
form	  fewer	  or	  weaker	  inter-­‐	  and	  intra-­‐molecular	  interactions.	  Under	  this	  assumption,	  we	  
proposed	  that	  H2A/ub*H2B	  would	  exhibit	  different	  thermodynamic	  properties	  than	  either	  
H2A/H2B	  or	  ub*H2A/H2B	  due	  to	  possible	  differences	  in	  intramolecular	  interactions	  
between	  Ub	  and	  the	  histones	  within	  the	  same	  histone	  dimer	  molecule	  or	  intermolecular	  
interactions	  between	  histone	  dimer	  molecules.	  Histone	  dimers	  were	  dialyzed	  together	  in	  
buffer	  containing	  300	  mM	  NaCl.	  Initial	  scans	  analyzing	  unmodified	  histone	  dimers	  showed	  
the	  unfolding	  and	  refolding	  was	  not	  reversible	  as	  the	  peaks	  observed	  in	  the	  heating	  and	  
cooling	  phases	  of	  the	  scan	  did	  not	  overlap	  (data	  not	  shown).	  Analysis	  showed	  there	  were	  
no	  major	  differences	  in	  the	  Tm	  or	  enthalpic	  properties	  of	  unmodified	  and	  ubiquitinated	  
histone	  dimers	  (Table	  2.1	  and	  Table	  2.2).	  These	  results	  suggest	  that	  Ub	  attached	  to	  either	  
H2A	  or	  H2B	  minimally	  contributes	  to	  inter-­‐	  and	  intra-­‐	  molecular	  interactions.	  Notably,	  the	  
Tm	  for	  Ub	  is	  above	  90	  °C	  and,	  therefore,	  does	  not	  contribute	  to	  the	  overall	  Tm	  of	  the	  






Table	  2.1.	  Enthalpic	  properties	  of	  histone	  dimers	  as	  determined	  by	  DSC	  analysis.	  
Histone	  dimer	   Tm	  (°C)	   ΔG	  (kJ/mol)	   ΔH	  (kJ/mol)	   ΔS	  (kJ/mol*K)	  
H2A/H2B	   55.88	  ±	  0.71	   29.65	  ±	  0.91	   325.19	  ±	  19.58	   0.99	  ±	  0.06	  
ub*H2A/H2B	   55.05	  ±	  0.13	   26.88	  ±	  2.12	   313.78	  ±	  45.44	   0.96	  ±	  0.15	  
H2A/ub*H2B	   55.45	  ±	  0.10	   26.22	  ±	  0.54	   297.48	  ±	  1.86	   0.91	  ±	  0.00	  
	  
Table	  2.2.	  Calculated	  differences	  in	  histone	  dimer	  enthalpic	  properties.	  Enthalpic	  
properties	  for	  unmodified	  and	  ubiquitinated	  histone	  dimers	  were	  averaged	  together.	  The	  
percent	  standard	  deviation	  was	  calculated	  to	  numerically	  determine	  the	  degree	  of	  
difference	  in	  enthalpic	  characteristics	  in	  all	  sample	  types.	  The	  low	  percent	  standard	  
deviation	  values	  indicate	  unmodified	  and	  ubiquitinated	  histone	  dimers	  share	  similar	  inter-­‐	  
and	  intra-­‐molecular	  interaction	  characteristics.	  
	   Tm	  (°C)	   ΔG	  (kJ/mol)	   ΔH	  (kJ/mol)	   ΔS	  (kJ/mol*K)	  
Average	   55.46	   27.58	   312.15	   0.95	  
Standard	  deviation	   0.49	   1.95	   25.41	   0.08	  
Percent	  deviation	   0.89	   7.05	   8.14	   8.36	  
	  
	  
2.3.2	  H2B	  Ubiquitination	  weakens	  LANA	  interaction	  with	  the	  nucleosome	  
	   Although	  DSC	  analysis	  suggested	  there	  were	  no	  major	  changes	  in	  the	  
thermodynamic	  properties	  of	  unmodified	  and	  ubiquitinated	  histone	  dimers,	  it	  was	  still	  
possible	  that:	  1)	  the	  DSC	  measurements	  were	  not	  sensitive	  enough	  to	  detect	  minor	  changes	  
in	  histone	  dimer	  stability	  and	  2)	  ub*H2B	  sterically	  occludes	  the	  acidic	  patch	  without	  
forming	  additional	  inter-­‐	  or	  intra-­‐molecular	  interactions	  and,	  therefore,	  was	  not	  detectible	  
by	  DSC	  analysis.	  
	   Between	  these	  sites	  of	  Ub	  attachment	  is	  a	  patch	  of	  acidic	  residues	  localized	  on	  the	  
H2A/H2B	  dimer	  (Figure	  2.2B).	  These	  residues	  stand	  out	  for	  2	  reasons:	  first,	  the	  residues	  in	  
the	  histone	  dimer	  are	  predominantly	  basic	  so	  the	  acidic	  patch	  provides	  an	  alternatively	  
charged	  region	  and	  secondly,	  multiple	  proteins	  interact	  with	  histones	  via	  this	  acidic	  patch	  
(Luger	  et	  al.,	  1997;	  Wyrick	  et	  al.,	  2012).	  We	  modeled	  the	  attachment	  of	  Ub	  to	  either	  H2A	  or	  
H2B	  (at	  K119	  and	  K120,	  respectively)	  and	  used	  HADDOCK	  to	  assess	  the	  ability	  of	  Ub	  to	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access	  the	  H2A/H2B	  acidic	  patch.	  Modeling	  suggested	  that	  Ub,	  when	  attached	  to	  H2B	  could	  
sterically	  hinder	  access	  to	  the	  acidic	  patch.	  On	  the	  other	  hand,	  Ub	  attached	  to	  H2A	  is	  
unlikely	  to	  sterically	  occlude	  the	  acidic	  patch	  due	  to	  the	  increased	  distance	  between	  the	  site	  
of	  Ub	  attachment	  and	  the	  acidic	  patch.	  The	  Kaposi’s	  sarcoma-­‐associated	  herpes	  virus	  
(KSHV)	  encodes	  a	  viral	  protein	  KSHV	  latency-­‐associated	  nuclear	  antigen	  (LANA).	  As	  viral	  
genomes	  don’t	  contain	  centromeres,	  the	  segregation	  of	  viral	  DNA	  is	  mediated	  in	  a	  LANA-­‐
dependent	  mechanism	  whereby	  LANA	  specifically	  interacts	  with	  the	  acidic	  patch	  within	  the	  
NCP	  to	  tether	  the	  viral	  genome	  to	  mitotic	  centromeres	  (Barbera	  et	  al.,	  2006)	  (Figure	  2.2C).	  
The	  N-­‐terminal	  residues	  of	  LANA	  (LANA	  1-­‐23)	  mediate	  the	  interaction	  with	  the	  NCP	  acidic	  
patch.	  To	  measure	  the	  effect	  of	  Ub	  on	  the	  acidic	  patch	  accessibility	  in	  the	  NCP,	  we	  measured	  
the	  affinity	  between	  unmodified	  and	  ub*H2A-­‐	  or	  ub*H2B-­‐contianing	  mononucleosomes	  
and	  the	  LANA	  peptide.	  Mononucleosomes	  were	  assembled	  on	  a	  147	  bp	  fragment	  of	  DNA	  
encoding	  the	  601	  nucleosome	  positioning	  sequence.	  LANA	  1-­‐23	  was	  tagged	  with	  GST	  and	  
purified	  as	  previously	  described	  (Barbera	  et	  al.,	  2006).	  Increasing	  amounts	  of	  GST-­‐LANA	  1-­‐
23	  were	  incubated	  with	  mononucleosomes.	  Complexes	  were	  separated	  on	  a	  6%	  TBE	  gel	  
and	  visualized	  by	  EtBr	  staining.	  Binding	  of	  GST-­‐LANA	  1-­‐23	  to	  nucleosomes	  was	  observed	  
by	  an	  upward	  shift	  in	  nucleosome	  migration	  (Figure	  2.3A).	  The	  percent	  of	  shifted	  
nucleosome	  was	  quantitated,	  plotted,	  and	  analyzed	  using	  a	  nonlinear	  regression	  fit	  to	  
obtain	  an	  apparent	  dissociation	  constant	  (Kdapp)	  where	  the	  Hill	  coefficient	  is	  approximately	  
2.2	  (Figure	  2.3B).	  We	  observed	  a	  small,	  but	  reproducible	  increase	  in	  the	  Kdapp	  for	  ub*H2B-­‐
containing	  nucleosomes	  (Figure	  2.3C).	  These	  data	  indicate	  that	  Ub	  when	  attached	  to	  H2B	  





2.3.3	  SILAC	  Nucleosome	  Affinity	  Purification	  (SNAP)	  
Some	  histone-­‐binding	  proteins	  preferentially	  bind	  histones	  within	  the	  context	  of	  an	  
H2A/H2B	  dimer,	  H3/H4	  tetramer,	  or	  when	  assembled	  into	  a	  NCP.	  This	  is	  partially	  
evidenced	  by	  the	  substrate	  specificity	  observed	  for	  many	  histone	  DUBs	  (Table	  1.2).	  
Therefore,	  we	  proposed	  the	  binding	  patterns	  of	  ubiquitinated	  histone	  dimers	  versus	  
ub*H2A-­‐	  or	  ub*H2B-­‐containing	  nucleosomes	  are	  different	  and	  identification	  of	  these	  
interacting	  proteins	  would	  give	  further	  insight	  into	  the	  mechanisms	  by	  which	  ub*H2A	  and	  
ub*H2B	  are	  regulated	  and	  signal	  in	  the	  cell.	  	  
In	  a	  previous	  study,	  effectors	  of	  H3	  methylation	  at	  various	  lysine	  residues	  were	  
identified	  by	  reconstituting	  modified	  histones	  into	  biotinylated	  mononucleosomes	  and	  
used	  mass	  spectrometry	  to	  identify	  bound	  proteins	  (Bartke	  et	  al.,	  2010).	  In	  particular,	  this	  
study	  used	  a	  Stable	  Isotope	  Labeling	  of	  Amino	  acids	  in	  Cell	  culture	  (SILAC)	  approach	  for	  
quantitative	  mass	  spectrometry	  rather	  than	  semi-­‐quantitative	  approaches	  such	  as	  spectral	  
counting.	  We	  sought	  to	  utilize	  a	  similar	  approach	  to	  identify	  “readers”	  of	  unmodified	  and	  
ub*H2A-­‐	  or	  ub*H2B-­‐containing	  nucleosomes.	  Similar	  as	  the	  previous	  study,	  we	  
reconstituted	  mononucleosomes	  with	  a	  biotinylated	  183	  bp	  DNA	  fragment	  (Figure.	  2.4A).	  
This	  fragment	  is	  consisted	  of	  16	  bp	  of	  DNA	  upstream	  and	  20	  bp	  downstream	  of	  a	  147	  bp	  
601	  nucleosome	  positioning	  sequence.	  The	  183	  bp	  fragment	  was	  prepared	  by	  amplification	  
with	  a	  biotinylated	  reverse	  primer	  and	  further	  purified	  on	  a	  MonoQ	  sepharose	  column	  
(Figure	  2.4B).	  Unmodified,	  ub*H2A,	  or	  ub*H2B	  histones	  were	  assembled	  into	  histone	  
octamers	  and	  used	  to	  reconstitute	  mononucleosomes	  (Figure	  2.4C).	  In	  comparison	  with	  
unmodified	  nucleosomes,	  Ub*histone-­‐containing	  nucleosomes	  migrate	  slower	  on	  a	  native	  





pulldown	  assays,	  biotinylated	  nucleosomes	  were	  immobilized	  onto	  magnetic	  streptavidin	  
Dynabeads	  (Figure	  2.4D).	  
SILAC	  is	  a	  popular	  method	  for	  obtaining	  reliable	  quantitative	  mass	  spectrometry	  
data	  in	  pulldown	  assays	  where	  cell	  extract	  is	  supplied	  as	  the	  source	  of	  prey	  proteins.	  In	  this	  
method,	  cells	  are	  cultured	  in	  media	  containing	  either	  light	  isotope-­‐labeled	  12C6	  L-­‐Lysine	  
and	  12C6	  14N4	  L-­‐Arginine	  or	  heavy	  isotope-­‐labeled	  13C6	  L-­‐Lysine	  and	  13C6	  15N4	  L-­‐Arginine.	  
Upon	  full	  incorporation	  of	  heavy	  or	  light	  amino	  acids,	  nuclear	  extract	  is	  prepared	  from	  
these	  cells.	  The	  light	  extract	  is	  then	  incubated	  with	  unmodified	  nucleosomes	  while	  the	  
heavy	  extract	  is	  incubated	  with	  modified	  nucleosomes.	  Bound	  fractions	  from	  unmodified	  
and	  modified	  nucleosomes	  are	  mixed	  in	  equal	  ratios,	  trypsin	  digested,	  and	  analyzed	  by	  LC-­‐	  
MS/MS.	  Peptides	  from	  proteins	  bound	  by	  modified	  nucleosomes	  can	  be	  identified	  by	  a	  
mass	  shift	  of	  +6	  Da	  (Lysine)	  or	  +10	  Da	  (Arginine)	  as	  trypsin	  cleaves	  after	  lysine	  and	  
arginine	  residues.	  In	  a	  “reverse”	  experiment,	  unmodified	  nucleosomes	  are	  incubated	  with	  
the	  heavy	  extract	  while	  modified	  nucleosomes	  are	  incubated	  with	  the	  light	  extract.	  For	  
each	  identified	  protein,	  the	  heavy/light	  (H/L)	  ratios	  from	  both	  the	  forward	  and	  reverse	  
experiments	  are	  plotted.	  Proteins	  that	  prefer	  binding	  the	  modified	  nucleosomes	  can	  be	  
distinguished	  from	  those	  that	  prefer	  binding	  the	  unmodified	  nucleosomes	  (Figure	  2.5).	  	  
The	  major	  advantage	  of	  using	  this	  method	  is	  that	  elution	  samples	  from	  both	  unmodified	  
and	  modified	  nucleosomes	  are	  mixed	  prior	  to	  analysis	  by	  LC-­‐MS/MS.	  This	  eliminates	  
erroneous	  quantitation	  due	  to	  differences	  in	  processing	  such	  as	  variation	  in	  digestion	  or	  
sample	  complexity.	  
For	  generation	  of	  light	  isotope-­‐	  and	  heavy	  isotope-­‐labeled	  nuclear	  extracts,	  cells	  





ensure	  full	  incorporation	  of	  the	  heavy	  isotope-­‐labeled	  amino	  acids,	  cultured	  cells	  were	  
grown	  for	  ~8	  cell	  divisions,	  lysed,	  and	  proteins	  were	  separated	  by	  SDS-­‐PAGE	  and	  
visualized	  by	  coomassie	  staining.	  Five	  bands	  from	  both	  the	  light	  isotope-­‐	  and	  heavy	  
isotope-­‐labeled	  cell	  extracts	  were	  excised	  and	  subjected	  to	  in-­‐gel	  trypsin	  digestion	  (Figure	  
2.6B).	  Digested	  peptides	  were	  subject	  to	  MALDI-­‐TOF	  analysis	  (Figure	  2.6C,	  top	  panel).	  
Incorporation	  of	  the	  heavy	  isotope-­‐containing	  amino	  acids	  was	  observed	  by	  a	  shift	  of	  either	  
6	  or	  10	  Da	  (Figure	  2.6C,	  bottom	  panels).	  Full	  incorporation	  of	  supplemented	  amino	  acids	  
was	  achieved	  as	  analysis	  of	  over	  50	  peptides	  showed	  spectra	  detected	  in	  the	  light	  sample	  
were	  all	  shifted	  by	  6	  or	  10	  kDa	  in	  the	  heavy	  spectra.	  Upon	  confirmation	  of	  heavy	  isotope-­‐
labeled	  amino	  acid	  incorporation,	  cells	  were	  expanded	  for	  a	  large-­‐scale	  preparation	  of	  
nuclear	  extract.	  	  
For	  SNAP	  experiments,	  unmodified,	  ub*H2A,	  and	  ub*H2B-­‐containing	  
mononucleosomes	  were	  assembled	  with	  the	  biotinylated	  183	  bp	  fragment	  and	  
immobilized	  to	  Dynabeads.	  Nucleosomes	  were	  incubated	  with	  light	  or	  heavy	  nuclear	  
extract.	  Bound	  proteins	  were	  eluted	  and	  visualized	  by	  SDS-­‐PAGE	  and	  silver	  staining	  (Figure	  
2.7).	  We	  noticed	  pulldowns	  using	  light	  extract	  as	  a	  source	  of	  prey	  proteins	  had	  an	  increased	  
number	  of	  bound	  proteins.	  Because	  silver	  staining	  of	  the	  1%	  input	  for	  light	  and	  heavy	  
extracts	  was	  also	  unequal,	  reevaluation	  of	  the	  total	  protein	  concentration	  by	  BCA	  of	  the	  
light	  nuclear	  extract	  showed	  the	  concentration	  was	  previously	  underestimated.	  Although	  
internal	  standards	  can	  be	  used	  for	  normalization	  of	  SILAC	  mass	  spectrometry	  data,	  data	  
analysis	  is	  simpler	  and	  more	  reliable	  if	  similar	  amounts	  of	  light	  and	  heavy	  pulldown	  elution	  
samples	  are	  mixed	  before	  LC-­‐MS/MS	  analysis.	  To	  account	  for	  differences	  in	  the	  amount	  of	  
bound	  proteins,	  3	  bands	  corresponding	  to	  DNA-­‐binding	  proteins	  were	  quantitated	  and	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used	  as	  a	  reference	  for	  normalization	  of	  total	  bound	  proteins.	  Based	  upon	  this	  
normalization,	  equal	  amounts	  of	  light	  and	  heavy	  elution	  fractions	  were	  mixed	  and	  sent	  for	  
LC-­‐MS/MS	  analysis.	  Unfortunately	  the	  results	  from	  the	  mass	  spectra	  results	  were	  difficult	  
to	  interpret	  and,	  in	  many	  cases,	  reliable	  quantitation	  was	  not	  possible	  due	  to	  poor	  
coverage.	  Optimization	  of	  future	  SNAP	  experiments	  is	  discussed	  in	  Section	  2.4.	  	  
	  
2.3.4	  FACT	  preferentially	  binds	  ub*H2B-­‐containing	  mononucleosomes	  
A	  number	  of	  proteins	  have	  been	  functionally	  linked	  to	  ubH2B	  in	  vivo.	  In	  particular,	  FACT	  
plays	  a	  major	  role	  in	  H2B	  ubiquitination	  and	  ubH2B-­‐related	  processes	  such	  as	  
transcription	  elongation	  and	  reassembly	  of	  nucleosomes	  during	  transcription	  and	  DNA	  
replication	  (see	  Section	  1.8).	  We	  found	  that	  FACT	  preferentially	  bound	  H2A/ub*H2B	  and,	  
because	  of	  its	  role	  in	  nucleosome	  disassembly	  and	  reassembly,	  were	  curious	  to	  see	  if	  FACT	  
also	  bound	  ub*H2B-­‐containing	  nucleosomes.	  Mononucleosome	  pulldown	  experiments	  
were	  performed	  as	  described	  above	  with	  the	  modification	  that	  unlabeled	  nuclear	  extract	  
was	  used	  as	  the	  source	  of	  prey	  proteins	  (Figure	  2.8A).	  Bound	  proteins	  were	  separated	  by	  
SDS-­‐PAGE	  and	  detected	  by	  either	  silver	  staining	  or	  western	  blotting.	  Results	  showed	  that	  
FACT	  preferentially	  bound	  ub*H2B-­‐containing	  nucleosomes	  (Figure	  2.8B).	  We	  also	  blotted	  
for	  a	  histone	  DUB,	  Usp15,	  which	  bound	  ubiquitinated	  histone	  dimers	  in	  our	  previous	  
pulldown	  studies	  and	  found	  that	  Usp15	  did	  not	  bind	  unmodified	  or	  Ub-­‐containing	  
mononucleosomes.	  Debuiquitination	  assays	  showed	  Usp15	  preferentially	  deubiquitinates	  
free	  histones	  rather	  than	  mononucleosomes,	  providing	  further	  evidence	  that	  the	  histone	  
dimer	  or	  nucleosomal	  context	  of	  ubiquitinated	  histones	  is	  a	  point	  of	  regulation	  of	  histone-­‐	  








ubiquitinated	  histone	  dimers	  versus	  Ub-­‐histone	  containing	  nucleosomes	  could	  provide	  
further	  mechanistic	  insight	  into	  the	  signaling	  mechanisms	  by	  which	  monoubiquitinated	  
histones	  function	  in	  various	  cellular	  processes.	  
	  
2.4	  Discussion	  
Advantages	  of	  nonhydrolyzable	  Ub*histone	  mimics—We	  developed	  a	  method	  to	  
generate	  large	  amounts	  of	  highly	  stable,	  nonhydrolyzable	  Ub*histone	  mimics.	  Pull-­‐down	  
assays	  using	  these	  mimics	  identified	  effectors	  of	  ubiquitinated	  histone	  dimers	  by	  
proteomics.	  Select	  proteins	  with	  distinct	  binding	  profiles	  were	  chosen	  for	  further	  
validation	  by	  western	  blotting	  using	  specific	  antibodies.	  	  
Traditionally,	  identification	  of	  histone	  modification-­‐binding	  proteins	  is	  performed	  using	  
modified	  (acetylated	  or	  methylated)	  histone	  peptides	  as	  baits	  in	  pull-­‐down	  assays.	  
Employing	  our	  method	  of	  Ub*histone	  generation,	  we	  were	  able	  to	  use	  the	  full-­‐length	  
modified	  histone	  as	  bait	  in	  our	  pull-­‐down	  assays.	  Utilizing	  the	  entire	  histone	  protein	  rather	  
than	  a	  histone	  peptide	  is	  advantageous	  in	  multiple	  ways.	  First,	  some	  Ub-­‐interacting	  
proteins	  recognize	  their	  substrates	  through	  direct	  interactions	  with	  both	  Ub	  and	  the	  
substrate	  protein	  (Bienko	  et	  al.,	  2005).	  Because	  multiple	  surfaces	  are	  often	  required	  for	  
protein-­‐protein	  interactions,	  using	  an	  entire	  modified	  histone	  rather	  than	  modified	  histone	  
peptides	  in	  pull-­‐down	  assays	  may	  result	  in	  the	  identification	  of	  more	  physiologically	  
relevant	  modification	  readers.	  
Another	  advantage	  of	  using	  full-­‐length	  ubiquitinated	  histones	  is	  these	  proteins	  can	  
be	  assembled	  into	  a	  variety	  of	  complexes	  including	  nucleosomes	  and	  H2A/H2B	  dimers	  






our	  knowledge	  of	  Ub-­‐histone	  effectors	  by	  defining	  the	  structural	  context	  in	  which	  specific	  
interactors	  bind	  ubiquitinated	  histones.	  Particularly,	  multiple	  cases	  have	  been	  reported	  
where	  histone	  DUB	  activity	  preferentially	  deubiquitinates	  free	  histones	  or	  nucleosomal	  
histones	  (Table	  1.2).	  As	  our	  Ub*histone	  mimics	  are	  nonhydrolyzable,	  these	  substrates	  can	  
be	  used	  within	  different	  structural	  contexts	  to	  obtain	  binding	  affinities	  with	  histone	  DUBs.	  
Recently,	  a	  pulldown	  study	  was	  carried	  out	  with	  nucleosome	  arrays	  assembled	  with	  
chemically	  synthesized	  ubH2B,	  which	  contains	  the	  native	  isopeptide	  linkage	  (Shema-­‐
Yaacoby	  et	  al.,	  2013).	  In	  comparison	  with	  these	  semi-­‐chemical	  synthesis	  strategies,	  our	  
crosslinking-­‐based	  method	  is	  much	  simpler.	  Additionally,	  our	  Ub*histone	  mimics	  are	  not	  
susceptible	  to	  cleavage	  by	  DUBs	  present	  in	  the	  nuclear	  extract,	  thus	  enhancing	  the	  
probability	  of	  identifying	  effector	  proteins.	  Notably,	  the	  recently	  published	  pulldown	  assay	  
using	  nucleosomal	  arrays	  containing	  the	  native	  ubH2B	  isopeptide	  linkage	  did	  not	  identify	  
any	  DUBs.	  Additionally,	  in	  contrast	  to	  our	  pulldown	  using	  histone	  dimers,	  many	  of	  the	  
proteins	  identified	  in	  the	  nucleosomal	  pulldown	  identified	  multiple	  components	  of	  the	  
transcriptional	  elongation	  machinery	  including	  components	  of	  the	  NELF,	  DSIF,	  and	  
SWI/SNF	  complexes.	  
Many	  sites	  of	  mono-­‐ubiquitination	  have	  been	  identified	  on	  H2A,	  H2B,	  H3,	  and	  H4	  in	  
mammalian	  cells	  (Table	  1.1).	  Compared	  to	  the	  extensive	  studies	  analyzing	  
monoubiquitination	  of	  H2A	  (Lys119)	  and	  H2B	  (Lys120),	  little	  is	  known	  about	  the	  effectors	  
of	  histone	  ubiquitination	  at	  other	  lysine	  residues.	  Therefore,	  generation	  of	  a	  variety	  of	  
monoubiquitinated	  histones	  could	  prove	  a	  useful	  tool	  for	  identifying	  effectors	  at	  these	  
other	  sites	  of	  ubiquitination.	  In	  addition	  to	  ubiquitination,	  the	  conjugation	  of	  an	  ubiquitin-­‐
like	  protein,	  small	  Ub-­‐related	  modifier	  (SUMO),	  onto	  histones	  has	  been	  described	  in	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multiple	  eukaryotes	  (Nathan	  et	  al.,	  2006;	  Shiio	  and	  Eisenman,	  2003).	  Like	  Ub,	  SUMO	  does	  
not	  contain	  any	  naturally	  occurring	  cysteine	  residues.	  In	  principle,	  this	  technique	  of	  
generating	  Ub*histones	  could	  also	  be	  applied	  to	  the	  generation	  of	  nonhydrolyzable	  
SUMO*histone	  mimics.	  Generation	  of	  a	  variety	  of	  ubiquitinated	  or	  SUMOylated	  histones	  
could	  prove	  to	  be	  useful	  tools	  to	  identify	  downstream	  effectors	  and	  to	  provide	  new	  
mechanistic	  insights	  into	  the	  functions	  of	  these	  modifications.	  	  
Instability	  of	  H2A/ub*H2B—In	  the	  histone	  dimer	  pulldown	  assays,	  Flag-­‐
H2A/ub*H2B	  was	  consistently	  unstable	  as	  ub*H2B	  dissociated	  from	  Flag-­‐H2A	  upon	  
incubation	  with	  nuclear	  extract	  (M.F.	  and	  T.Y.,	  unpublished	  results).	  We	  investigated	  the	  
possibility	  that	  Ub,	  when	  attached	  to	  H2B,	  interacts	  with	  H2A/H2B	  surface	  and	  perturb	  the	  
stability	  of	  the	  dimer.,DSC	  analysis	  unveiled	  no	  major	  changes	  in	  the	  stability	  of	  unmodified	  
and	  Ub-­‐containing	  histone	  dimers.	  From	  these	  data,	  we	  propose	  that	  H2A/ub*H2B	  is	  not	  
inherently	  less	  stable,	  but	  dissociate	  more	  easily	  in	  the	  presence	  of	  the	  nuclear	  extract.	  One	  
possiblity	  is,that	  H2A/ub*H2B	  are	  destabilized	  by	  particular	  protein(s)	  in	  the	  nuclear	  
extract.	  Alternatively,	  the	  unmodified	  and	  ub*H2A-­‐containing	  histone	  dimers	  are	  simply	  
stabilized	  by	  proteins	  in	  the	  nuclear	  extract	  that	  are	  excluded	  from	  binding	  to	  ub*H2B-­‐
containing	  histone	  dimers.	  
In	  support	  of	  the	  latter	  possibility,,	  binding	  assays	  using	  the	  GST-­‐LANA	  1-­‐23	  peptide	  
showed	  that,	  in	  the	  nucleosomal	  context,	  ub*H2B	  at	  least	  partially	  obscured	  the	  H2A/H2B	  
acidic	  patch.	  It	  is	  unclear	  whether	  ub*H2B	  also	  blocks	  binding	  proteins	  whose	  interactions	  
are	  mediated	  by	  the	  acidic	  patch	  within	  the	  context	  of	  the	  histone	  dimer.	  In	  the	  gel	  shift	  
assays	  we	  noticed	  that,	  at	  high	  concentrations	  of	  GST-­‐LANA	  1-­‐23,	  the	  shifted	  band	  migrated	  
as	  two	  distinct	  bands.	  Due	  to	  the	  presence	  of	  the	  GST	  tag,	  it’s	  likely	  that	  GST-­‐LANA	  1-­‐23	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exists	  as	  a	  dimer.	  Because	  each	  nucleosome	  contains	  two	  LANA	  peptide-­‐binding	  sites,	  it’s	  
possible	  that	  the	  slower	  migrating	  band	  represents	  the	  binding	  of	  two	  GST-­‐LANA	  peptides	  
while	  the	  faster	  migrating	  complex	  has	  bound	  only	  one	  GST-­‐LANA	  peptide.	  Alternatively,	  
it’s	  conceivable	  that	  one	  GST-­‐LANA	  1-­‐23	  dimer	  may	  bind	  acidic	  patch	  residues	  within	  the	  
same	  nucleosome	  or	  each	  monomer	  within	  the	  dimer	  may	  bind	  two	  different	  nucleosomes,	  
which	  may	  result	  in	  a	  change	  in	  migration	  pattern.	  	  
The	  GST-­‐LANA	  1-­‐23	  binding	  data	  were	  best	  described	  using	  a	  Hill	  coefficient	  model	  
with	  an	  n	  value	  of	  approximately	  2,	  suggesting	  a	  certain	  degree	  of	  cooperative	  binding.	  The	  
dimerization	  property	  of	  GST	  could	  also	  be	  a	  contributing	  factor	  to	  this	  cooperative	  binding	  
as	  the	  binding	  of	  one	  GST-­‐LANA	  peptide	  could	  enhance	  the	  affinity	  for	  binding	  of	  the	  
corresponding	  GST-­‐LANA	  peptide	  to	  the	  same	  nucleosome	  or	  a	  nucleosome	  near	  where	  the	  
first	  binding	  event	  occurred.	  Further	  studies	  using	  monomeric	  GST-­‐LANA	  1-­‐23	  or	  MBP-­‐
LANA	  1-­‐23	  could	  provide	  insight	  as	  to	  the	  degree	  of	  influence	  of	  the	  GST	  tag	  possesses	  with	  
respect	  to	  LANA	  peptide-­‐nucleosome	  binding	  models.	  
SNAP	  optimization—Obtaining	  reliable,	  quantitative	  mass	  spectrometry	  data	  was	  
unsuccessful	  in	  the	  pilot	  SNAP	  experiment	  and	  this	  is	  most	  likely	  a	  result	  of	  two	  major	  
factors.	  First,	  many	  of	  the	  proteins	  that	  bound	  the	  mononucleosomes	  were	  DNA-­‐binding	  
proteins.	  These	  interactions	  were	  presumably	  enhanced	  by	  the	  DNA	  overhangs	  present	  on	  	  
either	  side	  of	  the	  positioning	  sequence	  (Figure	  2.4A).	  Due	  to	  the	  sheer	  abundance	  of	  these	  
DNA-­‐binding	  proteins,	  detection	  of	  nucleosome-­‐specific	  interactors	  by	  the	  mass	  
spectrometer	  was	  more	  difficult.	  	  
Secondly,	  the	  previous	  study	  by	  which	  we	  modeled	  our	  SNAP	  experiment	  used	  more	  
nucleosomes	  and	  more	  isotope-­‐labeled	  nuclear	  extract	  per	  pulldown	  condition.	  Using	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nucleosomal	  arrays,	  the	  nucleosome:free	  DNA	  ratio	  would	  increase,	  thereby	  increasing	  the	  
abundance	  of	  nucleosome-­‐interacting	  proteins	  and	  decreasing	  the	  abundance	  of	  DNA-­‐
binding	  proteins.	  Consequently,	  identification	  of	  nucleosome-­‐binding	  proteins	  by	  the	  mass	  
spectrometer	  would	  be	  enhanced.	  Coupling	  an	  increase	  in	  nucleosome	  concentration	  with	  
an	  increase	  in	  SILAC	  extract	  for	  each	  pulldown	  would	  result	  in	  a	  greater	  quantity	  of	  eluted	  
proteins	  to	  be	  analyzed	  by	  mass	  spectrometry.	  Increasing	  the	  concentration	  of	  analyzed	  
sample	  is	  necessary	  for	  two	  reasons:	  this	  would	  enhance	  the	  identification	  of	  low	  
abundance	  nucleosome-­‐interacting	  proteins	  and	  would	  increase	  the	  spectral	  counts	  of	  
identified	  proteins,	  thereby	  improving	  the	  quantitation	  data.	  We	  plan	  to	  repeat	  the	  SNAP	  
experiments	  using	  unmodified	  and	  Ub-­‐containing	  nucleosomal	  arrays	  to	  gather	  more	  
reliable	  SILAC	  quantitation	  data	  in	  the	  future.	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CHAPTER	  3:	  THE	  U4/U6	  RECYCLING	  FACTOR	  SART3	  HAS	  HISTONE	  CHAPERONE	  
ACTIVITY	  AND	  ASSOCIATES	  WITH	  USP15	  TO	  REGULATE	  H2B	  DEUBIQUITINATION	  
	  
2Post-­‐translational	  modifications	  (PTMs)	  of	  histone	  proteins	  produce	  dynamic	  
signals	  that	  regulate	  the	  structure	  and	  function	  of	  chromatin.	  Monoubiquitination	  of	  H2B	  in	  
the	  histone	  tail	  (at	  K123	  in	  yeast	  or	  K120	  in	  humans)	  is	  a	  conserved	  modification	  that	  has	  
been	  implicated	  in	  the	  regulation	  of	  transcription,	  replication,	  and	  DNA	  repair	  processes.	  In	  
a	  search	  for	  direct	  effectors	  of	  ubH2B,	  we	  identified	  a	  deubiquitinating	  enzyme,	  Usp15,	  
through	  affinity	  purification	  with	  a	  nonhydrolyzable	  ubH2B	  mimic.	  In	  the	  nucleus,	  Usp15	  
indirectly	  associates	  with	  the	  ubH2B	  E3	  ligase,	  RNF20/RNF40,	  and	  directly	  associates	  with	  
a	  component	  of	  the	  splicing	  machinery,	  SART3	  (also	  known	  as	  TIP110	  or	  p110).	  These	  
physical	  interactions	  place	  Usp15	  in	  the	  vicinity	  of	  actively-­‐transcribed	  DNA.	  Importantly	  
we	  found	  that	  SART3	  has	  previously	  unrecognized	  histone	  chaperone	  activities.	  SART3,	  but	  
not	  the	  well-­‐characterized	  histone	  chaperone	  Nap1,	  enhances	  Usp15	  binding	  to	  ubH2B	  and	  
facilitates	  deubiquitination	  of	  ubH2B	  in	  free	  histones	  but	  not	  in	  nucleosomes.	  These	  results	  
suggest	  that	  SART3	  recruits	  ubH2B,	  which	  may	  be	  evicted	  from	  DNA	  during	  transcription,	  
for	  deubiquitination	  by	  Usp15.	  In	  light	  of	  the	  function	  played	  by	  SART3	  in	  U4/U6	  di-­‐snRNP	  
formation,	  our	  discovery	  points	  to	  a	  direct	  link	  between	  eviction-­‐coupled	  erasure	  of	  the	  Ub	  
mark	  from	  ubH2B	  and	  co-­‐transcriptional	  pre-­‐mRNA	  splicing.	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2	  This	  chapter	  is	  related	  to	  Long,	  L.	  et	  al.	  (2014)	  J	  Biol	  Chem	  289,	  8916-­‐8930.	  Published	  
figures	  include	  3.1,	  3.2A,	  3.2C,	  3.4,	  3.5,	  3.6A,	  3.6B,	  3.7A,	  3.8B,	  3.8C,	  3.10A,	  3.11A-­‐D,	  3.11F,	  
3.12,	  3.13,	  3.14,	  3.15,	  3.16D,	  and	  3.17.	  I	  heavily	  contributed	  to	  experimental	  conception,	  
data	  collection,	  and	  analysis	  including	  all	  in	  vivo	  experiments,	  in	  vitro	  deubiquitinating	  
assays,	  and	  supercoiling	  assays.	  Joe	  Thelen	  carried	  out	  the	  experiments	  in	  figures	  3.3B,	  




In	  eukaryotes,	  the	  state	  of	  chromatin	  affects	  all	  processes	  that	  require	  access	  to	  
DNA,	  such	  as	  transcription,	  replication	  and	  DNA	  repair.	  DNA	  accessibility	  is	  regulated	  in	  
part	  by	  numerous	  post-­‐translational	  modifications	  (PTMs)	  on	  histones;	  these	  include	  
acetylation,	  methylation,	  phosphorylation,	  ADP-­‐ribosylation,	  ubiquitination,	  and	  
sumoylation.	  The	  reversibility	  of	  these	  covalent	  modifications	  and	  their	  combinatorial	  
occurrence	  contribute	  to	  their	  function	  as	  highly	  diverse	  and	  dynamic	  signals	  (Kouzarides,	  
2007;	  Patel	  and	  Wang,	  2013).	  In	  comparison	  to	  most	  other	  PTMs,	  ubiquitination	  stands	  out	  
because	  of	  its	  considerable	  size.	  Ubiquitin	  (Ub)	  is	  a	  protein	  of	  76	  amino	  acids	  with	  a	  well-­‐
folded	  and	  highly	  stable	  structure.	  It	  is	  attached	  to	  other	  proteins	  through	  the	  formation	  of	  
an	  isopeptide	  linkage	  between	  the	  C-­‐terminal	  carboxylate	  of	  Ub	  and	  a	  lysine	  sidechain	  of	  
the	  substrate	  protein.	  In	  addition,	  Ub	  can	  be	  attached	  to	  other	  Ub	  molecules	  to	  form	  poly-­‐
Ub	  chains	  (Pickart	  and	  Eddins,	  2004).	  Although	  all	  four	  core	  histones	  and	  linker	  histone	  H1	  
have	  been	  reported	  to	  undergo	  ubiquitination	  at	  various	  positions,	  the	  predominant	  
ubiquitinated	  histones	  in	  humans	  are	  H2A	  ubiquitinated	  at	  K119	  and	  H2B	  ubiquitinated	  at	  
K120	  (hereafter	  referred	  to	  as	  ubH2A	  and	  ubH2B)	  (Osley,	  2006).	  Monoubiquitination	  of	  
histones	  H2A	  or	  H2B	  does	  not	  lead	  to	  their	  degradation,	  but	  instead	  serves	  as	  a	  non-­‐
proteolytic	  signal	  that	  regulates	  gene	  expression	  and	  DNA	  repair	  processes.	  Interestingly,	  
the	  same	  modification	  on	  different	  histones	  is	  associated	  with	  opposite	  effects:	  whereas	  
ubH2A	  is	  associated	  with	  gene	  silencing,	  ubH2B	  is	  implicated	  primarily	  in	  active	  
transcription	  (Weake	  and	  Workman,	  2008).	  
UbH2B	  is	  conserved	  from	  yeast	  to	  man	  (Osley,	  2006).	  In	  humans,	  it	  is	  catalyzed	  by	  
the	  RNF20/RNF40	  heterodimeric	  E3	  ligase,	  which	  interacts	  with	  the	  PAF	  complex	  and	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rides	  with	  the	  RNA	  polymerase	  II	  (RNAPII)	  in	  transcription	  elongation	  (Kim	  et	  al.,	  2005;	  
Kim	  and	  Roeder,	  2009;	  Xiao	  et	  al.,	  2005).	  Consistently,	  genome-­‐wide	  localization	  studies	  
suggest	  that	  ubH2B	  is	  largely	  associated	  with	  actively-­‐transcribed	  genes	  (Jung	  et	  al.,	  2012;	  
Minsky	  et	  al.,	  2008;	  Shieh	  et	  al.,	  2011).	  However,	  how	  ubH2B	  regulates	  transcription	  
elongation	  has	  been	  enigmatic.	  Multiple	  observations	  that	  link	  ubH2B	  to	  various	  steps	  of	  
the	  elongation	  process	  include:	  1)	  ubH2B	  stimulates	  H3K4	  di-­‐	  and	  tri-­‐methylation	  as	  well	  
as	  H3K79	  di-­‐	  and	  tri-­‐methylation	  (Lee	  et	  al.,	  2007;	  Sun	  and	  Allis,	  2002);	  2)	  ubH2B	  inhibits	  
compaction	  of	  nucleosomal	  arrays	  in	  vitro	  (Fierz	  et	  al.,	  2010);	  3)	  ubH2B	  co-­‐operates	  with	  
the	  histone	  chaperone	  FACT	  and	  remodeling	  enzyme	  Chd1	  to	  reassemble	  nucleosomes	  in	  
the	  wake	  of	  elongating	  RNAPII	  (Fleming	  et	  al.,	  2008;	  Lee	  et	  al.,	  2012;	  Pavri	  et	  al.,	  2006);	  4)	  
ubH2B	  inhibits	  recruitment	  of	  elongation	  factors,	  such	  as	  Ctk1	  in	  yeast	  (Wyce	  et	  al.,	  2007)	  
and	  TFIIS	  in	  humans	  (Shema	  et	  al.,	  2011),	  to	  impede	  elongation.	  Inhibitory	  functions	  of	  
ubH2B	  in	  promoter	  regions	  have	  also	  been	  reported	  (Batta	  et	  al.,	  2011;	  Turner	  et	  al.,	  2002).	  
That	  ubH2B	  can	  affect	  transcription	  both	  positively	  and	  negatively	  underscores	  the	  
importance	  of	  ubH2B	  dynamics.	  	  
Several	  deubiquitinating	  enzymes	  (DUBs)	  have	  been	  reported	  that	  target	  ubH2B	  
(Weake	  and	  Workman,	  2008).	  The	  best-­‐characterized	  histone	  DUB,	  the	  Spt-­‐Ada-­‐Gcn5-­‐
acetyltransferase	  (SAGA)	  complex,	  is	  conserved	  throughout	  eukaryotes	  and	  has	  important	  
roles	  in	  transcription	  and	  mRNA	  export	  (Henry	  et	  al.,	  2003;	  Rodriguez-­‐Navarro,	  2009).	  
Recent	  reports	  that	  ubH2B	  is	  enriched	  at	  the	  intron-­‐exon	  boundaries	  in	  yeast,	  flies	  and	  
humans	  suggest	  a	  novel	  link	  between	  ubH2B	  and	  co-­‐transcriptional	  pre-­‐mRNA	  splicing	  
(Jung	  et	  al.,	  2012;	  Shieh	  et	  al.,	  2011).	  In	  yeast,	  deletion	  of	  the	  ubH2B	  ligase	  has	  mild	  splicing	  
defects	  but	  exhibits	  synthetic	  sickness	  with	  components	  of	  the	  U1,	  U2	  and	  U5	  snRNP	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(Moehle	  et	  al.,	  2012;	  Shieh	  et	  al.,	  2011).	  Whether	  and	  how	  ubH2B	  regulates	  splicing	  directly	  
or	  indirectly	  is	  unclear.	  
We	  have	  developed	  a	  method	  to	  synthesize	  nonhydrolyzable	  mimics	  of	  ubH2A	  and	  
ubH2B	  in	  large	  quantities.	  Using	  these	  proteins	  in	  pulldown	  assays	  from	  nuclear	  extracts,	  
we	  identified	  a	  DUB,	  Usp15,	  that	  binds	  to	  ubiquitinated	  histones	  with	  high	  affinity.	  We	  also	  
found	  that	  Usp15	  associates	  indirectly	  with	  the	  ubH2B	  ligase	  RNF20/RNF40	  and	  directly	  
with	  a	  component	  of	  the	  splicing	  machinery,	  SART3.	  Our	  characterization	  of	  the	  
Usp15/SART3/ubH2B	  interactions	  points	  to	  a	  direct	  link	  between	  H2B	  deubiquitination	  
and	  co-­‐transcriptional	  pre-­‐mRNA	  splicing.	  
	  
3.2	  Experimental	  Procedures	  
3.2.1	  Plasmids	  and	  antibodies	  
The	  coding	  sequences	  of	  Usp158,	  Usp15NTD(1-­‐222),	  Usp15CTD(256-­‐952),	  Usp49	  and	  
SART310,	  were	  cloned	  into	  the	  pcDNA5	  FRT/TO	  vector	  (Life	  Technologies)	  downstream	  of	  
a	  tandem	  Flag-­‐Flag-­‐HA	  epitope	  tag.	  Site-­‐directed	  mutagenesis	  was	  used	  to	  generate	  all	  
point	  mutations.	  The	  following	  plasmids	  were	  used	  for	  bacterial	  expression:	  pMal-­‐C2	  
Usp15,	  pGEX4T-­‐2	  Usp15-­‐His6,	  pGEX4T-­‐2	  Usp4-­‐His6,	  pET21a	  Flag-­‐HA-­‐H2A,	  pET21a	  Flag-­‐
HA-­‐H2B,	  pET21a	  H2A(K119C),	  pET21a	  H2B(K120C),	  and	  pET3a	  His6-­‐Ub(G76C).	  For	  
expression	  in	  Sf21	  insect	  cells,	  the	  coding	  sequences	  of	  Usp15,	  SART3,	  RNF20,	  and	  RNF40	  
were	  cloned	  into	  pBacPAK6	  vectors	  with	  N-­‐terminal	  His6-­‐Flag	  or	  His6-­‐Myc	  sequences	  and	  
recombinant	  viruses	  were	  generated	  following	  the	  manufacturer’s	  instructions	  (Clontech).	  	  
Antibodies	  were	  purchased	  for	  detection	  of	  tubulin	  (DM1A)	  (Sigma	  T9026),	  Usp15	  
(abcam	  ab56900),	  Usp4	  (Bethyl	  A300-­‐830A),	  RNF20	  (Abcam	  ab32629),	  RNF40	  (Abcam	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ab26082),	  SART3	  (Abcam	  ab36137),	  Nap1L1	  (Abcam	  ab21630),	  ubH2A	  (Cell	  Signaling	  
82405),	  ubH2B	  (MediMabs	  MM-­‐0029P),	  H2B	  (Millipore	  07-­‐371),	  H3	  (Abcam	  ab1791),	  
H3K4me3	  (Abcam	  ab8580),	  H3K79me2	  (Abcam	  ab3594),	  H3K36me3	  (Abcam	  ab9050),	  
RNAPII	  CTD	  S2P	  (Abcam	  ab5095),	  RNAPII	  CTD	  S5P	  (Abcam	  ab5131),	  RNAPII	  CTD	  
(Covance	  MMS-­‐126R),	  Myc	  (9E10)	  (Millipore	  05-­‐419),	  Flag	  (Sigma	  F7425),	  and	  Flag	  (Pierce	  
MA1-­‐91878).	  
	  
3.2.2	  Cell	  culture,	  transfections	  and	  treatments	  
DMEM	  supplemented	  with	  10%	  fetal	  bovine	  serum	  (FBS),	  2	  mM	  GlutaMAX,	  100	  
units/mL	  pen/strep	  (Life	  Technologies)	  was	  used	  to	  culture	  HeLa,	  HEK293	  and	  their	  
derivatives.	  DMEM/F-­‐12	  (1:1)	  supplemented	  with	  2.5	  mM	  L-­‐Glutamine,	  10%	  FBS,	  15	  mM	  
Hepes-­‐KOH,	  pH	  7.5,	  and	  antibiotics	  as	  described	  above	  was	  used	  to	  culture	  hTERT-­‐RPE-­‐1	  
cells.	  Stable	  cell	  lines	  were	  generated	  with	  pcDNA5	  FRT/TO	  constructs	  using	  the	  parental	  
Flp-­‐In	  T-­‐REx	  cell	  lines	  (Life	  Technologies)	  as	  described	  by	  Yao	  et	  al.	  (Yao	  et	  al.,	  2006).	  
Doxycycline	  at	  1	  μg/mL	  was	  routinely	  used	  to	  induce	  target	  gene	  expression.	  Sf21	  cells	  
were	  cultured	  at	  27	  °C	  in	  Sf900-­‐II	  SFM	  medium	  according	  to	  ATCC	  guidelines.	  	  
DNA	  and	  siRNA	  were	  transfected	  with	  Lipofectamine	  2000	  or	  Lipofectamine	  
RNAiMax	  (Life	  Technologies),	  respectively,	  according	  to	  manufacturer’s	  instructions.	  
Depletion	  of	  RNAi	  target	  was	  assayed	  72	  hours	  post-­‐transfection	  by	  reverse	  transcription	  
(iScript,	  BioRad)	  and	  real-­‐time	  PCR	  (SYBR	  Green	  Supermix,	  Bio-­‐Rad),	  or	  by	  
immunoblotting.	  siRNA	  sequences	  used	  are:	  Usp4	  (5’CGAAGAAUGGAGAGGAACAUU3’),	  
RNF20	  (5’GAAGGCAGCUGUUGAAGAU3’),	  SART3	  #1	  (5’GGAGACAGGAAAUGCCUUA3’),	  and	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SART3	  #2	  (5’GAUGUGGUGUCCUGAGAUA3’).	  siGenome	  pools	  against	  Usp15	  and	  Usp11	  
were	  purchased	  from	  Dharmacon.	  	  
For	  cycloheximide	  chase	  experiments,	  cells	  were	  treated	  with	  100	  μg/mL	  
cycloheximide	  72	  hours	  after	  siRNA	  transfection.	  At	  indicated	  times,	  cells	  were	  harvested	  
in	  SDS-­‐lysis	  buffer	  (50	  mM	  Tris,	  pH	  8.1,	  10	  mM	  EDTA,	  1%	  SDS)	  and	  target	  protein	  levels	  
were	  analyzed	  by	  SDS-­‐PAGE	  and	  quantitative	  immunoblotting.	  The	  same	  procedure	  was	  
employed	  for	  experiments	  with	  the	  E1	  inhibitor,	  except	  that	  cells	  were	  treated	  with	  10	  μM	  
E1	  inhibitor.	  Quantitative	  immunoblots	  used	  fluorescent	  secondary	  antibodies	  and	  were	  
analyzed	  with	  a	  Li-­‐COR	  Odyssey	  scanner	  and	  Image	  Studio	  Software.	  
	  
3.2.3	  Recombinant	  proteins	  
For	  recombinant	  proteins	  expressed	  in	  bacteria,	  BL21(DE3)	  E.	  coli	  bearing	  the	  
expression	  plasmid	  were	  grown	  to	  log	  phase	  and	  expression	  was	  induced	  with	  0.4	  mM	  
IPTG	  at	  37	  °C	  for	  3	  hours.	  The	  only	  exception	  was	  MBP-­‐Usp15,	  whose	  expression	  was	  
induced	  at	  19	  °C	  for	  16	  hours	  before	  harvesting.	  	  
GST-­‐Usp15-­‐His6	  purification:	  cell	  pellets	  were	  resuspended	  in	  PBS	  containing	  1%	  
Tween-­‐20	  and	  PIC	  (protease	  inhibitor	  cocktail:	  1	  mM	  PMSF,	  50	  mM	  TLCK,	  1	  mg/mL	  
Pepstatin,	  1	  mg/mL	  Leupeptin)	  and	  lysed	  by	  sonication.	  Affinity	  purification	  with	  
glutathione-­‐agarose	  (GE	  Healthcare)	  was	  performed	  according	  to	  manufacturer’s	  
instructions.	  The	  eluate	  was	  further	  purified	  with	  Ni-­‐NTA	  agarose	  (Qiagen)	  following	  
manufacturer’s	  instructions.	  Final	  elutions	  containing	  >90%	  full-­‐length	  Usp15	  were	  




MBP	  and	  MBP-­‐Usp15	  purification:	  cell	  pellets	  were	  lysed	  in	  50	  mM	  Tris,	  pH	  7.6,	  300	  
mM	  NaCl,	  1	  mM	  EDTA,	  10	  mM	  MgCl2,	  0.01	  mg/mL	  DNase	  I,	  5	  mM	  bME;	  affinity	  purification	  
with	  amylose	  resin	  (New	  England	  Biolabs)	  were	  done	  according	  to	  manufacturer’s	  
instructions.	  Eluates	  containing	  purified	  proteins	  were	  dialyzed	  against	  20	  mM	  Tris,	  pH	  7.6,	  
50	  mM	  NaCl,	  5	  mM	  bME,	  10%	  glycerol.	  MBP-­‐Usp15	  was	  further	  purified	  on	  a	  Mono	  Q	  
column	  using	  a	  0.05-­‐0.8	  M	  linear	  gradient	  of	  NaCl.	  	  
His6-­‐Ub(G76C)	  was	  purified	  using	  Ni-­‐NTA	  agarose	  according	  to	  manufacturer’s	  
protocol	  except	  that	  5	  mM	  bME	  was	  added	  in	  all	  buffers.	  Eluates	  were	  dialyzed	  against	  10	  
mM	  Tris,	  pH	  8.0,	  50	  mM	  NaCl,	  0.2	  mM	  EDTA,	  10	  mM	  bME,	  and	  then	  passed	  through	  Q	  
Sepharose	  Fast	  Flow	  resin	  (GE	  Healthcare).	  His6-­‐Ub(G76C)	  remained	  in	  the	  flow-­‐through,	  
which	  was	  dialyzed	  into	  1	  mM	  HOAc	  prior	  to	  lyophilization.	  	  
Recombinant	  histones	  were	  expressed	  and	  purified	  according	  to	  Dyer	  et	  al.	  (Dyer	  et	  
al.,	  2004).	  Those	  that	  contained	  the	  cysteine	  substitution	  were	  dialyzed	  into	  1	  mM	  HOAc	  in	  
the	  final	  step	  prior	  to	  lyophilization.	  His6-­‐Usp2cc	  and	  His6-­‐Nap1	  were	  purified	  as	  
described	  (Baker	  et	  al.,	  2005;	  McBryant	  et	  al.,	  2003).	  
His6-­‐Flag-­‐SART3	  was	  expressed	  in	  Sf21	  insect	  cells	  using	  the	  BacPAK	  baculovirus	  
expression	  system	  (Clontech).	  72	  hours	  post-­‐	  infection	  with	  recombinant	  virus,	  cells	  were	  
harvested	  and	  recombinant	  SART3	  was	  enriched	  with	  Ni-­‐NTA	  agarose.	  Eluates	  from	  the	  Ni-­‐
NTA	  column	  were	  dialyzed	  against	  20	  mM	  Tris,	  pH	  7.6,	  50	  mM	  NaCl,	  5	  mM	  bME,	  followed	  
by	  further	  purification	  on	  a	  Mono	  Q	  5/50	  GL	  column	  (GE	  Healthcare)	  by	  HPLC.	  A	  linear	  
gradient	  of	  0.05–0.8	  M	  NaCl	  in	  20	  mM	  Tris,	  pH	  7.6,	  5	  mM	  bME,	  10%	  glycerol	  was	  applied	  
and	  SART3	  was	  eluted	  at	  450	  mM	  NaCl.	  To	  eliminate	  contaminating	  DUB	  activities	  that	  co-­‐
purified	  with	  SART3,	  peak	  fractions	  from	  the	  Mono	  Q	  column	  were	  diluted	  to	  lower	  the	  salt	  
	  
	  69	  
to	  200	  mM,	  incubated	  with	  1.7	  μM	  Ub-­‐vinyl	  sulfone	  (Ub-­‐VS;	  BostonBiochem)	  for	  2	  hours	  at	  
37	  °C,	  and	  then	  passed	  through	  a	  Superdex	  200	  column	  to	  remove	  excess	  Ub-­‐VS.	  The	  Ub-­‐
VS-­‐treated	  SART3	  did	  not	  affect	  Ub-­‐AMC	  hydrolysis	  by	  Usp15	  (data	  not	  shown).	  
	  
3.2.4	  Histone	  dimer,	  octamer	  and	  mononucleosome	  reconstitution	  
147	  bp	  DNA	  containing	  601	  positioning	  sequence	  were	  prepared	  according	  to	  Dyer	  
et	  al.	  (Dyer	  et	  al.,	  2004).	  Purified	  recombinant	  human	  H2A,	  H2B	  (or	  semi-­‐synthetic	  ubH2B),	  
H3.3	  and	  H4	  were	  assembled	  into	  octamers	  and	  further	  purified	  on	  a	  Superdex	  200	  
column.	  H2A/H2B	  dimers	  were	  assembled	  similarly	  and	  further	  purified	  on	  a	  Superdex	  75	  
column.	  Canonical	  mononucleosomes	  were	  reconstituted	  by	  salt	  dialysis	  (Dyer	  et	  al.,	  2004)	  
and	  ubH2B-­‐containing	  nucleosomes	  were	  prepared	  by	  salt	  dilution	  according	  to	  McGinty	  et	  
al.	  (McGinty	  et	  al.,	  2008).	  Acid-­‐extracted	  histones	  were	  prepared	  as	  described	  by	  Rogakou	  
et	  al.	  except	  that	  acid-­‐soluble	  proteins	  were	  dialyzed	  against	  water	  to	  allow	  refolding	  of	  
histones	  (Rogakou	  et	  al.,	  2000).	  To	  prepare	  native	  nucleosomal	  substrates,	  HEK293	  cells	  
were	  lysed	  in	  hypotonic	  buffer	  (20	  mM	  Tris,	  pH	  8.0,	  10	  mM	  KCl,	  1	  mM	  MgCl2,	  0.3%	  NP-­‐40,	  
30	  mM	  N-­‐ethylenemaleimide	  and	  PIC)	  on	  ice	  for	  10	  minutes	  and	  centrifuged	  to	  collect	  
nuclei.	  Nuclei	  were	  resuspended	  at	  1x108	  cells/mL	  in	  hypotonic	  buffer	  supplemented	  with	  
420	  mM	  NaCl.	  Nuclei	  were	  again	  pelleted	  and	  washed	  twice	  in	  MNase	  (micrococcal	  
nuclease)	  digestion	  buffer	  (50	  mM	  Tris,	  pH	  8,	  10	  mM	  CaCl2,	  2	  mM	  MgCl2).	  Digestion	  was	  
performed	  with	  80	  U/mL	  MNase	  at	  25	  °C	  for	  30	  minutes	  and	  then	  the	  soluble	  fraction	  was	  
collected	  and	  digested	  again	  with	  20	  U/mL	  MNase	  to	  achieve	  homogeneous	  




3.2.5	  Semi-­‐synthesis	  of	  native	  ubH2B	  
The	  coding	  sequence	  of	  H2B(1-­‐116)	  was	  cloned	  into	  pTXB1	  vector	  (New	  England	  
Biolabs)	  between	  NdeI	  and	  SapI	  sites.	  The	  resulting	  plasmid	  was	  transformed	  into	  ER2566	  
cells	  (New	  England	  Biolabs)	  and	  expression	  of	  H2B(1-­‐116)-­‐intein	  fusion	  was	  induced	  with	  
0.5	  mM	  IPTG	  at	  25	  °C	  	  for	  6	  h.	  Cells	  were	  harvested	  and	  lysed	  in	  lysis	  buffer	  (50	  mM	  Tris,	  
pH	  7.6,	  200	  mM	  NaCl,	  1	  mM	  EDTA,	  supplemented	  with	  10	  mM	  MgCl2,	  20	  ug/mL	  DNase	  I	  
and	  PIC).	  Cleared	  lysates	  were	  incubated	  with	  chitin	  beads	  at	  4	  °C	  overnight,	  followed	  by	  
extensive	  wash	  of	  the	  beads	  with	  lysis	  buffer.	  To	  generate	  H2B(1-­‐116)-­‐a-­‐thioester,	  beads	  
were	  incubated	  with	  lysis	  buffer	  containing	  50	  mM	  mercaptoethansulfonate	  at	  4	  °C	  
overnight,	  followed	  by	  elution	  with	  SAU	  buffer	  (20	  mM	  NaOAc,	  pH	  5.2,	  7M	  urea).	  Eluates	  
were	  further	  purified	  on	  a	  Mono	  S	  column	  by	  HPLC.	  Fractions	  containing	  >90%	  H2B(1-­‐
116)	  were	  pooled	  and	  presence	  of	  the	  thioester	  was	  confirmed	  by	  MALDI-­‐TOF	  mass	  
spectrometry.	  Subsequent	  synthesis	  follows	  the	  scheme	  as	  reported	  previously	  (Haj-­‐Yahya	  
et	  al.,	  2012).	  
	  
3.2.6	  Supercoiling	  assay	  
Supercoiling	  assays	  were	  performed	  as	  described	  previously	  (Dechassa	  et	  al.,	  2011)	  
except	  that	  pGEM3Z	  plasmid	  DNA	  was	  used	  instead	  of	  pBR322	  and	  the	  final	  products	  were	  








Cells	  were	  cultured	  on	  coverslips	  and	  fixed	  with	  2.5%	  paraformaldehyde	  at	  37	  °C	  for	  
10	  minutes.	  After	  washing	  with	  PBS,	  cells	  were	  permeabilized	  in	  wash	  buffer	  (PBS,	  0.1%	  
Triton	  X-­‐100)	  at	  25	  °C	  for	  20	  minutes.	  This	  was	  followed	  by	  blocking	  in	  PBS,	  5%	  BSA,	  0.1%	  
Triton	  X-­‐100,	  2	  mM	  MgCl2	  for	  10	  minutes,	  and	  incubations	  with	  primary	  and	  secondary	  
antibodies	  with	  washes	  in	  between.	  Cells	  were	  then	  stained	  with	  DAPI	  (1ug/mL)	  for	  5	  
minutes	  before	  coverslips	  were	  mounted	  to	  glass	  slides	  with	  ProLong	  Gold	  antifade	  reagent	  
(Life	  Technologies).	  For	  staining	  using	  ubH2B	  antibody	  (Cell	  Signaling),	  cells	  were	  fixed	  
and	  permeabilized	  as	  described	  above.	  Next,	  chromatin	  was	  unwound	  by	  treating	  with	  2	  M	  
HCl	  in	  PBS	  for	  10	  minutes	  at	  37	  °C.	  The	  remainder	  of	  the	  staining	  protocol	  was	  as	  described	  
above	  except	  PBS	  was	  used	  for	  all	  wash	  steps.	  
	  
3.2.8	  Generation	  of	  crosslinked	  ub*histone	  mimics	  
Crosslinking	  reactions	  adopted	  the	  procedure	  described	  by	  Yin	  et	  al.	  (Yin	  et	  al.,	  
2000b).	  Lyophilized	  His6-­‐Ub(G76C),	  H2A(K119C),	  or	  H2B(K120C)	  was	  resuspended	  in	  10	  
mM	  HOAc,	  7	  M	  urea	  at	  10	  mg/mL.	  Histone	  and	  Ub	  were	  at	  a	  2:1	  molar	  ratio	  in	  6	  M	  urea,	  50	  
mM	  sodium	  borate,	  pH	  8.5,	  5	  mM	  TCEP	  (tris(2-­‐carboxyethyl)phosphine).	  The	  crosslinker,	  
1,3-­‐dichloroacetone,	  was	  added	  at	  a	  molar	  concentration	  equal	  to	  half	  of	  the	  sum	  of	  all	  free	  
cysteines	  in	  the	  reaction.	  After	  incubation	  on	  ice	  for	  30	  min,	  the	  reaction	  was	  stopped	  with	  
5	  mM	  βME.	  To	  remove	  unreacted	  histones,	  the	  mixture	  was	  diluted	  1:10	  in	  denaturing	  
binding	  buffer	  (50	  mM	  NaPi,	  pH	  8,	  300	  mM	  NaCl,	  6	  M	  urea,	  10	  mM	  imidazole,	  5	  mM	  βME)	  
and	  incubated	  with	  Ni-­‐NTA	  agarose.	  After	  washing	  with	  the	  same	  buffer,	  the	  bound	  
fraction,	  which	  contained	  Ub,	  Ub*Ub	  and	  Ub*histones,	  was	  eluted	  with	  the	  binding	  buffer	  
	  
	  72	  
plus	  250	  mM	  imidazole.	  Eluate	  was	  used	  to	  reconstitute	  either	  histone	  dimers	  or	  octamers	  
directly.	  Ub	  and	  Ub*Ub	  were	  removed	  during	  the	  subsequent	  gel	  filtration	  step.	  
To	  generate	  ub*GSH	  (Ub	  crosslinked	  to	  glutathione),	  a	  1:5	  molar	  ratio	  of	  His6-­‐
Ub(G76C)	  to	  glutathione	  was	  used	  to	  perform	  the	  crosslinking	  as	  described	  above,	  except	  
that	  urea	  was	  omitted	  from	  the	  reaction.	  The	  reaction	  mixture	  was	  loaded	  on	  a	  Mono	  S	  
5/50	  column	  in	  50	  mM	  ammonium	  acetate,	  pH	  5.5,	  5	  mM	  βME	  and	  proteins	  were	  eluted	  
with	  a	  linear	  gradient	  of	  0–1	  M	  NaCl	  in	  the	  same	  buffer.	  Peak	  fractions	  containing	  ub*GSH	  
were	  pooled	  and	  purified	  further	  with	  the	  same	  column.	  The	  ub*GSH	  product	  was	  
confirmed	  by	  MALDI-­‐TOF	  mass	  spectrometry	  (data	  not	  shown).	  
	  
3.2.9	  Deubiquitination	  assays	  
For	  deubiquitination	  of	  Ub-­‐AMC	  (BostonBiochem),	  reactions	  were	  performed	  in	  
assay	  buffer	  (50	  mM	  Hepes,	  pH	  7.5,	  0.5	  mM	  EDTA,	  0.5	  mg/mL	  BSA,	  200	  mM	  NaCl,	  5	  mM	  
DTT)	  with	  2	  nM	  enzyme	  unless	  otherwise	  indicated;	  0.05%	  Brij-­‐35	  was	  added	  to	  reactions	  
containing	  SART3.	  In	  competition	  assays,	  competitor	  proteins	  were	  added	  to	  an	  enzyme-­‐
containing	  master	  mix	  and	  reactions	  were	  initiated	  by	  addition	  of	  the	  substrate.	  Ub-­‐AMC	  
hydrolysis	  was	  monitored	  continuously	  for	  1	  h	  at	  30	  °C	  on	  a	  fluorescence	  plate	  reader	  
(BioTek	  Synergy	  4,	  λex	  =	  340	  nm	  and	  λem	  =	  440	  nm);	  initial	  velocities	  of	  fluorescence	  
increases	  were	  converted	  to	  concentration	  of	  AMC	  released	  per	  min	  by	  reference	  to	  an	  
AMC	  standard.	  Data	  were	  fitted	  with	  the	  Michaelis-­‐Menten	  equation	  and,	  for	  competition	  
assays,	  with	  a	  one-­‐site	  binding	  model	  using	  PRISM	  (Graphpad	  Software).	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Qualitative	  deubiquitinating	  assays	  using	  native	  or	  semi-­‐synthetic	  ubH2B	  substrates	  
were	  done	  at	  37	  °C	  for	  indicated	  times	  in	  reaction	  buffer	  (10	  mM	  Hepes,	  pH	  7.5,	  200	  mM	  
NaCl,	  0.05%	  Brij-­‐35,	  25	  μM	  ZnSO4,	  5	  mM	  DTT,	  0.5	  mg/mL	  BSA).	  	  
	  
3.3	  Results	  
3.3.1	  Usp15	  and	  Usp4	  bind	  to	  monoubiquitinated	  histone	  H2A	  or	  H2B	  in	  vitro	  
Although	  ubiquitination	  of	  histone	  H2A	  or	  H2B	  has	  been	  associated	  with	  a	  variety	  of	  
biological	  consequences	  in	  the	  cell,	  few	  direct	  effectors	  of	  ubiquitinated	  histones	  have	  been	  
identified.	  We	  aimed	  to	  identify	  proteins	  that	  bind	  preferentially	  to	  either	  unmodified,	  
ubH2A-­‐containing,	  or	  ubH2B-­‐containing	  histone	  dimers.	  To	  avoid	  heterogeneous	  post-­‐
translational	  modifications	  that	  naturally	  occur	  on	  histones	  prepared	  from	  cells,	  we	  
adopted	  a	  strategy	  that	  was	  previously	  employed	  to	  synthesize	  nonhydrolyzable	  di-­‐Ub	  
analogues	  (Yin	  et	  al.,	  2000b)	  and	  mono-­‐	  and	  poly-­‐ubiquitinated	  PCNA	  (Carlile	  et	  al.,	  2009)	  
from	  recombinant	  proteins.	  Because	  there	  are	  no	  native	  cysteines	  in	  Ub,	  H2A,	  or	  H2B,	  we	  
used	  site-­‐directed	  mutagenesis	  to	  incorporate	  a	  cysteine	  at	  the	  C-­‐terminus	  of	  Ub	  (UbG76C)	  
and	  the	  primary	  ubiquitination	  site	  on	  H2A	  or	  H2B	  (H2AK119C	  and	  H2BK120C,	  
respectively).	  Each	  mutant	  protein	  was	  expressed	  in	  E.	  coli	  and	  purified	  to	  homogeneity.	  Ub	  
was	  then	  crosslinked	  to	  each	  histone	  with	  a	  bifunctional	  thiol	  crosslinker,	  dichloroacetone	  
(Figure	  3.1A).	  The	  resulting	  crosslink	  is	  one	  C-­‐C	  bond	  longer	  than	  an	  isopeptide	  linkage	  and	  
bears	  an	  additional	  carboxylate	  group,	  but	  has	  the	  advantage	  that	  it	  is	  highly	  stable	  and	  not	  
susceptible	  to	  deubiquitinating	  activities.	  Purified	  ub*H2A	  or	  ub*H2B	  (*	  denotes	  the	  
crosslink),	  was	  assembled	  with	  Flag-­‐tagged	  H2B	  or	  H2A	  into	  histone	  dimers	  (Figure	  3.1B)	  





	   Proteins	  bound	  to	  unmodified	  or	  ubiquitinated	  dimers	  under	  stringent	  conditions	  
(470	  mM	  NaCl)	  were	  identified	  by	  mass	  spectrometry.	  Among	  the	  few	  proteins	  that	  
preferentially	  bound	  to	  ub*H2A	  or	  ub*H2B-­‐containing	  histone	  dimers,	  we	  identified	  Usp15.	  
Immunoblotting	  analysis	  confirmed	  that	  Usp15	  bound	  only	  to	  ubiquitinated	  histone	  dimers	  
(i.e.,	  ub*H2A/H2B	  or	  H2A/ub*H2B),	  but	  not	  to	  Ub	  or	  unmodified	  H2A/H2B	  (Figure	  3.1C	  
and	  Supplemental	  Fig.	  S1A).	  Nucleosome	  assembly	  protein-­‐1	  (Nap1)	  was	  used	  as	  a	  control	  
as	  it	  showed	  no	  preference	  for	  unmodified	  or	  ubiquitinated	  histone	  dimers	  (Fierz	  et	  al.,	  
2012a).	  Human	  Usp15	  has	  73%	  sequence	  similarity	  with	  another	  DUB,	  Usp4.	  Although	  
Usp4	  was	  not	  identified	  by	  mass	  spectrometry,	  when	  we	  immunoblotted	  for	  Usp4	  in	  the	  
pull-­‐downs,	  we	  found	  that	  it	  behaved	  identically	  to	  Usp15	  (Figure	  3.1C).	  
Although	  histones	  are	  highly	  charged	  and	  aggregation-­‐prone,	  among	  the	  numerous	  
proteins	  present	  in	  the	  nuclear	  extract,	  Usp15	  was	  one	  of	  the	  few	  proteins	  that	  bound	  
exclusively	  to	  ubiquitinated	  but	  not	  unmodified	  histones.	  In	  order	  to	  quantify	  the	  affinity	  
and	  specificity	  of	  the	  interactions	  between	  Usp15	  and	  the	  ubiquitinated	  histones,	  we	  used	  
the	  nonhydrolyzable	  ub*histone	  mimics	  in	  DUB	  activity	  assays	  as	  potential	  inhibitors	  of	  
deubiquitination.	  Purified	  recombinant	  Usp15	  can	  hydrolyze	  Ub-­‐AMC,	  a	  minimal	  and	  
general	  DUB	  substrate	  composed	  of	  Ub	  conjugated	  to	  7-­‐amino-­‐4-­‐methylcoumarin	  (AMC)	  
(Figure	  3.2).	  Upon	  addition	  of	  ub*H2A/H2B	  or	  H2A/ub*H2B	  dimers,	  Ub-­‐AMC	  hydrolysis	  by	  
Usp15	  was	  inhibited	  in	  a	  dose-­‐dependent	  manner	  (Figure	  3.3A).	  In	  contrast,	  similar	  
concentrations	  of	  unmodified	  H2A/H2B	  dimers	  did	  not	  inhibit	  Usp15	  significantly.	  To	  
address	  whether	  the	  artificial	  crosslink	  mediates	  unexpected	  interactions	  with	  the	  DUB,	  we	  
prepared	  UbG76C	  crosslinked	  to	  glutathione	  via	  dichloroacetone.	  Whereas	  the	  IC50	  values	  









nearly	  60-­‐fold	  higher	  (Figure	  3.3A).	  Like	  Usp15,	  Usp4	  was	  strongly	  inhibited	  by	  
H2A/ub*H2B	  with	  an	  IC50	  of	  0.39	  mM	  (Figure	  3.3B).	  Further	  kinetic	  analysis	  showed	  that	  
inhibition	  of	  Usp15	  by	  H2A/ub*H2B	  was	  best	  described	  using	  a	  competitive	  binding	  model	  
with	  a	  Ki	  of	  34	  nM	  (Figure	  3.3C).	  These	  results	  demonstrate	  that	  the	  interactions	  between	  
Usp15	  and	  ubiquitinated	  histones	  are	  direct,	  specific,	  and	  of	  high	  affinity.	  Furthermore,	  
because	  H2A/ub*H2B	  did	  not	  affect	  Ub-­‐AMC	  hydrolysis	  by	  the	  Usp2	  catalytic	  core	  domain	  
(Usp2cc)	  (Figure	  3.3A)	  (Ryu	  et	  al.,	  2006),	  this	  behavior	  is	  not	  a	  property	  shared	  among	  the	  
USP	  family	  of	  DUBs.	  	  
	  
3.3.2	  Usp15	  deubiquitinates	  free	  and	  nucleosomal	  histones	  with	  a	  strong	  preference	  for	  
free	  histones	  
	   To	  test	  directly	  whether	  Usp15	  deubiquitinates	  free	  histones	  or	  nucleosomes,	  we	  
prepared	  acid-­‐extracted	  histones	  from	  HEK293	  cells	  and	  mononucleosomes	  purified	  from	  
micrococcal	  nuclease-­‐digested	  chromatin.	  As	  a	  positive	  control,	  we	  used	  the	  recombinant	  
DUB	  module	  of	  the	  yeast	  SAGA	  complex	  (SAGADUB),	  which	  is	  known	  to	  deubiquitinate	  H2B	  
in	  vivo	  and	  in	  vitro	  (Kohler	  et	  al.,	  2010;	  Samara	  et	  al.,	  2010).	  Figure	  3.4A	  shows	  that	  both	  
Usp15	  and	  SAGADUB	  deubiquitinated	  H2B	  as	  free	  histones	  or	  in	  nucleosomes.	  Because	  
histones	  and	  nucleosomes	  purified	  from	  cells	  are	  heterogeneous,	  we	  sought	  to	  obtain	  a	  
chemically-­‐defined	  substrate.	  Using	  a	  strategy	  that	  combined	  solid	  phase	  peptide	  synthesis	  
and	  native	  chemical	  ligation	  (Figure	  3.5A)	  we	  obtained	  ubH2B	  that	  has	  a	  native	  Ub–histone	  
isopeptide	  linkage	  and	  is	  free	  of	  other	  post-­‐translational	  modifications	  (Figure	  3.5B)(Haj-­‐
Yahya	  et	  al.,	  2012;	  Kumar	  et	  al.,	  2011).	  The	  ubH2B	  was	  successfully	  assembled	  with	  









(Figure	  3.5C).	  Using	  these	  chemically-­‐defined	  substrates,	  we	  found	  that	  both	  Usp15	  and	  
SAGADUB	  deubiquitinated	  H2B	  in	  the	  context	  of	  histone	  octamers	  or	  mononucleosomes	  
(Figure	  3.4B).	  However,	  with	  either	  the	  cell-­‐derived	  or	  semi-­‐synthetic	  substrates,	  Usp15	  
preferentially	  deubiquitinated	  the	  histones	  whereas	  SAGADUB	  preferred	  the	  ubH2B-­‐
containing	  nucleosomes.	  Recombinant	  Usp15	  and	  SAGADUB	  have	  comparable	  activities	  
against	  nucleosomal	  substrates,	  but	  Usp15	  is	  ~10-­‐fold	  more	  active	  against	  the	  histone	  
substrates	  (Figure	  3.4C).	  	  
	  
3.3.3	  Usp4	  and	  Usp15	  associate	  with	  RNF20/RNF40	  and	  promote	  RNF40	  stability	  
	   We	  established	  inducible	  stable	  cell	  lines	  that	  express	  full-­‐length	  or	  truncated	  
versions	  of	  Usp15	  and	  Usp4.	  Previously,	  a	  large-­‐scale	  effort	  by	  Sowa	  et	  al.	  had	  surveyed	  
potential	  DUB-­‐associated	  proteins	  by	  overexpressing	  HA-­‐tagged	  DUBs	  in	  HEK293	  cells,	  
followed	  by	  anti-­‐HA	  immunoprecipitation	  and	  identification	  of	  co-­‐immuoprecipitated	  
proteins	  by	  mass	  spectrometry	  (Sowa	  et	  al.,	  2009).	  Among	  the	  potential	  interactors	  of	  
Usp15,	  RNF40,	  a	  subunit	  of	  the	  mammalian	  H2B	  E3	  ligase,	  was	  identified	  with	  high	  
confidence.	  Our	  cell	  lines	  have	  the	  advantage	  that,	  because	  of	  leaky	  expression	  in	  the	  
absence	  of	  doxycycline	  (Dox)	  (Figure	  3.6A),	  we	  could	  examine	  protein-­‐protein	  interactions	  
with	  a	  physiologically-­‐relevant	  level	  of	  Flag-­‐Usp15.	  We	  found	  that	  both	  endogenous	  RNF20	  
and	  RNF40	  co-­‐immunoprecipitated	  with	  Usp15	  either	  with	  or	  without	  overexpression	  by	  
induction	  with	  Dox	  (Figure	  3.6B).	  Similarly,	  Flag-­‐tagged	  Usp4	  co-­‐immunoprecipitated	  with	  
endogenous	  RNF20	  and	  RNF40,	  albeit	  less	  efficiently	  (Figure	  3.6C).	  	  
The	  N-­‐terminal	  portion	  (NTD)	  of	  Usp15	  or	  Usp4	  is	  comprised	  of	  two	  well-­‐defined	  





the	  large	  C-­‐terminal	  portion	  (CTD)	  contains	  the	  catalytic	  residues	  (Figure	  3.7A).	  The	  DUSP	  
domain	  has	  been	  suggested	  to	  mediate	  protein-­‐protein	  interactions.	  However,	  we	  found	  
that	  the	  NTD	  of	  Usp15	  did	  not	  associate	  with	  RNF20,	  whereas	  the	  full-­‐length	  protein,	  or	  to	  
a	  lesser	  extent,	  the	  CTD,	  bound	  to	  endogenous	  RNF20	  (Figure	  3.7B).	  	  
	   Other	  DUB–E3	  associations	  have	  been	  reported	  previously	  (Clague	  et	  al.,	  2012;	  
Sowa	  et	  al.,	  2009).	  The	  best-­‐studied	  example	  is	  the	  Usp7–Mdm2	  pair	  that	  regulates	  p53	  
ubiquitination.	  Depending	  on	  protein	  levels	  and	  other	  signals,	  Usp7	  could	  either	  
deubiquitinate	  p53	  to	  promote	  substrate	  stability	  or	  deubiquitinate	  Mdm2	  to	  stabilize	  the	  
E3	  ligase,	  thus	  leading	  to	  opposite	  downstream	  consequences	  (Li	  et	  al.,	  2004;	  Meulmeester	  
et	  al.,	  2005).	  We	  sought	  to	  examine	  the	  function	  of	  the	  Usp15–RNF20/RNF40	  pair	  in	  HeLa	  
cells.	  Upon	  siRNA-­‐mediated	  knockdown	  of	  Usp15	  or	  Usp4,	  we	  did	  not	  observe	  significant	  
changes	  of	  steady-­‐state	  levels	  of	  either	  ubH2B	  or	  RNF20	  (Figure	  3.8A).	  The	  human	  genome	  
encodes	  a	  paralogue	  of	  Usp15	  and	  Usp4,	  Usp11	  (Elliott	  et	  al.,	  2011).	  We	  attempted	  to	  
knockdown	  Usp11	  or	  a	  combination	  of	  all	  three	  DUBs,	  but	  we	  still	  did	  not	  observe	  
significant	  changes	  of	  ubH2B	  or	  RNF20	  levels	  (Figure	  3.8A).	  By	  quantitative	  mRNA	  
analysis,	  the	  knockdowns	  appeared	  to	  be	  effective	  (Figure	  3.9A);	  however,	  due	  to	  lack	  of	  
high-­‐affinity	  antibodies,	  we	  could	  only	  monitor	  knockdown	  at	  the	  protein	  level	  for	  Usp15	  
(Figure	  3.8A).	  
	   Steady-­‐state	  protein	  levels	  are	  determined	  by	  both	  the	  rates	  of	  synthesis	  and	  
degradation.	  To	  monitor	  directly	  the	  rate	  of	  degradation,	  we	  performed	  a	  cycloheximide	  
chase	  in	  cells	  depleted	  of	  Usp15	  and	  Usp4	  (Figure	  3.8B).	  In	  cells	  treated	  with	  control	  siRNA,	  
both	  RNF20	  and	  RNF40	  were	  highly	  stable	  and	  showed	  no	  detectable	  changes	  of	  protein	  








	  the	  stability	  of	  RNF20	  but	  did	  accelerate	  turnover	  of	  RNF40.	  The	  effect	  on	  RNF40	  half-­‐life	  
was	  moderate,	  but	  reproducible	  (Figure	  3.8C	  shows	  quantitation	  from	  three	  independent	  
experiments).	  Therefore,	  Usp15	  and	  Usp4	  play	  only	  a	  minor	  role	  in	  protecting	  the	  E3	  ligase	  
RNF40	  from	  degradation,	  possibly	  by	  counteracting	  its	  auto-­‐ubiquitination.	  
	   To	  test	  whether	  Usp15	  directly	  interacts	  with	  RNF20	  or	  RNF40,	  we	  co-­‐expressed	  all	  
three	  proteins	  in	  insect	  cells.	  We	  observed	  a	  1:1	  complex	  formed	  between	  RNF20	  and	  
RNF40,	  but	  failed	  to	  detect	  significant	  co-­‐immunoprecipitation	  with	  Usp15	  despite	  robust	  
expression	  levels	  (data	  not	  shown).	  We	  note	  that	  co-­‐immunoprecipitation	  of	  Usp15	  and	  
RNF20/RNF40	  in	  mammalian	  cells	  was	  also	  inefficient	  (Figure	  3.6A).	  These	  led	  us	  to	  
conclude	  that	  Usp15’s	  association	  with	  RNF20/RNF40	  is	  likely	  to	  be	  indirect.	  
	  
3.3.4	  Usp15	  directly	  associates	  with	  the	  U4/U6	  recycling	  factor	  SART3	  
	   	  Previously,	  Song	  et	  al.	  reported	  that	  knockdown	  of	  Usp4	  leads	  to	  cell	  cycle	  defects	  
that	  are	  indicative	  of	  spindle	  checkpoint	  bypass.	  This	  was	  due	  to	  Usp4’s	  role	  in	  facilitating	  
pre-­‐mRNA	  splicing	  through	  its	  interactions	  with	  the	  splicesosome	  tri-­‐snRNP	  recycling	  
factor,	  Squamous	  cell	  Antigen	  Recognized	  by	  T	  cells	  3	  (SART3)	  (also	  called	  p110	  or	  Tip110)	  
(Song	  et	  al.,	  2010).	  One	  important	  point	  of	  splicing	  regulation	  is	  the	  formation/recycling	  of	  
the	  U4/U6.U5	  tri-­‐snRNP	  and	  this	  process	  is	  expedited	  by	  SART3	  (Ghetti	  et	  al.,	  1995).	  In	  the	  
early	  stage	  of	  spliceosome	  assembly,	  SART3	  promotes	  the	  formation	  of	  the	  U4/U6	  di-­‐
snRNP	  (Bell	  et	  al.,	  2002;	  Rader	  and	  Guthrie,	  2002).	  As	  the	  spliceosome	  matures,	  the	  U4	  






SART3	  homologs	  can	  be	  found	  in	  eukaryotes	  ranging	  from	  S.	  cerevisae	  to	  human	  
(Bell	  et	  al.,	  2002).	  The	  N-­‐terminal	  domain	  is	  comprised	  of	  7	  HAT	  (Half	  A	  TPR)	  domains,	  
which	  are	  critical	  for	  protein-­‐protein	  interactions	  during	  U4/U6	  recycling	  (Medenbach	  et	  
al.,	  2004).	  SART3	  also	  encodes	  a	  C-­‐terminal	  LSM	  domain,	  which	  is	  required	  for	  interactions	  
with	  the	  Lsm	  proteins	  associated	  with	  U4/U6	  (Rader	  and	  Guthrie,	  2002).	  Unlike	  other	  
SART3	  orthologs,	  the	  yeast	  ortholog	  Prp24	  exists	  as	  an	  N-­‐terminally	  truncated	  form	  of	  
SART3	  (Bell	  et	  al.,	  2002).	  It	  shares	  only	  22%	  sequence	  identity	  and	  contains	  4	  RRMs	  
compared	  to	  the	  2	  RRMs	  found	  in	  SART3.	  In	  addition	  to	  interacting	  with	  U4/U6-­‐associated	  
proteins,	  SART3	  also	  interacts	  directly	  with	  the	  RNA	  component	  of	  the	  U6	  snRNP	  (Bell	  et	  
al.,	  2002).	  Notably,	  SART3	  is	  not	  found	  in	  the	  tri-­‐snRNP	  complex	  (U4/U6.U5)	  or	  associated	  
with	  the	  spliceosome.	  
Within	  the	  cell,	  SART3	  is	  localized	  in	  the	  nucleus	  but	  is	  highly	  concentrated	  in	  Cajal	  
bodies	  (CBs)	  through	  an	  interaction	  with	  the	  CB-­‐associated	  protein	  coilin	  (Novotny	  et	  al.,	  
2011;	  Stanek	  and	  Neugebauer,	  2006).	  CBs	  have	  been	  characterized	  as	  centers	  of	  
spliceosome	  recycling,	  snRNP	  biogenesis,	  and	  histone	  mRNA	  processing.	  Within	  the	  CB,	  the	  
tri-­‐snRNP	  is	  recycled	  10-­‐times	  faster	  than	  the	  recycling	  rate	  outside	  of	  the	  CB	  (230	  tri-­‐SNPs	  
formed	  per	  minute	  per	  CB)	  (Novotny	  et	  al.,	  2011).	  	  	  
SART3	  also	  plays	  a	  role	  in	  the	  maintenance	  of	  pluripotency	  of	  ESCs	  by	  regulating	  the	  
alternative	  splicing	  of	  OCT4.	  In	  the	  undifferentiated	  state,	  the	  high	  expression	  level	  of	  
SART3	  is	  maintained	  by	  CMYC	  and	  the	  OCT4A	  isoform	  is	  produced	  (Liu	  et	  al.,	  2011).	  Upon	  
differentiation,	  CMYC	  and,	  consequently,	  SART3	  levels	  decrease.	  As	  a	  result,	  OCT4	  
undergoes	  alternative	  splicing	  and	  OCT4B	  is	  expressed,	  promoting	  cell	  differentiation	  (Liu	  
et	  al.,	  2013).	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Usp4	  was	  shown	  to	  directly	  bind	  SART3,	  facilitating	  Usp4-­‐mediated	  
deubiquitination	  of	  Prp3,	  a	  component	  of	  the	  U4	  snRNP,	  in	  order	  to	  facilitate	  the	  ejection	  of	  
U4	  and	  allow	  formation	  of	  the	  U2/U5/U6	  active	  splicing	  complex	  (Song	  et	  al.,	  2010).	  	  
Because	  of	  the	  high	  homology	  between	  Usp15	  and	  Usp4,	  we	  examined	  the	  
association	  between	  Usp15	  and	  SART3.	  Like	  Usp4,	  Usp15	  co-­‐immunoprecipitates	  via	  its	  
NTD	  with	  endogenous	  SART3	  (Figure	  3.10A).	  Additionally,	  SART3	  co-­‐immunoprecipitates	  
endogenous	  Usp15	  through	  the	  N-­‐terminal	  half	  of	  SART3	  that	  contains	  the	  HAT	  repeats	  
(Figures	  3.10B-­‐C).	  When	  we	  examined	  the	  cellular	  localization	  of	  Usp15,	  we	  found	  that	  
endogenous	  Usp15	  predominantly	  localizes	  to	  the	  cytoplasm	  with	  a	  small,	  but	  clearly	  
detectable,	  fraction	  that	  is	  nuclear	  (Figure	  3.11A).	  Interestingly,	  the	  Usp15	  NTD	  or	  CTD	  
expressed	  alone	  are	  primarily	  nuclear	  (Figure	  3.11B);	  these	  observations	  suggest	  that	  
intramolecular	  interactions	  within	  Usp15	  modulate	  its	  localization.	  SART3	  is	  exclusively	  
nuclear	  with	  a	  small	  fraction	  that	  localizes	  to	  nuclear	  puncta	  that	  have	  been	  reported	  to	  be	  
Cajal	  bodies	  (Stanek	  et	  al.,	  2003)	  where	  snRNP	  biogenesis	  and	  recycling	  is	  thought	  to	  occur	  
(Figure	  3.11C).	  Overexpression	  of	  SART3	  strongly	  enhanced	  localization	  of	  Usp15	  to	  the	  
nucleoplasm,	  but	  did	  not	  recruit	  Usp15	  to	  the	  Cajal	  bodies	  (Figure	  3.11C).	  	  
The	  Usp15–SART3	  interaction	  is	  direct,	  as	  purified	  recombinant	  Usp15	  and	  SART3	  
bind	  to	  each	  other	  in	  vitro	  (Figure	  3.8D).	  Using	  a	  ligand	  depletion	  assay,	  we	  estimated	  that	  










3.3.5	  SART3	  has	  histone	  chaperone-­‐like	  activities	  and	  enhances	  H2B	  deubiquitination	  by	  
Usp15	  
	   We	  noticed	  that	  SART3	  was	  identified	  by	  mass	  spectrometry	  in	  our	  previous	  
H2A/H2B	  histone	  dimer	  pull-­‐down	  experiments.	  Immunoblotting	  analysis	  confirmed	  that	  
SART3	  bound	  to	  unmodified	  H2A/H2B,	  ub*H2A/H2B,	  or	  H2A/ub*H2B	  histone	  dimers	  
(Figure	  3.12A).	  Note	  that	  under	  the	  high	  salt	  condition	  of	  the	  nuclear	  extract,	  SART3	  no	  
longer	  associates	  with	  Usp15	  (data	  not	  shown);	  thus,	  the	  association	  between	  SART3	  and	  
H2A/H2B	  is	  independent	  of	  Usp15	  and	  insensitive	  to	  Ub	  modification	  of	  the	  histones.	  
Because	  SART3	  and	  some	  of	  its	  associated	  proteins	  interact	  with	  RNA,	  we	  wanted	  to	  test	  if	  
its	  interactions	  with	  the	  histones	  were	  mediated	  by	  RNA.	  We	  treated	  the	  nuclear	  extract	  
with	  RNase	  A	  and	  repeated	  the	  pull-­‐down	  experiments.	  We	  found	  that	  RNase	  A	  treatment	  
had	  no	  effect	  on	  SART3–H2A/H2B	  binding	  (Figure	  3.12B).	  
Using	  purified	  recombinant	  proteins,	  we	  found	  that	  SART3	  not	  only	  directly	  binds	  to	  
H2A/H2B	  dimers,	  but	  also	  to	  H3/H4	  tetramers	  and	  histone	  octamers	  (Figure	  3.13A).	  In	  
contrast,	  we	  observed	  no	  binding	  to	  mononucleosomes.	  These	  properties	  suggest	  that	  
SART3	  has	  histone	  chaperone-­‐like	  activities.	  Classic	  histone	  chaperones,	  such	  as	  Nap1,	  
promote	  nucleosome	  assembly	  by	  disaggregating	  free	  histones	  to	  allow	  productive	  
histone–DNA	  interactions	  (Andrews	  et	  al.,	  2010;	  Elsasser	  and	  D'Arcy,	  2012).	  This	  
nucleosome	  assembly	  activity	  can	  be	  tested	  in	  an	  assay	  in	  which	  nucleosome	  formation	  on	  
relaxed	  circular	  DNA	  leads	  to	  supercoiling	  (Lusser	  and	  Kadonaga,	  2004).	  Using	  this	  assay,	  
we	  found	  that	  SART3	  promoted	  nucleosome	  formation	  in	  a	  dose-­‐dependent	  manner	  
(Figure	  3.13B).	  In	  comparison	  with	  Nap1,	  SART3’s	  ability	  to	  promote	  supercoiling	  is	  much	  







nucleosome	  assembly	  on	  a	  large	  scale.	  However,	  we	  cannot	  rule	  out	  that	  certain	  types	  of	  
post-­‐translationally	  modified	  histones	  or	  other	  associating	  factors	  may	  enhance	  
nucleosome	  assembly	  by	  SART3,	  or	  that	  SART3	  might	  facilitate	  assembly	  at	  specific	  sites	  on	  
chromatin.	  
	   Because	  SART3	  and	  Usp15	  interact,	  we	  explored	  the	  possibility	  that	  the	  interaction	  
could	  affect	  the	  Usp15	  deubiquitination	  activity.	  In	  vitro,	  SART3	  did	  not	  affect	  Ub-­‐AMC	  
hydrolysis	  by	  Usp15	  (Figure	  3.14A).	  However,	  the	  H2A/ub*H2B	  dimer	  was	  a	  much	  
stronger	  inhibitor	  of	  Usp15	  in	  the	  presence	  of	  SART3,	  suggesting	  that	  SART3	  could	  play	  a	  
role	  in	  substrate	  recruitment	  (Figure	  3.14B).	  Moreover,	  in	  contrast	  to	  SART3,	  addition	  of	  
the	  Nap1	  histone	  chaperone	  abolished	  the	  inhibition	  by	  H2A/ub*H2B.	  In	  experiments	  
where	  we	  assayed	  for	  a	  direct,	  positive	  effect	  of	  SART3	  on	  Usp15	  activity,	  we	  found	  
consistently	  that	  SART3	  enhanced	  deubiquitination	  of	  ubH2B	  in	  the	  context	  of	  histone	  
octamers,	  whereas	  Nap1	  inhibited	  (Figure	  3.14C).	  When	  ubH2B-­‐containing	  nucleosomes	  
were	  used	  as	  substrates,	  neither	  SART3	  nor	  Nap1	  affected	  deubiquitination	  (Figure	  3.14D).	  
These	  data	  strongly	  suggest	  that	  SART3	  is	  a	  specialized	  histone	  chaperone	  that	  helps	  to	  
recruit	  substrates	  to	  Usp15.	  	  
	  
3.3.6	  SART3	  regulates	  global	  ubH2B	  levels	  
	   Despite	  that	  Usp15	  binds	  to	  ubiquitinated	  histones	  with	  high	  affinity	  and	  efficiently	  
deubiquitinates	  histones	  in	  vitro,	  knockdown	  of	  Usp15	  alone	  or	  in	  combination	  with	  Usp4	  
did	  not	  affect	  global	  ubH2A	  or	  ubH2B	  levels	  (Figures	  3.8A	  and	  3.15B).	  One	  possibility	  is	  
that	  other	  cellular	  DUBs	  have	  redundant	  functions	  in	  histone	  deubiquitination.	  However,	  to	  






there	  was	  no	  effect	  on	  ubH2A	  levels	  (Figure	  3.15A).	  The	  increase	  in	  ubH2B	  was	  not	  caused	  
by	  increased	  levels	  of	  either	  subunit	  of	  the	  H2B	  E3	  ligase,	  RNF20	  or	  RNF40.	  Also,	  
knockdown	  of	  SART3	  did	  not	  affect	  Usp4	  or	  Usp15	  protein	  levels.	  When	  we	  examined	  other	  
histone	  modifications	  associated	  with	  active	  transcription,	  we	  found	  no	  changes	  in	  
H3K36me3	  or	  H3K4me3	  levels.	  However,	  the	  increase	  of	  ubH2B	  was	  accompanied	  by	  a	  
small	  increase	  in	  H3K79me2	  (Figure	  3.15A).	  Although	  both	  H3K4me3	  and	  H3K79me2	  are	  
dependent	  on	  ubH2B	  (Ng	  et	  al.,	  2002;	  Sun	  and	  Allis,	  2002),	  H3K4me3	  primarily	  localizes	  to	  
promoters	  and	  H3K79me2	  is	  found	  in	  ORFs.	  Genome-­‐wide,	  ubH2B	  localization	  correlates	  
poorly	  with	  H3K4me3,	  but	  strongly	  with	  H3K79me2	  (Jung	  et	  al.,	  2012).	  These	  observations	  
suggest	  that	  the	  increase	  in	  ubH2B	  upon	  SART3	  knockdown	  most	  likely	  occurs	  in	  gene	  
bodies,	  which	  is	  consistent	  with	  the	  role	  of	  SART3	  in	  co-­‐transcriptional	  splicing.	  	  
The	  effect	  of	  SART3	  knockdown	  on	  ubH2B	  levels	  is	  not	  restricted	  to	  HeLa	  cells.	  We	  
observed	  similar	  phenotypes	  in	  MD-­‐MBA-­‐231	  breast	  cancer	  cells	  (Figure	  3.15B)	  and	  non-­‐
cancerous	  hTERT-­‐RPE-­‐1	  cells	  (Figure	  3.15C).	  Furthermore,	  to	  rule	  out	  off-­‐target	  effects,	  we	  
demonstrate	  that	  depletion	  of	  SART3	  with	  two	  different	  siRNA	  oligonucleotides	  each	  led	  to	  
increased	  ubH2B	  levels	  (Figure	  3.7C).	  When	  we	  examined	  ubH2B	  levels	  by	  
immunofluorescence,	  we	  found	  that	  ubH2B	  was	  increased	  in	  almost	  all	  of	  the	  cells	  that	  had	  
SART3	  depleted	  (Figures	  3.15D-­‐E),	  ruling	  out	  that	  this	  is	  a	  cell	  cycle-­‐related	  phenotype.	  
Because	  genetic	  and	  biochemical	  evidence	  have	  established	  a	  strong	  link	  between	  H2B	  
ubiquitination	  and	  transcription	  elongation	  (Pirngruber	  et	  al.,	  2009b),	  we	  also	  examined	  
the	  global	  pool	  of	  actively	  transcribing	  RNAPII.	  In	  SART3-­‐depleted	  cells,	  we	  found	  no	  
changes	  in	  RNAPII	  CTD	  Ser2	  or	  Ser5	  phosphorylation,	  which	  are	  hallmarks	  of	  the	  








transient	  transfection	  led	  to	  decreased	  ubH2B	  levels	  (Figure	  3.15G).	  Similar	  phenotypes	  
were	  observed	  with	  a	  stable	  cell	  line	  that	  overexpresses	  SART3	  upon	  addition	  of	  Dox	  
(Figure	  3.15H).	  
	   Knockdown	  of	  Usp4	  or	  SART3	  leads	  to	  similar	  cell	  cycle	  defects	  (Sowa	  et	  al.,	  2009).	  
The	  fact	  that	  ubH2B	  was	  only	  elevated	  in	  SART3	  knockdown	  suggests	  that	  this	  phenotype	  
is	  independent	  of	  the	  cell	  cycle	  defects.	  Consistently,	  when	  we	  examined	  ubH2B	  levels	  by	  
immunofluorescence	  in	  cells	  treated	  with	  Control	  or	  SART3	  siRNA,	  we	  found	  that	  ubH2B	  
was	  increased	  in	  almost	  all	  of	  the	  cells	  that	  had	  SART3	  depleted	  (Figure	  3.15D).	  Because	  
genetic	  and	  biochemical	  evidence	  have	  established	  a	  strong	  link	  between	  H2B	  
ubiquitination	  and	  transcription	  elongation	  (Pirngruber	  et	  al.,	  2009a;	  Pirngruber	  et	  al.,	  
2009b),	  we	  also	  sought	  to	  examine	  the	  global	  pool	  of	  actively	  transcribing	  RNAPII.	  In	  
SART3	  depleted	  cells,	  we	  found	  no	  changes	  in	  the	  levels	  of	  RNAPII	  CTD	  Ser2	  or	  Ser5	  
phosphorylation,	  which	  are	  hallmarks	  of	  the	  elongating	  polymerase	  (Figure	  3.15F).	  	  
	   Steady-­‐state	  ubH2B	  levels	  are	  determined	  by	  the	  rates	  of	  both	  conjugation	  and	  
deconjugation.	  Upon	  SART3	  depletion,	  we	  found	  no	  global	  changes	  in	  either	  the	  
RNF20/RNF40	  E3	  ligase	  levels	  or	  RNAPII	  CTD	  phosphorylation	  levels,	  both	  of	  which	  are	  
determining	  factors	  in	  the	  rate	  of	  ubH2B	  conjugation.	  These	  observations	  suggested	  that	  
the	  effect	  of	  SART3	  knockdown	  on	  ubH2B	  might	  result	  from	  decreased	  deubiquitination.	  
To	  deconvolute	  the	  possible	  contributions	  of	  conjugation	  and	  deconjugation,	  we	  treated	  
cells	  with	  a	  highly	  specific	  E1	  inhibitor	  (Chen	  et	  al.,	  2011)	  to	  block	  Ub	  conjugation	  and	  
monitored	  ubH2A	  and	  ubH2B	  levels	  over	  time.	  Both	  ubH2A	  and	  ubH2B	  levels	  decreased	  
over	  the	  course	  of	  one	  hour	  after	  E1	  inhibition	  (Figures	  3.16A-­‐E).	  The	  ubH2B	  half-­‐life	  was	  






resulted	  in	  a	  doubling	  of	  the	  ubH2B	  half-­‐life	  to	  about	  35	  min	  (Figure	  3.16D).	  In	  contrast,	  no	  
effect	  on	  the	  ubH2A	  half-­‐life	  was	  observed	  (Figure	  3.16E).	  Knockdown	  of	  Usp15	  and	  Usp4	  
did	  not	  affect	  the	  half-­‐lives	  of	  either	  ubH2A	  or	  ubH2B	  (data	  not	  shown).	  These	  data	  show	  
that	  SART3	  plays	  an	  important	  role	  in	  H2B	  deubiquitination.	  However,	  whereas	  our	  pull-­‐
down	  results	  and	  in	  vitro	  characterization	  strongly	  implicate	  Usp15	  in	  this	  process,	  other	  
DUB(s)	  might	  be	  involved	  as	  well.	  
	  
3.4	  Discussion	  
It	  is	  well	  established	  that	  ubiquitination	  of	  H2B	  is	  a	  highly	  conserved	  PTM	  that	  has	  
important	  functions	  in	  the	  regulation	  of	  transcription,	  but	  how	  this	  modification	  supports	  
these	  functions	  is	  uncertain	  and	  complex.	  The	  lack	  of	  knowledge	  of	  direct	  effectors	  of	  
ubH2B	  is	  a	  major	  obstacle	  in	  understanding	  the	  underlying	  mechanisms.	  A	  related	  open	  
question	  is	  whether	  H2A/H2B	  dimers	  or	  nucleosome	  complexes	  are	  the	  substrates	  for	  Ub	  
attachment	  or	  removal	  in	  vivo.	  Ubiquitination	  of	  H2B	  is	  known	  to	  accompany	  transcription,	  
a	  process	  during	  which	  nucleosomes	  are	  disassembled	  or	  remodeled	  to	  allow	  access	  for	  
transcription	  activators	  and	  RNAPII;	  following	  passage	  of	  the	  transcribing	  RNAPII,	  
nucleosomes	  are	  reassembled	  to	  prevent	  unwanted	  access	  to	  DNA.	  H2A/H2B	  dimers	  
clearly	  are	  obligatory	  intermediates	  in	  this	  complex	  process,	  but	  their	  states	  with	  regard	  to	  
ubiquitination	  or	  other	  PTMs	  are	  not	  well	  characterized.	  
	  The	  specificity	  of	  histone	  deubiquitination—In	  mammals,	  the	  PRC1	  and	  
RNF20/RNF40	  complexes	  catalyze	  Ub	  conjugation	  to	  H2A	  residue	  K119	  and	  H2B	  residue	  
K120,	  respectively	  (Weake	  and	  Workman,	  2008).	  In	  contrast,	  many	  histone	  DUBs	  identified	  
to	  date	  are	  promiscuous	  towards	  these	  functionally	  distinct	  substrates	  (Frappier	  and	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Verrijzer,	  2011).	  The	  SAGADUB,	  Usp44	  and	  Usp3	  have	  all	  been	  reported	  to	  deubiquitinate	  
both	  H2A	  and	  H2B	  (Fuchs	  et	  al.,	  2012;	  Lang	  et	  al.,	  2011;	  Mosbech	  et	  al.,	  2013;	  Nicassio	  et	  al.,	  
2007),	  suggesting	  that	  targeting	  of	  these	  DUBs	  is	  the	  main	  factor	  in	  determining	  specificity.	  
Because	  ubH2A	  and	  ubH2B	  may	  exist	  both	  inside	  and	  outside	  nucleosomes,	  another	  aspect	  
of	  substrate	  specificity	  is	  whether	  these	  DUBs	  differentiate	  nucleosomal	  from	  free	  Ub–
histone	  conjugates.	  This	  question	  had	  not	  been	  addressed	  for	  the	  three	  DUBs	  mentioned	  
above.	  However,	  from	  qualitative	  activity	  assays,	  two	  other	  DUBs,	  Usp16	  and	  Usp49	  (Joo	  et	  
al.,	  2007;	  Zhang	  et	  al.,	  2013),	  have	  been	  reported	  to	  preferentially	  deubiquitinate	  
nucleosomal	  ubH2A	  and	  ubH2B,	  respectively.	  	  	  
To	  define	  rigorously	  the	  substrate	  specificities	  of	  these	  DUBs	  requires	  appreciable	  
quantities	  of	  chemically-­‐defined	  ubH2A	  and	  ubH2B.	  Through	  semi-­‐chemical	  synthesis,	  we	  
have	  produced	  ubH2B;	  we	  currently	  are	  developing	  methods	  to	  synthesize	  the	  
complementary	  substrate,	  ubH2A.	  Nonetheless,	  using	  our	  nonhydrolyzable	  analogs,	  we	  
were	  able	  to	  show	  that	  Usp4	  and	  Usp15	  bind	  to	  ub*H2A	  and	  ub*H2B-­‐containing	  histone	  
dimers	  with	  similar	  affinities.	  This	  observation	  is	  consistent	  with	  our	  results	  that	  used	  cell-­‐
derived	  ubH2A	  and	  ubH2B	  as	  substrates	  in	  assays	  that	  show	  Usp15	  deubiquitinates	  both	  
efficiently	  (Figure	  3.4A).	  Interestingly,	  when	  we	  compared	  the	  synthetic	  ubH2B	  substrate	  
in	  the	  histone	  octamer	  or	  nucleosomal	  form,	  Usp15	  showed	  a	  strong	  preference	  for	  ubH2B-­‐
containing	  octamers,	  whereas	  SAGADUB	  preferred	  nucleosomal	  ubH2B	  (Figures	  3.4B-­‐C).	  
Note	  that	  these	  DUB	  assay	  reactions	  contained	  200	  mM	  NaCl;	  in	  that	  salt	  condition,	  the	  
histone	  octamers	  most	  likely	  dissociate	  into	  H2A/H2B	  dimers	  and	  H3/H4	  tetramers.	  
SAGADUB	  	  has	  a	  conserved	  arginine-­‐rich	  surface	  whose	  mutation	  affects	  SAGA	  function	  in	  
yeast	  (Kohler	  et	  al.,	  2010).	  It	  was	  postulated	  that	  this	  surface	  may	  mediate	  interactions	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with	  nucleosomal	  DNA	  (Samara	  et	  al.,	  2010).	  Our	  data	  provides	  the	  first	  evidence	  for	  
preferential	  deubiquitination	  of	  nucleosomal	  versus	  free	  histones	  by	  SAGADUB	  	  and	  
supports	  this	  idea.	  Usp15	  by	  itself	  showed	  little	  specificity	  for	  binding	  to	  unmodified	  
H2A/H2B	  dimers,	  yet	  it	  binds	  to	  ub*H2A	  or	  ub*H2B-­‐containing	  dimers	  ~60-­‐fold	  better	  
than	  to	  Ub	  alone.	  This	  suggests	  that	  surfaces	  on	  histones	  and	  Ub	  might	  both	  contact	  Usp15,	  
and	  that	  their	  combined	  effects	  contribute	  to	  specificity	  for	  Ub–histone	  conjugates.	  
However,	  in	  the	  cell,	  histones	  that	  are	  not	  in	  nucleosomes	  are	  most	  likely	  complexed	  with	  
histone	  chaperones;	  thus,	  physiologically,	  Usp15	  might	  never	  encounter	  free	  histone	  
substrates.	  This	  is	  in	  fact	  suggested	  by	  our	  observation	  that	  Nap1,	  a	  generic	  histone	  
chaperone,	  blocked	  Usp15	  binding	  to	  ub*H2B	  (Figure	  3.14B).	  Our	  discovery	  that	  SART3	  is	  a	  
binding	  partner	  of	  Usp15	  and	  has	  histone	  chaperone-­‐like	  properties	  resolves	  this	  apparent	  
conundrum.	  In	  contrast	  to	  Nap1,	  SART3	  enhanced	  ub*H2B	  binding	  to	  Usp15	  and	  also	  
ubH2B	  hydrolysis	  by	  Usp15	  (Figures	  3.14B-­‐C).	  These	  data	  strongly	  argue	  that	  free	  histones,	  
rather	  than	  nucleosomes,	  are	  the	  likely	  substrates	  for	  the	  Usp15/SART3	  complex.	  
Usp15	  has	  been	  implicated	  in	  the	  deubiquitination	  of	  a	  wide	  variety	  of	  substrates,	  
including	  proteins	  in	  the	  TGFb-­‐signaling	  pathway	  and	  several	  E3	  ligases	  (Eichhorn	  et	  al.,	  
2012b;	  Faronato	  et	  al.,	  2013;	  Hayes	  et	  al.,	  2012;	  Hetfeld	  et	  al.,	  2005;	  Inui	  et	  al.,	  2011;	  
Villeneuve	  et	  al.,	  2013).	  Although	  Usp4	  and	  Usp15	  sequences	  are	  very	  similar,	  they	  most	  
likely	  perform	  overlapping,	  but	  non-­‐identical,	  functions.	  Purified	  Usp4	  binds	  to	  ub*H2B	  
with	  4-­‐fold	  lower	  affinity	  than	  Usp15.	  When	  present	  in	  nuclear	  extract,	  Usp15	  but	  not	  Usp4	  
was	  identified	  by	  mass	  spectrometry	  as	  bound	  to	  ubiquitinated	  histones.	  This	  suggests	  
that,	  of	  these	  two	  DUBs,	  Usp15	  is	  selective	  for	  histone	  substrates.	  On	  the	  other	  hand,	  
knockdown	  of	  Usp4	  but	  not	  Usp15	  leads	  to	  cell	  cycle	  defects,	  thus	  Usp4	  is	  primarily	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responsible	  for	  deubiquitination	  of	  the	  splicing	  factor	  Prp3	  (Sowa	  et	  al.,	  2009).	  Knockdown	  
of	  Usp15,	  Usp4,	  or	  Usp15	  and	  Usp4	  together	  failed	  to	  change	  appreciably	  global	  ubH2A	  or	  
ubH2B	  levels.	  This	  could	  be	  due	  to	  existence	  of	  other	  DUBs	  that	  deubiquitinate	  H2A	  or	  H2B.	  
An	  alternative	  possibility	  is	  the	  depletion	  of	  Usp15	  and	  Usp4	  was	  not	  efficient	  enough	  to	  
observe	  changes	  in	  ubH2B	  levels	  as	  the	  remaining	  protein	  was	  sufficient	  to	  deubiquitinate	  
H2A	  and	  H2B.	  Quantitative	  RT-­‐PCR	  showed	  that	  combinatorial	  knockdown	  of	  both	  Usp15	  
and	  Usp4	  resulted	  in	  less	  efficient	  depletion	  of	  both	  DUBs	  (Figure	  3.9B).	  Substantial	  
redundancy	  has	  been	  observed	  for	  deubiquitination	  events	  associated	  with	  DNA	  DSB	  
repair	  (Mosbech	  et	  al.,	  2013).	  Another	  possibility	  is	  that	  only	  a	  subset	  of	  ubH2A	  or	  ubH2B	  
is	  regulated	  by	  Usp15	  in	  specific	  cellular	  processes.	  Defining	  this	  subset	  will	  be	  the	  goal	  of	  
our	  future	  work.	  
SART3	  is	  a	  histone	  chaperone	  that	  functions	  in	  co-­‐transcriptional	  splicing—In	  
eukaryotes,	  transcription	  and	  mRNA	  processing	  are	  tightly	  coupled	  processes,	  both	  of	  
which	  are	  regulated	  by	  dynamic	  chromatin	  disassembly	  and	  reassembly.	  SART3	  is	  a	  
recycling	  factor	  that	  assists	  pre-­‐mRNA	  splicing	  by	  promoting	  formation	  of	  the	  U4/U6	  di-­‐
snRNP.	  The	  CTD	  of	  SART3	  is	  homologous	  to	  the	  protein	  encoded	  by	  PRP24,	  an	  essential	  
gene	  in	  budding	  yeast	  whose	  protein	  product	  performs	  the	  same	  recycling	  function	  to	  
ensure	  efficient	  splicing	  of	  mRNA	  encoding	  ribosomal	  proteins	  (Raghunathan	  and	  Guthrie,	  
1998).	  The	  NTD	  of	  SART3,	  although	  not	  present	  in	  Prp24,	  is	  present	  in	  its	  homologs	  in	  S.	  
pombe	  and	  metazoans	  and	  it	  is	  responsible	  for	  binding	  to	  Usp4	  or	  Usp15.	  Our	  discovery	  
that	  SART3	  binds	  to	  histones	  suggests	  that	  components	  of	  the	  splicing	  machinery	  may	  
regulate	  aspects	  of	  chromatin	  dynamics.	  Capturing	  displaced	  histones	  during	  transcription	  
to	  prevent	  exchange	  with	  the	  free	  histone	  pool	  could	  be	  one	  of	  the	  functions	  of	  SART3.	  An	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emerging	  concept	  is	  that	  chromatin	  structure	  and	  the	  rate	  of	  transcription	  elongation	  
regulate	  the	  efficiency	  of	  splicing	  and	  outcomes	  of	  alternative	  splicing	  (de	  Almeida	  and	  
Carmo-­‐Fonseca,	  2012;	  Luco	  et	  al.,	  2011).	  Nucleosomes	  have	  higher	  occupancy	  in	  exons	  
than	  in	  introns	  (Schwartz	  et	  al.,	  2009),	  and	  multiple	  histone	  PTMs,	  including	  H3K4Me3	  and	  
H3K36Me3,	  have	  been	  shown	  to	  recruit	  splicing	  factors	  (Luco	  et	  al.,	  2010;	  Sims	  et	  al.,	  
2007).	  Conversely,	  it	  has	  been	  known	  for	  a	  long	  time	  that	  the	  presence	  of	  introns	  
stimulates	  transcription	  and	  that	  inhibition	  of	  splicing	  can	  inhibit	  transcription.	  These	  
observations	  indicate	  that	  the	  splicing	  machinery	  can	  somehow	  provide	  feedback	  to	  
regulate	  transcription	  machinery	  and	  chromatin	  (Lin	  et	  al.,	  2008;	  Sims	  et	  al.,	  2007).	  	  
Our	  biochemical	  analyses	  suggest	  that	  one	  of	  the	  functions	  of	  SART3–histone	  
interactions	  is	  to	  assist	  Usp15-­‐mediated	  H2B	  deubiquitination.	  Evidence	  from	  multiple	  
organisms	  indicates	  a	  conserved	  role	  for	  ubH2B	  in	  regulating	  co-­‐transcriptional	  pre-­‐mRNA	  
splicing.	  ubH2B	  is	  enriched	  at	  the	  5’-­‐ends	  of	  actively	  transcribed	  genes	  and	  exon/intron	  
boundaries	  (Jung	  et	  al.,	  2012;	  Shieh	  et	  al.,	  2011).	  In	  yeast,	  deletion	  of	  either	  BRE1	  (H2B	  E3	  
ligase)	  or	  UBP8	  (an	  H2B	  DUB)	  enhances	  the	  splicing	  defect	  of	  ribosomal	  protein	  genes	  
when	  splicing	  is	  compromised	  by	  deletion	  of	  NPL3,	  which	  functions	  to	  promote	  
recruitment	  of	  U1	  and	  U2	  snRNPs	  (Kress	  et	  al.,	  2008).	  Similarly,	  depletion	  of	  the	  BRE1	  
counterpart,	  RNF20,	  suppresses	  exon	  skipping	  in	  human	  cells	  (Jung	  et	  al.,	  2012).	  It	  remains	  
unclear	  whether	  ubH2B	  plays	  a	  direct	  role,	  such	  as	  recruiting	  splicing	  factors,	  or	  an	  indirect	  
role	  in	  splicing	  through	  its	  function	  in	  transcription	  elongation.	  Regardless,	  the	  SART3–
Usp15	  complex	  is	  most	  likely	  responsible	  for	  erasing	  the	  Ub	  mark	  from	  histones	  that	  are	  
evicted	  during	  transcription.	  This	  function	  may	  be	  particularly	  important	  to	  maintain	  low	  
ubH2B	  levels	  in	  introns.	  Because	  ubH2B	  assists	  in	  nucleosome	  reassembly	  after	  RNAPII	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passage,	  erasure	  of	  the	  mark	  may	  help	  to	  maintain	  low	  nucleosome	  occupancy	  in	  introns,	  
thus	  enhancing	  the	  chromatin	  signatures	  that	  direct	  the	  next	  round	  of	  transcription	  and	  
splicing	  (Figure	  3.17).	  A	  recent	  report	  identified	  another	  DUB,	  Usp49,	  that	  specifically	  
deubiquitinates	  H2B	  in	  nucleosomes	  (Zhang	  et	  al.,	  2013).	  Loss	  of	  Usp49	  leads	  to	  a	  decrease	  
in	  splicing	  efficiency	  in	  a	  subset	  of	  genes.	  Among	  a	  limited	  set	  of	  genes	  that	  we	  tested,	  genes	  
whose	  splicing	  are	  affected	  by	  Usp49	  were	  not	  affected	  by	  SART3	  knockdown	  (L.L.	  and	  T.Y.,	  
unpublished	  results).	  Therefore,	  it	  is	  likely	  that	  SART3–Usp15	  and	  Usp49	  have	  different	  
sets	  of	  target	  genes.	  
Using	  an	  inhibitor	  of	  the	  E1	  Ub-­‐activating	  enzyme,	  we	  report	  for	  the	  first	  time	  that	  in	  HeLa	  
cells	  ubH2A	  and	  ubH2B	  have	  half-­‐lives	  of	  40	  min	  and	  15	  min,	  respectively	  (Figures	  3.16A-­‐
E).	  The	  half-­‐life	  of	  ubH2B	  is	  very	  similar	  as	  what	  was	  observed	  upon	  inhibition	  of	  
transcription	  (Pirngruber	  et	  al.,	  2009a),	  supporting	  the	  idea	  that	  ubH2B	  conjugation	  is	  
largely	  co-­‐transcriptional.	  It	  has	  been	  estimated	  that	  at	  steady	  state	  10-­‐15%	  of	  H2A	  is	  
ubiquitinated,	  whereas	  only	  1-­‐5%	  of	  H2B	  is	  ubiquitinated.	  Our	  data	  suggest	  that	  the	  faster	  
turnover	  of	  ubH2B	  is	  at	  least	  in	  part	  responsible	  for	  its	  lower	  abundance.	  Interestingly,	  
knockdown	  of	  SART3	  leads	  to	  a	  ~2-­‐fold	  increase	  in	  ubH2B	  half-­‐life	  with	  no	  effect	  on	  
ubH2A,	  yet	  knockdown	  of	  Usp15	  or	  Usp4	  had	  no	  effect	  on	  global	  ubH2B	  or	  ubH2A	  levels.	  At	  
this	  point,	  it	  is	  unclear	  whether	  the	  ubH2B	  increase	  we	  observed	  upon	  SART3	  knockdown	  
is	  a	  direct	  effect	  mediated	  by	  SART3-­‐associated	  DUBs,	  or	  if	  it	  is	  an	  indirect	  effect	  mediated	  
by	  other	  genes	  whose	  expression	  depend	  on	  SART3.	  Very	  little	  is	  known	  about	  the	  genes	  	  
that	  SART3	  regulates	  directly.	  Identification	  of	  these	  target	  genes	  in	  the	  future	  will	  be	  









	   UbH2B	  plays	  a	  critical	  signaling	  role	  in	  the	  cell	  in	  various	  processes,	  including	  
transcription	  and	  pre-­‐mRNA	  splicing	  (Wright	  et	  al.,	  2012).	  During	  active	  transcription,	  the	  
H2B	  E3	  ligase,	  RNF20/RNF40	  travels	  along	  with	  elongating	  RNAPII	  via	  associations	  with	  
the	  Paf1	  complex	  (Paf1C)	  (Wood	  et	  al.,	  2003b).	  Dynamic	  ubiquitination	  and	  
deubiquitination	  of	  H2B	  is	  required	  for	  processive	  elongation	  of	  many	  genes	  (Henry	  et	  al.,	  
2003).	  UbH2B	  is	  also	  required	  for	  proper	  nucleosome	  reassembly	  in	  the	  wake	  of	  elongating	  
polymerase	  (Fleming	  et	  al.,	  2008;	  Kaplan	  et	  al.,	  2003;	  Pavri	  et	  al.,	  2006).	  In	  addition,	  ubH2B	  
has	  also	  been	  demonstrated	  to	  play	  a	  role	  in	  the	  regulation	  of	  alternative	  splicing:	  1)	  
deletion	  of	  splicing	  components,	  such	  as	  components	  of	  the	  U1,	  U2,	  and	  U5	  snRNPs,	  in	  an	  
htb-­‐K123R	  or	  bre1Δ	  yeast	  strain	  leads	  to	  sickness	  and/or	  lethality	  (Moehle	  et	  al.,	  2012;	  
Shieh	  et	  al.,	  2011);	  2)	  ubH2B	  is	  required	  for	  proper	  recruitment	  of	  splicing	  factors	  to	  
nascent	  RNA	  transcripts	  (Herissant	  et	  al.,	  2014);	  3)	  ubH2B	  levels	  are	  elevated	  at	  a	  subset	  of	  
intron/exon	  junctions	  (Jung	  et	  al.,	  2012).	  The	  interactions	  between	  transcription	  and	  
splicing	  machineries,	  and	  involvement	  of	  chromatin	  modifications	  possibly	  as	  messengers,	  
have	  attracted	  rising	  interests	  in	  recent	  years	  (Luco	  et	  al.,	  2011).	  	  
We	  recently	  identified	  a	  previously	  uncharacterized	  histone	  DUB,	  Usp15,	  which	  
directly	  interacts	  with	  the	  U4/U6	  spliceosome	  recycling	  factor	  and	  histone	  chaperone,	  
SART3.	  We	  found	  that	  H2B	  deubiquitination	  by	  Usp15	  is	  enhanced	  by	  SART3	  in	  vitro.	  
Depletion	  of	  SART3	  from	  cells	  results	  in	  a	  global	  increase	  in	  ubH2B	  levels	  due	  to	  a	  
decreased	  rate	  of	  Ub	  deconjugation	  (Long	  et	  al.,	  2014).	  These	  observations	  led	  us	  to	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investigate	  whether	  changes	  in	  ubH2B	  levels	  observed	  upon	  SART3	  depletion	  could	  result	  
in	  transcriptional	  and	  splicing	  defects.	  	  
	   To	  analyze	  changes	  in	  transcript	  levels	  and	  alternative	  splicing	  events	  upon	  SART3	  
knockdown,	  we	  depleted	  SART3	  using	  two	  different	  methods	  and	  subjected	  the	  RNA	  to	  
Next	  Generation	  Sequencing	  (NGS)	  analysis	  (RNA-­‐seq).	  We	  identified	  a	  diverse	  set	  of	  genes	  
that	  displayed	  aberrant	  transcriptional	  and	  splicing	  patterns	  upon	  SART3	  depletion	  and	  
validated	  a	  few	  of	  these	  transcriptional	  changes	  using	  qRT-­‐PCR.	  ChIP	  analysis	  of	  a	  subset	  of	  
genes	  whose	  transcript	  levels	  decreased	  in	  SART3	  depleted	  cells	  revealed	  that	  SART3	  is	  
localized	  to	  these	  genes,	  suggesting	  the	  observed	  changes	  in	  transcript	  abundance	  are	  
likely	  a	  direct	  consequence	  of	  SART3	  loss.	  Interestingly,	  despite	  decreased	  transcript	  levels	  
at	  these	  genes,	  RNAPII	  levels	  were	  only	  mildly	  affected;	  suggesting	  the	  reduction	  in	  
transcript	  levels	  is	  due	  to	  defects	  in	  transcription	  elongation	  or	  RNA	  stability.	  We	  propose	  a	  
splicing	  defect	  in	  SART3-­‐depleted	  cells	  leads	  to	  defects	  in	  transcription	  elongation	  at	  
particular	  genes.	  
	  
4.2	  Experimental	  Procedures	  
4.2.1	  Generation	  of	  SART3	  knockdown	  stable	  cell	  lines	  
	   Production	  of	  SART3	  shRNA	  lentivirus:	  Lentiviruses	  were	  packaged	  and	  produced	  in	  
293T	  cells.	  Cells	  were	  plated	  in	  a	  6	  cm	  dish	  and	  transfected	  with	  2	  μg	  pPAX	  (encoding	  Gag-­‐
Pol),	  1	  μg	  PMD2.G	  (encoding	  VSV-­‐G),	  and	  2	  μg	  of	  desired	  plasmid	  to	  be	  packaged	  (i.e.	  
shSART3-­‐	  or	  GFP-­‐encoding	  vectors).	  DNA	  was	  mixed	  with	  32	  μL	  of	  2	  M	  CaPO4	  in	  a	  final	  
volume	  of	  260	  μL.	  An	  equal	  volume	  of	  2X	  HBS	  was	  added	  to	  the	  DNA	  mixture	  while	  
vortexing.	  Following	  a	  15-­‐minute	  incubation,	  the	  transfection	  mixture	  was	  added	  drop	  wise	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to	  cells.	  The	  following	  day,	  the	  media	  was	  replaced	  with	  3	  mL	  of	  fresh	  DMEM.	  24	  hours	  
after	  replacing	  the	  media,	  virus-­‐containing	  media	  was	  harvested	  and	  filtered	  through	  a	  
0.45	  μm	  filter	  to	  remove	  residual	  293T	  cells	  from	  the	  supernatant.	  Viruses	  were	  aliquoted	  
and	  stored	  at	  -­‐80	  °C.	  
	   Generation	  of	  SART3	  shRNA	  expression	  cell	  lines:	  Approximately	  6x105	  HeLa	  cells	  
were	  plated	  in	  a	  6	  cm	  dish.	  The	  following	  day	  (Day	  1),	  cells	  were	  approximately	  40-­‐70%	  
confluent	  and	  the	  media	  was	  exchanged	  with	  3	  mL	  of	  DMEM	  containing	  34	  μg	  Polybrene.	  
HeLa	  cells	  were	  then	  infected	  using	  1	  mL	  of	  lentivirus-­‐containing	  supernatant.	  After	  a	  4-­‐6	  
hour	  incubation,	  an	  additional	  2	  mL	  of	  DMEM	  was	  added	  to	  the	  transduction	  plate.	  On	  Day	  
2,	  cells	  were	  re-­‐seeded	  to	  a	  confluency	  of	  50%.	  Two	  days	  post-­‐transduction	  (Day	  3),	  the	  
media	  was	  replaced	  with	  DMEM	  containing	  10	  µg/mL	  puromycin	  to	  select	  for	  cells	  that	  had	  
integrated	  the	  virus.	  As	  a	  negative	  control,	  uninfected	  HeLa	  cells	  were	  subject	  to	  puromycin	  
selection	  and	  complete	  cell	  death	  was	  observed	  in	  less	  than	  24	  hours.	  On	  Day	  5,	  cells	  
infected	  with	  a	  GFP-­‐encoding	  virus	  were	  visualized	  using	  microscopy.	  We	  observed	  100%	  
of	  the	  viable	  cells	  fluoresced,	  implicating	  efficient	  transduction	  and	  successful	  selection	  by	  
puromycin.	  After	  selection,	  cells	  were	  either	  harvested	  for	  protein	  or	  RNA	  analysis,	  frozen,	  
or	  subjected	  to	  isolation	  of	  monoclonal	  cell	  lines.	  	  
	   Purification	  of	  RNA	  for	  RNA-­‐seq	  and	  qRT-­‐PCR:	  Cells	  were	  either	  transfected	  with	  
siRNA	  as	  described	  in	  Section	  3.2.2	  or	  transduced	  cells	  were	  plated	  in	  a	  6-­‐well	  dish	  and	  
grown	  to	  confluency.	  Approximately	  1.0x106	  cells	  were	  lysed	  in	  1	  mL	  TRIzol®	  Reagent	  
(Life	  Technologies),	  and	  RNA	  was	  extracted	  according	  to	  manufacturer’s	  instructions.	  RNA	  




4.2.2	  Generation	  of	  the	  HA-­‐SART3	  inducible	  stable	  cell	  line	  	  
Stable	  cell	  lines	  were	  generated	  with	  pcDNA5	  FRT/TO	  constructs	  using	  the	  parental	  
Flp-­‐In	  HeLa	  cell	  lines	  (Life	  Technologies)	  as	  described	  by	  Yao	  et	  al.	  (Yao	  et	  al.,	  2006).	  
SART3	  constructs	  encoded	  N-­‐terminal	  Flag-­‐Flag-­‐HA	  epitope	  tags.	  
	  
	  4.2.3	  Chromatin	  immunoprecipitation	  (ChIP)	  assay	  
Prepare	  and	  harvest	  cells:	  For	  ChIP	  analysis	  under	  control	  and	  SART3	  knockdown	  
conditions,	  1.8x106	  cells	  were	  transfected	  using	  19.8	  nM	  siRNA	  and	  48	  μL	  RNAiMax.	  72-­‐
hours	  post-­‐transfection,	  cells	  were	  fixed	  and	  harvested	  as	  described	  below.	  Approximately	  
3.3x106	  and	  7.4x106	  cells	  were	  present	  per	  each	  10	  cm	  dish	  for	  siControl	  and	  siSART3,	  
respectively	  because	  transfection	  of	  Control	  siRNA	  resulted	  in	  greater	  cell	  death	  when	  
compared	  to	  transfection	  with	  SART3	  siRNA.	  A	  minimum	  of	  2.5x106	  and	  0.9x106	  cells	  was	  
used	  for	  immunoprecipitation	  of	  ubH2B	  and	  H2B,	  respectively.	  For	  ChIP	  analysis	  of	  HA-­‐
SART3	  stable	  cell	  lines,	  cells	  were	  plated	  at	  25%	  confluency	  (approximately	  3x106	  
cells/dish)	  in	  10	  cm	  dishes	  and	  induced	  with	  Doxycycline	  (Dox)	  at	  1	  μg/mL	  for	  48	  hours	  
before	  fixing	  and	  harvesting.	  Typically,	  we	  harvested	  1.2x107	  cells	  per	  10	  cm	  dish,	  and,	  
therefore,	  approximately	  0.5	  to	  1	  confluent	  10	  cm	  dishes	  were	  used	  for	  each	  IP.	  
	   Cross-­‐linking:	  Confluent	  plates	  were	  washed	  with	  PBS	  before	  cross-­‐linking	  with	  1%	  
formaldehyde/PBS	  at	  room	  temperature	  for	  10	  minutes.	  Cross-­‐linking	  reactions	  were	  
stopped	  upon	  the	  addition	  of	  120	  mM	  sterile	  glycine	  at	  room	  temperature	  for	  5	  minutes.	  
Fixed	  cells	  were	  washed	  and	  harvested	  in	  chilled	  1xPBS,	  1	  mM	  PMSF.	  Cells	  were	  pelleted	  
for	  5	  minutes	  at	  4	  °C	  at	  2000	  rpm	  and	  either	  stored	  at	  -­‐80	  °C	  or	  lysed	  and	  sonicated.	  
	   Lysis	  and	  sonication:	  Cell	  pellets	  were	  thawed	  on	  ice	  and	  resuspended	  in	  1	  mL	  of	  cell	  
lysis	  buffer	  (5	  mM	  PIPES,	  pH	  8,	  85	  mM	  KCl,	  1%	  NP-­‐40,	  PIC)	  per	  1.2x107-­‐1.4x107	  cells.	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Resuspended	  cells	  were	  transferred	  to	  sonication	  tubes	  and	  incubated	  on	  ice	  for	  20	  
minutes.	  The	  chromatin-­‐containing	  fraction	  was	  pelleted	  at	  5000	  rpm	  at	  4°C	  for	  5	  minutes	  
and	  resuspended	  in	  200	  μL	  of	  0.5%	  SDS	  lysis	  buffer	  (50	  mM	  Tris,	  pH	  8,	  10	  mM	  EDTA,	  0.5%	  
SDS)	  per	  1.2x107-­‐1.4x107	  cells.	  Chromatin	  was	  sonicated	  for	  45	  minutes	  in	  a	  cyclic	  fashion	  
where	  a	  30	  second	  sonication	  was	  followed	  by	  a	  30	  second	  rest	  period.	  Samples	  were	  
quickly	  centrifuged	  every	  15	  minutes	  to	  pellet	  the	  liquid	  that	  accumulated	  on	  the	  sides	  of	  
the	  tubes.	  After	  sonication,	  cells	  were	  centrifuged	  at	  13,200	  rpm	  for	  10	  minutes	  at	  15	  °C,	  
and	  the	  supernatant	  was	  transferred	  into	  fresh	  tubes.	  Chromatin	  concentration	  was	  
measured	  by	  mixing	  5	  μL	  sonicated	  chromatin	  with	  495	  μL	  0.1	  M	  NaOH	  and	  measuring	  the	  
OD260.	  Typically,	  an	  OD260	  between	  0.4	  and	  0.5	  is	  achieved.	  The	  concentrations	  of	  different	  
sample	  types	  are	  normalized	  based	  upon	  the	  OD260	  reading	  by	  the	  addition	  of	  0.5%	  SDS	  
lysis	  buffer.	  
	   Sonication	  analysis:	  To	  monitor	  the	  efficiency	  of	  chromatin	  fragmentation	  by	  
sonication,	  a	  small	  sample	  is	  processed	  to	  remove	  the	  DNA-­‐bound	  proteins	  and	  visualize	  
the	  DNA	  on	  an	  agarose	  gel.	  In	  this	  process,	  5	  μL	  of	  sonicated	  chromatin	  is	  diluted	  in	  45	  μL	  
elution	  buffer	  (1%	  SDS,	  0.1M	  NaHCO3,	  made	  freshly).	  The	  cross-­‐link	  is	  reversed	  though	  the	  
addition	  of	  2	  μL	  of	  5	  M	  NaCl	  at	  95	  °C	  for	  15	  minutes.	  Samples	  are	  cooled	  to	  room	  
temperature	  before	  adding	  RNase	  A	  at	  0.2	  mg/mL	  for	  15-­‐30	  minutes	  at	  37	  °C.	  DNA	  is	  
extracted	  with	  50	  μL	  of	  Phenol/Chloroform/Isoamylalcohol	  (PCI)	  and	  ethanol	  precipitated	  
with	  100	  μL	  ice	  cold	  100%	  EtOH.	  Pellets	  are	  washed	  with	  70%	  EtOH,	  dried,	  and	  gently	  
resuspended	  in	  40	  μL	  nuclease-­‐free	  water.	  Sucrose	  is	  added	  to	  a	  final	  concentration	  of	  2%	  
to	  2	  μg	  of	  DNA.	  The	  DNA	  is	  separated	  on	  a	  2%	  agarose	  gel	  and	  visualized	  by	  ethidium	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bromide	  staining.	  An	  ideal	  sonication	  produces	  DNA	  fragments	  from	  200	  to	  600	  base	  pairs	  
in	  length.	  
	   Immunoprecipitation:	  For	  each	  immunoprecipitation	  (IP),	  10	  μL	  of	  Protein	  G	  
Dynabead	  slurry	  is	  washed	  twice	  with	  500	  μL	  IP	  dilution	  buffer	  (16.7	  mM	  Tris,	  pH	  8,	  1.2	  
mM	  EDTA,	  167	  mM	  NaCl,	  1.1%	  Triton	  X-­‐100,	  0.01%	  SDS).	  1	  μg	  of	  the	  appropriate	  antibody	  
is	  diluted	  in	  500	  μL	  of	  IP	  dilution	  buffer	  and	  incubated	  with	  the	  washed	  Protein	  G	  beads	  for	  
2	  hours	  at	  4°C	  while	  rotating.	  Lysates	  are	  diluted	  1:10	  in	  IP	  dilution	  buffer	  to	  reduce	  the	  
SDS	  concentration	  to	  0.05%.	  The	  unconjugated	  antibody	  is	  removed	  and	  up	  to	  1.5	  mL	  of	  the	  
diluted	  lysates	  are	  incubated	  with	  the	  antibody-­‐bound	  beads	  overnight	  at	  4°C	  while	  
rotating.	  The	  next	  day,	  IP	  samples	  are	  sequentially	  washed	  with	  for	  5	  minutes	  at	  4	  °C	  with	  1	  
mL	  of	  Low	  salt	  buffer	  (20	  mM	  Tris,	  pH	  8,	  2	  mM	  EDTA,	  150	  mM	  NaCl,	  1%	  Triton	  X-­‐100,	  0.1%	  
SDS),	  High	  salt	  buffer	  (20	  mM	  Tris,	  pH	  8,	  2	  mM	  EDTA,	  500	  mM	  NaCl,	  1%	  Triton	  X-­‐100,	  0.1%	  
SDS)	  and,	  LiCl	  buffer	  (10	  mM	  Tris,	  pH	  8,	  1	  mM	  EDTA,	  0.25	  M	  LiCl,	  1%	  NP-­‐40,	  1%	  NaDOC).	  
These	  wash	  steps	  are	  followed	  by	  2	  additional	  washes	  using	  TE	  buffer	  (10	  mM	  Tris,	  pH	  8,	  1	  
mM	  EDTA).	  IP	  samples	  are	  transferred	  to	  low-­‐binding	  tubes	  as	  detergent-­‐free	  solutions	  
cause	  mild	  adhesion	  of	  Dynabeads	  to	  the	  tube	  surface.	  IP	  samples	  are	  incubated	  with	  250	  
μL	  of	  fresh	  elution	  buffer	  at	  65°C	  for	  5	  minutes,	  followed	  by	  rotation	  at	  room	  temperature	  
for	  15	  minutes.	  Eluates	  are	  transferred	  from	  the	  bead-­‐containing	  tubes	  into	  Sure-­‐lock	  
tubes.	  The	  elution	  step	  is	  repeated	  and	  eluates	  are	  combined.	  Reverse	  cross-­‐linking	  is	  
mediated	  by	  the	  addition	  of	  20	  μL	  of	  5	  M	  NaCl	  and	  incubation	  at	  65	  °C	  overnight.	  
	   DNA	  purification:	  After	  reversing	  the	  cross-­‐link,	  20	  uL	  of	  1	  M	  Tris-­‐HCl,	  pH	  6.5,	  10	  μL	  
0.5	  mM	  EDTA,	  pH	  8,	  and	  1	  uL	  of	  20	  mg/mL	  Proteinase	  K	  are	  added	  to	  the	  elution	  fractions	  
and	  incubated	  at	  45	  °C	  for	  1	  hour.	  DNA	  is	  extracted	  using	  550	  μL	  PCI.	  Glycogen	  (2	  μL	  of	  a	  20	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mg/mL	  stock	  solution)	  is	  added	  to	  the	  extracted	  DNA	  along	  with	  1	  mL	  of	  100%	  EtOH	  to	  
enhance	  visualization	  of	  the	  DNA	  pellet.	  Samples	  are	  incubated	  at	  -­‐20	  °C	  for	  at	  least	  2	  
hours.	  DNA	  is	  pelleted,	  washed	  with	  70%	  EtOH,	  dried,	  and	  resuspended	  in	  50-­‐100	  μL	  
nuclease	  free	  water.	  
	   Input	  processing:	  For	  input	  samples,	  250	  μL	  of	  the	  sample	  lysate	  (which	  has	  already	  
been	  diluted	  1:10	  in	  IP	  dilution	  buffer)	  is	  mixed	  with	  250	  uL	  water	  and	  20	  μL	  of	  5	  M	  NaCl	  at	  
65	  °C	  overnight.	  The	  next	  day,	  20	  μL	  of	  1	  M	  Tris-­‐HCl,	  pH	  6.5,	  10	  μL	  0.5	  M	  EDTA,	  Ph	  8,	  2.5	  μL	  
20	  mg/mL	  Proteinase	  K,	  and	  2	  μL	  of	  10	  mg/mL	  RNase	  A	  is	  added	  and	  incubated	  at	  55	  °C	  for	  
2	  hours.	  The	  DNA	  is	  extracted	  as	  described	  above	  for	  the	  IP	  samples	  and	  dissolved	  in	  40	  μL	  
nuclease-­‐free	  water.	  	  
	   Quantitative	  real-­‐time	  PCR	  (qRT-­‐PCR):	  QRT-­‐PCR	  reactions	  were	  comprised	  of	  7.5	  μL	  
2x	  Sybr	  Green	  RT-­‐PCR	  mix,	  0.75	  μL	  of	  10	  µM	  forward	  and	  reverse	  primers,	  3	  μL	  of	  water,	  
and	  3	  μL	  of	  IP	  DNA.	  Input	  DNA	  was	  diluted	  1:40	  prior	  to	  qRT-­‐PCR	  analysis.	  For	  each	  primer	  




4.3.1	  Generation	  of	  cell	  lines	  stably	  depleted	  of	  SART3	  using	  shRNA	  
	   To	  comprehensively	  investigate	  the	  role	  of	  SART3	  in	  transcription	  and	  splicing,	  we	  
decided	  to	  perform	  RNA-­‐seq	  analysis	  of	  RNA	  harvested	  from	  control	  and	  SART3-­‐depleted	  
cells.	  Because	  SART3	  is	  involved	  in	  splicing	  and	  because	  SART3	  depletion	  affects	  ubH2B	  
levels,	  which	  has	  also	  been	  implicated	  in	  transcription	  and	  alternative	  splicing,	  we	  
proposed	  that	  RNA-­‐seq	  data	  would	  reveal	  transcription	  and/or	  splicing	  defects	  at	  SART3-­‐
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regulated	  genes.	  Typically,	  studies	  involving	  genome-­‐wide	  analysis	  of	  knockdown	  samples	  
deplete	  the	  protein	  of	  interest	  using	  two	  different	  RNAi	  sequences,	  and	  high	  confidence	  
data	  points	  are	  changes	  that	  are	  observed	  in	  both	  knockdown	  samples.	  We	  took	  a	  slightly	  
different	  approach	  to	  this	  method	  in	  that,	  in	  one	  case,	  we	  chose	  to	  deplete	  SART3	  using	  
siRNA	  and	  in	  the	  other	  case,	  we	  generated	  cell	  lines	  with	  SART3	  stably	  depleted	  using	  
shRNA.	  One	  advantage	  to	  using	  this	  approach	  is	  that	  transcriptional	  changes	  observed	  in	  
both	  data	  sets	  would	  be	  more	  likely	  caused	  by	  depletion	  of	  SART3	  rather	  than	  due	  to	  off-­‐
target	  effects	  of	  the	  RNAi	  or	  the	  method	  of	  RNAi	  introduction	  (transfection	  vs.	  
transduction).	  
	   To	  generate	  cell	  lines	  stably	  depleted	  of	  SART3,	  we	  packaged	  SART3	  shRNA	  
encoding	  a	  puromycin	  resistance	  cassette	  into	  lentiviruses,	  infected	  HeLa	  cells,	  and	  
selected	  for	  puromycin-­‐resistant	  cells.	  For	  the	  initial	  screen	  of	  SART3	  depletion	  efficiency,	  
12	  SART3	  shRNA	  plasmids,	  each	  encoding	  a	  unique	  sequence	  to	  target	  SART3	  for	  depletion,	  
were	  assayed	  (Table	  A2.2).	  These	  plasmids	  were	  packaged	  into	  lentiviruses	  and	  on	  Day	  1,	  
HeLa	  cells	  were	  infected	  with	  each	  virus.	  Lentivirus	  packaged	  with	  a	  plasmid	  encoding	  GFP	  
was	  used	  as	  a	  positive	  control	  for	  infection	  (as	  this	  could	  be	  visualized	  by	  microscopy)	  and	  
was	  used	  as	  a	  negative	  control	  for	  SART3	  depletion.	  On	  Day	  3,	  cells	  were	  subjected	  to	  
selection	  by	  10	  µg/ml	  puromycin	  treatment.	  Cell	  lysates	  were	  harvested	  for	  western	  blot	  
analysis	  on	  Day	  6.	  Western	  blotting	  analysis	  showed	  each	  shRNA	  construct	  depleted	  SART3	  
to	  different	  degrees.	  The	  efficiency	  of	  SART3	  depletion	  using	  plasmids	  1,	  2,	  and	  10	  seemed	  
comparable	  to	  SART3	  depletion	  using	  siRNA	  (Figure	  4.1A).	  For	  this	  reason,	  we	  chose	  to	  









	   To	  identify	  the	  best	  candidate	  for	  RNA-­‐seq	  analysis,	  HeLa	  cells	  were	  treated	  
according	  to	  the	  schematic	  depicted	  in	  Figure	  4.1B.	  On	  Day	  1,	  cells	  were	  infected	  with	  
lentivirus	  packaged	  with	  plasmids	  encoding	  GFP	  or	  shSART3	  sequences	  1,	  2,	  or	  10.	  
Puromycin	  selection	  was	  employed	  on	  Day	  2	  and	  cell	  lysates	  were	  harvested	  for	  western	  
blot	  analysis	  on	  Day	  8.	  Cells	  were	  passaged	  until	  Day	  13	  when	  total	  RNA	  was	  harvested	  
from	  cells	  using	  the	  Trizol	  reagent.	  	  
Cell	  lysates	  harvested	  on	  Day	  8	  were	  separated	  by	  SDS-­‐PAGE	  and	  subjected	  to	  
analysis	  by	  immunoblotting.	  As	  was	  previously	  observed,	  ubH2B	  levels	  did	  not	  increase	  
upon	  depletion	  of	  SART3	  using	  shRNA	  (Figures	  4.1C	  and	  4.1A).	  Notably,	  shSART3	  plasmid	  
2	  showed	  a	  large	  reduction	  in	  tubulin	  levels,	  indicating	  SART3	  depletion	  for	  an	  extended	  
amount	  of	  time	  using	  shSART3	  plasmid	  2	  might	  have	  global	  effects.	  	  
RNA	  harvested	  on	  Day	  13	  was	  reverse	  transcribed	  into	  cDNA	  and	  SART3	  transcript	  
levels	  were	  measured	  using	  quantitative	  real-­‐time	  PCR	  (qRT-­‐PCR).	  GAPDH	  transcript	  levels	  
were	  used	  for	  normalization	  and	  the	  efficiency	  of	  SART3	  knockdown	  was	  compared	  to	  
either	  siControl	  or	  lentivirus	  GFP	  (for	  siSART3,	  and	  shSART3	  plasmids	  1,	  2,	  and	  10,	  
respectively).	  SART3	  was	  most	  efficiently	  depleted	  using	  siSART3	  (Figure	  4.1D).	  At	  first	  
glance,	  shSART3	  plasmid	  2	  seemed	  to	  exhibit	  the	  most	  efficient	  SART3	  depletion	  when	  
compared	  to	  plasmids	  1	  and	  10	  (3%	  SART3	  transcripts	  remaining	  versus	  13%	  and	  58%	  
SART3	  transcripts	  remaining,	  respectively).	  Because	  western	  blot	  analysis	  showed	  similar	  
SART3	  depletion	  at	  the	  protein	  level	  for	  each	  of	  these	  shSART3	  plasmids	  (Figure	  4.1A),	  it	  
seemed	  unusual	  that	  there	  would	  be	  such	  a	  large	  discrepancy	  between	  the	  transcript	  and	  
the	  protein	  levels	  for	  each	  shSART3	  sample.	  Additionally,	  despite	  the	  fact	  that	  equal	  
amounts	  of	  total	  RNA	  for	  each	  sample	  type	  were	  reverse	  transcribed	  into	  cDNA,	  we	  noticed	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the	  GAPDH	  transcript	  levels	  for	  shSART3	  plasmid	  2	  were	  unusually	  high.	  This	  was	  
accompanied	  by	  the	  strange	  observation	  that	  tubulin	  protein	  levels	  were	  also	  reduced	  in	  
this	  sample	  (Figure	  4.1C,	  lane	  5).	  Therefore,	  SART3	  transcript	  levels	  were	  also	  analyzed	  
without	  normalization	  to	  GAPDH	  and	  compared	  to	  control	  knockdown	  samples	  (Figure	  
4.1E).	  Using	  this	  analysis	  method	  and	  the	  GAPDH	  normalization	  method,	  we	  found	  
shSART3	  plasmid	  1	  most	  efficiently	  depleted	  SART3	  transcript	  levels	  when	  compared	  to	  
plasmids	  2	  and	  10.	  For	  this	  reason,	  RNA	  extracted	  from	  GFP-­‐	  and	  shSART3	  plasmid	  1-­‐
infected	  cells	  13	  days	  post-­‐infection	  and	  siControl-­‐	  and	  siSART3	  cells	  3	  days	  post-­‐
transfection	  were	  sent	  for	  RNA-­‐seq	  analysis.	  
	  
4.3.2	  RNA-­‐seq	  analysis	  revealed	  changes	  in	  transcript	  levels	  and	  splicing	  defects	  in	  SART3-­‐
depleted	  cells	  
	   RNA	  samples	  were	  submitted	  to	  the	  Colorado	  State	  University	  Next	  Generation	  
Sequencing	  Core	  for	  analysis.	  Ribosomal	  RNA	  depletion,	  reverse	  transcription,	  and	  
additional	  sample	  processing	  was	  performed	  at	  the	  core	  facility.	  Because	  one	  of	  our	  
objectives	  was	  to	  identify	  intron	  inclusion	  and	  alternative	  splicing	  patterns	  upon	  SART3	  
depletion,	  obtaining	  sequence	  reads	  at	  the	  unspliced	  intron/exon	  and	  spliced	  exon/exon	  
junctions	  was	  critical.	  For	  this	  and	  other	  reasons,	  we	  chose	  to	  use	  the	  Ion	  Torrent	  
sequencing	  platform	  over	  the	  Illumina	  sequencing	  platform	  as	  the	  average	  read	  length	  is	  
substantially	  longer	  (up	  to	  250	  base	  pairs	  versus	  up	  to	  150	  base	  pairs	  per	  read)	  and	  the	  
chances	  of	  mapping	  reads	  corresponding	  to	  spliced	  exon/exon	  junctions	  and	  unspliced	  
intron/exon	  junctions	  are	  enhanced.	  Data	  processing	  were	  carried	  out	  by	  the	  Core	  
personnel	  using	  Nextgene	  to	  trim	  reads	  with	  a	  quality	  score	  lower	  than	  13	  and	  filter	  out	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reads	  with	  length	  less	  than	  35	  bp,	  followed	  by	  expression	  analysis	  using	  AvardisNGS.	  
Sequence	  reads	  were	  normalized	  using	  either	  total	  read	  count	  (TC)	  or	  DESeq	  normalization	  
methods.	  Notably,	  both	  normalization	  methods	  gave	  very	  similar	  results.	  	  
Using	  the	  TC	  normalization	  method	  and	  excluding	  fold-­‐changes	  <2	  and	  adjusted	  p-­‐
value	  >	  0.05,	  we	  found	  1181	  genes	  had	  increased	  transcript	  levels	  upon	  SART3	  depletion	  
using	  the	  siRNA	  depletion	  method	  (Figure	  4.2A).	  A	  comparatively	  equal	  number	  of	  genes	  
(1175)	  exhibited	  decreased	  transcript	  levels	  upon	  siSART3	  transfection.	  In	  stark	  contrast,	  
only	  272	  genes	  displayed	  increased	  transcript	  levels	  upon	  depletion	  of	  SART3	  using	  shRNA	  
while	  1959	  genes	  showed	  decreased	  transcript	  levels.	  This	  large	  discrepancy	  between	  the	  
number	  of	  genes	  with	  increased	  and	  decreased	  transcript	  levels	  is	  alarming.	  We	  think	  that	  
the	  long-­‐term	  SART3	  knockdown	  (13	  days)	  in	  the	  shSART3	  samples	  possibly	  led	  to	  total	  
collapse	  of	  splicing,	  transcription	  and	  other	  function	  of	  the	  cell.	  Therefore,	  many	  of	  the	  
observed	  changes	  in	  transcription	  are	  likely	  due	  to	  secondary	  effects	  of	  long-­‐term	  SART3	  
depletion.	  In	  contrast,	  SART3	  depletion	  by	  siRNA	  was	  carried	  out	  in	  3	  days.	  Additionally,	  
there	  are	  only	  a	  small	  overlap	  between	  the	  genes	  affected	  by	  shSART3	  knockdown	  and	  
those	  affected	  by	  siSART3	  knockdown.	  For	  these	  reasons,	  we	  chose	  to	  continue	  analysis	  
using	  only	  the	  data	  obtained	  from	  the	  siControl	  and	  siSART3	  samples.	  
To	  validate	  the	  observed	  fold-­‐changes	  identified	  in	  the	  RNA-­‐seq	  analysis,	  at	  least	  5	  
genes	  from	  each	  category	  (transcript	  abundance	  either	  increased	  or	  decreased	  upon	  
SART3	  depletion)	  were	  chosen.	  Transcript	  levels	  were	  determined	  with	  qRT-­‐PCR	  using	  
primers	  designed	  to	  amplify	  a	  region	  within	  a	  single	  exon,	  thus	  eliminating	  changes	  in	  





to	  GAPDH	  as	  previously	  described.	  The	  fold-­‐change	  observed	  in	  the	  Next	  Generation	  
Sequencing	  (NGS)	  data	  set	  and	  the	  fold-­‐change	  observed	  in	  the	  qRT-­‐PCR	  validation	  are	  
listed	  in	  Figure	  4.2B.	  In	  each	  case,	  the	  observed	  trend	  in	  the	  NGS	  results	  agreed	  with	  the	  
trend	  obtained	  in	  the	  qRT-­‐PCR	  validation	  results	  (either	  increased	  or	  decreased	  transcript	  
level	  in	  the	  siSART3	  sample,	  indicated	  by	  the	  red	  and	  blue	  arrows)	  (Figure	  4.2B).	  In	  many	  
cases,	  the	  degree	  of	  fold-­‐change	  observed	  in	  the	  NGS	  and	  qRT-­‐PCR	  validation	  was	  not	  
identical,	  but	  this	  can	  most	  likely	  be	  attributed	  to	  differences	  in	  sample	  preparation,	  
reverse	  transcription,	  amplification,	  and	  normalization	  methods.	  
Because	  SART3	  is	  a	  U4/U6	  spliceosome	  recycling	  factor,	  we	  analyzed	  the	  RNA-­‐seq	  
data	  to	  look	  for	  genes	  that	  displayed	  alternative	  splicing	  patterns	  upon	  SART3	  depletion	  
using	  the	  AvardisNGS	  software	  on	  a	  trial	  basis.	  In	  this	  analysis,	  the	  data	  were	  normalized	  
using	  the	  DESeq	  normalization	  method.	  Additionally,	  expression	  and	  splicing	  changes	  were	  
not	  restricted	  to	  a	  p-­‐value	  of	  less	  than	  0.05	  as	  was	  previously	  described	  (Figure	  4.2A).	  
Using	  these	  parameters,	  we	  observed	  1115	  genes	  that	  displayed	  differential	  splicing	  
patterns	  upon	  SART3	  depletion	  (Figure	  4.2C).	  A	  fraction	  of	  these	  alternatively	  spliced	  
genes	  also	  displayed	  an	  increase	  or	  decrease	  in	  transcript	  level	  in	  SART3	  knockdown	  cells	  
(157	  versus	  130	  genes,	  respectively)	  (Figure	  4.2C).	  These	  differential	  splicing	  events	  have	  
not	  been	  confirmed	  by	  qRT-­‐PCR.	  The	  bioinformatic	  analysis	  also	  needs	  to	  be	  repeated	  in	  
the	  future	  to	  ensure	  appropriate	  parameters	  were	  chosen	  in	  the	  process.	  
	  
4.3.3	  SART3	  localizes	  to	  genes	  that	  are	  down-­‐regulated	  upon	  SART3	  depletion	  
	   Using	  RNA-­‐seq	  and	  validation	  by	  qRT-­‐PCR,	  we	  identified	  many	  genes	  whose	  
transcript	  abundance	  were	  either	  increased	  or	  decreased	  upon	  SART3	  depletion.	  To	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identify	  if	  the	  changes	  in	  transcription	  are	  directly	  modulated	  through	  the	  action	  of	  SART3,	  
we	  used	  Chromatin	  Immunoprecipitation	  (ChIP)	  to	  detect	  the	  presence	  of	  SART3	  at	  these	  
particular	  genes.	  For	  these	  initial	  studies,	  we	  chose	  to	  focus	  on	  a	  subset	  of	  genes	  whose	  
transcript	  level	  decreased	  upon	  SART3	  depletion.	  
	   For	  ChIP	  analysis	  of	  SART3,	  we	  used	  a	  HeLa	  Flp-­‐In	  stable	  cell	  line	  that,	  upon	  the	  
addition	  of	  doxycycline	  (Dox),	  induces	  the	  expression	  of	  HA-­‐tagged	  SART3.	  An	  anti-­‐HA	  
antibody	  was	  used	  to	  immunoprecipitate	  (IP)	  HA-­‐SART3	  (Figure	  4.3,	  red	  bars).	  Negative	  
controls	  include	  IP	  using	  normal	  IgG	  antibodies	  in	  Dox-­‐induced	  cells	  and	  IP	  using	  anti-­‐HA	  
antibodies	  in	  uninduced	  cells	  (Figure	  4.3,	  black	  bars	  and	  blue	  bars,	  respectively).	  
Localization	  of	  SART3	  was	  monitored	  using	  two	  or	  three	  primer	  sets	  for	  CTR9,	  F11R,	  and	  
FAT3.	  For	  each	  gene,	  we	  designed	  primers	  to	  amplify	  a	  region	  within	  the	  first	  exon	  or	  to	  
amplify	  the	  intron/exon	  junction	  at	  the	  3’	  end	  of	  intron	  1	  and	  the	  5’	  end	  of	  exon	  2	  (Figure	  
4.3).	  In	  the	  case	  of	  the	  FAT3	  genes,	  an	  additional	  primer	  set	  was	  designed	  to	  amplify	  the	  
exon/intron	  junction	  region	  at	  the	  3’	  end	  of	  exon	  1	  and	  the	  5’	  end	  of	  intron	  1.	  Unfortunately	  
the	  resolution	  obtained	  in	  ChIP	  analysis	  is	  not	  enough	  to	  accurately	  localize	  SART3	  
between	  exon	  1	  and	  the	  first	  exon/intron	  junction	  in	  CTR9	  and	  F11R	  as	  the	  length	  of	  the	  
first	  exon	  is	  relatively	  short.	  	  
Nevertheless,	  we	  found	  high	  levels	  of	  SART3	  at	  these	  particular	  genomic	  regions	  
when	  compared	  to	  negative	  controls	  (IgG	  and	  HA	  (–Dox)),	  suggesting	  that	  changes	  in	  CTR9,	  
F11R,	  and	  FAT3	  transcript	  levels	  in	  SART3-­‐depleted	  cells	  could	  be	  a	  direct	  effect,	  rather	  
than	  an	  indirect	  effect	  of	  SART3	  loss	  (Figure	  4.3).	  While	  SART3	  levels	  increase	  at	  the	  
intron/exon	  junction	  of	  CTR9	  (amplicon	  1	  vs.	  amplicon	  2),	  we	  observed	  a	  decrease	  in	  






SART3	  is	  detected	  at	  the	  F11R	  exon	  1	  and	  intron/exon	  junction	  positions	  at	  similar	  levels.	  
The	  reason	  for	  the	  different	  patterns	  of	  SART3	  localization	  is	  unclear,	  but	  one	  possible	  
explanation	  is	  that	  the	  size	  of	  the	  intron	  could	  affect	  the	  level	  of	  SART3	  occupancy	  
(compare	  CTR9	  vs.	  F11R	  and	  FAT3).	  A	  more	  comprehensive	  analysis	  of	  SART3	  localization	  
throughout	  multiple	  genes	  is	  necessary	  to	  discern	  any	  pattern.	  	  
Typically,	  an	  additional	  normalization	  parameter	  is	  applied	  to	  ChIP	  data	  analysis	  
where	  ChIP	  signal	  is	  normalized	  to	  the	  signal	  detected	  within	  a	  region	  void	  of	  the	  target	  
protein	  (in	  this	  case,	  HA-­‐SART3).	  Classically,	  for	  normalization	  of	  proteins	  involved	  in	  
transcription,	  these	  primers	  are	  designed	  to	  amplify	  a	  transcriptionally	  silent	  region.	  
Because	  little	  is	  known	  about	  the	  function	  of	  SART3,	  in	  the	  future,	  primers	  designed	  to	  
amplify	  different	  silent	  regions	  of	  chromatin	  such	  as	  the	  centromeric	  DNA	  have	  to	  be	  tested	  
in	  order	  to	  identify	  suitable	  negative	  controls.	  
	  
4.3.4	  RNAPII	  localization	  in	  SART3-­‐depleted	  cells	  
	   Because	  depletion	  of	  SART3	  causes	  a	  decrease	  in	  transcript	  level	  of	  multiple	  genes,	  
we	  sought	  to	  assay	  RNAPII	  patterns	  at	  these	  genes.	  We	  performed	  ChIP	  analysis	  with	  
8WG16	  antibodies	  in	  siControl	  and	  siSART3	  cells	  and	  used	  the	  previously	  described	  primer	  
sets	  to	  assay	  the	  localization	  of	  RNAPII.	  Despite	  the	  observed	  decrease	  in	  transcript	  level	  
upon	  SART3	  depletion,	  only	  minor	  changes	  in	  RNAPII	  levels	  were	  detected	  (Figure	  4.4).	  
Furthermore,	  in	  the	  case	  of	  F11R,	  we	  observed	  a	  slight	  increase	  in	  RNAPII	  at	  the	  
intron/exon	  junctions	  in	  SART3-­‐depleted	  cells.	  These	  data	  suggest	  that	  RNAPII	  may	  be	  
piling	  up	  at	  the	  F11R	  intron/exon	  junction,	  possibly	  due	  to	  a	  defect	  in	  splicing,	  leading	  to	  






In	  the	  case	  of	  CTR9,	  the	  levels	  of	  RNAPII	  did	  not	  change	  at	  the	  intron/exon	  junction	  
upon	  SART3	  knockdown,	  but	  it	  is	  important	  to	  note	  that	  the	  fold-­‐change	  of	  RNAPII	  levels	  
between	  exon	  1	  and	  the	  intron/exon	  junction	  is	  greater	  in	  the	  siControl	  sample	  than	  the	  
siSART3	  sample	  (3.46-­‐fold	  vs.	  2.17-­‐fold,	  respectively).	  Future	  ChIP-­‐seq	  studies	  analyzing	  
global	  RNAPII	  occupancy	  coupled	  with	  CTD	  phosphorylation	  status	  will	  be	  needed	  to	  




In	  this	  study,	  we	  used	  RNA-­‐seq	  analysis	  to	  identify	  changes	  in	  transcript	  levels	  and	  
splicing	  patterns	  in	  SART3-­‐depleted	  cells.	  We	  used	  qRT-­‐PCR	  to	  validate	  the	  observed	  
changes	  in	  transcript	  levels	  from	  NGS	  analysis	  for	  10	  different	  genes	  and	  found	  that	  100%	  
of	  the	  tested	  genes	  displayed	  consistent	  trend	  in	  transcript	  level	  change	  (either	  an	  increase	  
or	  decrease	  in	  transcript	  levels).	  Presumably,	  at	  least	  a	  fraction	  of	  these	  genes	  are	  directly	  
regulated	  by	  SART3	  as	  ChIP	  analysis	  revealed	  SART3	  localization	  to	  regions	  within	  the	  
CTR9,	  F11R,	  and	  FAT3	  genes.	  Despite	  significant	  decrease	  in	  transcript	  levels	  of	  these	  
genes,	  we	  found	  RNAPII	  levels	  did	  not	  decrease	  at	  5’	  end	  of	  each	  gene.	  On	  the	  contrary,	  our	  
preliminary	  data	  suggest	  RNAPII	  may	  be	  piling	  up	  at	  intron/exon	  junctions,	  possibly	  due	  to	  
defects	  in	  splicing	  in	  the	  absence	  of	  SART3.	  
SART3	  depletion	  using	  shRNA	  does	  not	  increase	  ubH2B	  levels—Upon	  transfection,	  
ubH2B	  levels	  are	  reduced	  when	  compared	  to	  untransfected	  HeLa	  cells	  (Figure	  4.1A,	  
compare	  lanes	  1	  and	  2).	  Others	  and	  we	  have	  consistently	  observed	  this	  phenomenon	  using	  
a	  variety	  of	  control	  siRNA	  sequences.	  For	  this	  reason,	  untransfected	  HeLa	  cell	  lysate	  was	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used	  as	  a	  standard	  to	  monitor	  changes	  in	  ubH2B	  levels	  in	  cells	  depleted	  of	  SART3	  using	  
shRNA.	  Note	  that	  ubH2B	  levels	  in	  the	  GFP	  control	  were	  comparable	  to	  ubH2B	  levels	  in	  the	  
untransfected	  HeLa	  cell	  lysate	  (data	  not	  shown).	  	  
We	  found	  that	  both	  ubH2A	  and	  ubH2B	  levels	  changed	  to	  various	  degrees	  with	  each	  
shRNA	  plasmid	  6	  days	  post-­‐transduction,	  but	  we	  did	  not	  observe	  an	  increase	  in	  ubH2B	  
under	  any	  condition	  (Figure	  4.1A).	  Furthermore,	  the	  observed	  changes	  in	  ubH2A	  and	  
ubH2B	  levels	  did	  not	  seem	  to	  correlate	  with	  the	  efficiency	  of	  SART3	  depletion.	  One	  
explanation	  is	  that,	  when	  compared	  to	  SART3	  knockdown	  using	  siRNA,	  stable	  depletion	  of	  
SART3	  using	  lentiviral	  shRNA	  occurs	  over	  a	  longer	  period	  of	  time	  (3	  days	  vs.	  6-­‐8	  days)	  and	  
cells	  may	  undergo	  further	  changes	  in	  response	  to	  the	  depletion	  of	  SART3	  over	  an	  extended	  
amount	  of	  time.	  One	  of	  these	  adaptation	  mechanisms	  may	  involve	  the	  reorganization,	  
redistribution,	  and	  changes	  in	  global	  levels	  of	  ubH2B.	  	  
RNAPII	  occupancy—Despite	  a	  decrease	  in	  transcript	  levels	  of	  CTR9,	  F11R,	  and	  FAT3	  
upon	  SART3	  knockdown,	  we	  observed	  only	  a	  mild	  decrease	  in	  RNAPII	  levels	  at	  exon	  1	  in	  
CTR9.	  Meanwhile,	  RNAPII	  levels	  in	  exon	  1	  of	  F11R	  and	  FAT3	  either	  remained	  unchanged	  or	  
slightly	  increased.	  These	  data	  suggest	  transcript	  levels	  are	  not	  reduced	  due	  to	  a	  decrease	  in	  
RNAPII	  recruitment	  to	  the	  5’	  end	  of	  the	  gene.	  Recent	  studies	  have	  shown	  SART3	  is	  
recruited	  to	  the	  HIV	  promoter	  and	  enhances	  P-­‐TEFb	  recruitment	  to	  the	  promoter,	  which	  
leads	  to	  increased	  Serine	  2	  phosphorylation	  (Ser2P)	  of	  the	  RNAPII	  CTD	  (Zhao	  et	  al.,	  2014).	  
This	  Ser2P	  enhances	  processive	  elongation	  and	  is	  required	  for	  efficient	  synthesis	  of	  full-­‐
length	  transcripts.	  Like	  our	  findings,	  this	  study	  also	  observed	  that	  total	  RNAPII	  CTD	  levels	  
did	  not	  change,	  suggesting	  the	  phosphorylation	  status	  of	  the	  RNAPII	  CTD,	  and	  not	  
recruitment	  of	  RNAPII	  itself,	  may	  be	  changed	  upon	  SART3	  depletion.	  Therefore,	  ChIP	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analysis	  of	  different	  phosphorylated	  forms	  of	  RNAPII	  could	  provide	  further	  insight	  into	  the	  
relationship	  between	  SART3	  and	  the	  transcription	  apparatus.	  Notably,	  global	  levels	  of	  
Ser2P	  and	  Ser5P	  of	  the	  CTD	  are	  unaffected	  in	  SART3-­‐depleted	  cells,	  but	  this	  type	  of	  global	  
analysis	  may	  not	  reveal	  changes	  of	  CTD	  phosphorylation	  at	  specific	  genes	  (Figure	  3.12F).	  	  
It	  is	  also	  important	  to	  note	  that	  the	  afore	  mentioned	  ChIP	  studies	  analyzing	  the	  
presence	  of	  SART3,	  P-­‐TEFb,	  and	  RNAPII	  CTD-­‐Ser2P	  utilized	  a	  reporter	  gene	  system	  
whereby	  transcription	  of	  the	  reporter	  gene	  (Luciferase)	  was	  driven	  by	  the	  HIV	  promoter	  
(Zhao	  et	  al.,	  2014).	  Because	  the	  reporter	  gene	  does	  not	  contain	  an	  intron,	  the	  function	  of	  
SART3	  in	  splicing	  may	  not	  be	  recapitulated	  in	  this	  system.	  These	  data	  also	  suggest	  SART3	  
could	  affect	  transcription	  in	  a	  splicing-­‐independent	  manner.	  Future	  analysis	  of	  
transcription	  and	  splicing	  machinery	  at	  SART3-­‐regulated	  genes	  is	  necessary	  to	  provide	  
mechanistic	  insight	  into	  the	  function	  of	  SART3	  in	  transcription	  and	  splicing.	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CHAPTER	  5:	  DISCUSSION	  AND	  PERSPECTIVES	  
	  
	  
5.1	  Co-­‐transcriptional	  pre-­‐mRNA	  splicing	  
	   Generally	  speaking,	  most	  splicing	  events	  of	  mammalian	  genes	  occur	  co-­‐
transcriptionally.	  This	  is	  evidenced,	  in	  part,	  by	  the	  fact	  that	  most	  c-­‐Src	  and	  fibronectin	  
mRNA	  introns	  are	  removed	  prior	  to	  release	  from	  the	  chromatin	  (Pandya-­‐Jones	  and	  Black,	  
2009).	  Additionally,	  many	  splicing	  factors	  are	  recruited	  to	  and	  directly	  bind	  the	  RNAPII	  
CTD,	  and	  this	  recruitment	  is	  dependent	  upon	  processive	  pre-­‐mRNA	  synthesis	  (Misteli	  and	  
Spector,	  1999;	  Sapra	  et	  al.,	  2009).	  An	  intimate	  relationship	  between	  transcription	  and	  
splicing	  has	  also	  been	  demonstrated	  in	  that	  the	  RNAPII	  CTD	  is	  required	  for	  proper	  pre-­‐
mRNA	  splicing	  and	  processing.	  Specifically,	  substituting	  RNAPI,	  RNAPIII,	  or	  a	  RNAPII	  CTD	  
deletion	  mutant	  in	  place	  of	  wild-­‐type	  RNAPII	  results	  in	  defects	  in	  pre-­‐mRNA	  processing	  due	  
to	  the	  inability	  to	  properly	  and	  efficiently	  recruit	  the	  splicing	  machinery	  (McCracken	  et	  al.,	  
1997;	  Misteli	  and	  Spector,	  1999).	  Furthermore,	  perturbation	  of	  transcription	  rates	  affect	  
alternative	  splicing	  (Luco	  et	  al.,	  2011).	  An	  example	  of	  this	  relationship	  was	  demonstrated	  
via	  modulation	  of	  the	  RNAPII	  elongation	  rate.	  In	  this	  study,	  implementation	  of	  a	  mutant	  
RNAPII	  with	  an	  abnormally	  slow	  elongation	  rate	  resulted	  in	  inclusion	  of	  alternative	  exons	  
into	  the	  final	  pre-­‐mRNA	  product	  (de	  la	  Mata	  et	  al.,	  2003).	  Conversely,	  increasing	  the	  rate	  of	  
RNAPII	  transcription	  elongation	  results	  in	  inefficient	  splicing	  and	  intron	  retention	  (Braberg	  
et	  al.,	  2013).	  In	  the	  first	  case,	  intron	  removal	  is	  presumably	  more	  efficient	  because	  the	  
slowed	  RNAPII	  elongation	  rate	  allows	  temporal	  recruitment	  of	  splicing	  factors	  that	  may	  
normally	  not	  be	  recruited	  under	  normal	  rates	  of	  RNAPII	  elongation.	  Alternatively,	  when	  the	  
elongation	  rate	  of	  RNAPII	  is	  increased,	  intron	  removal	  is	  presumably	  less	  efficient	  due	  to	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inefficient	  recruitment	  of	  splicing	  factors.	  This	  model	  by	  which	  the	  elongation	  rate	  of	  
RNAPII	  directly	  modulates	  splicing	  efficiency	  is	  referred	  to	  as	  the	  “kinetic”	  model.	  
	  
5.2	  Chromatin	  structure	  affects	  alternative	  splicing	  
	   Additionally,	  chromatin	  architecture	  and	  chromatin	  remodeling	  factors	  have	  been	  
demonstrated	  to	  affect	  alternative	  splicing	  patterns.	  Characterization	  of	  nucleosome	  
positioning	  using	  genome-­‐wide	  mapping	  techniques	  revealed	  that	  nucleosomes	  are	  
enriched	  at	  intron-­‐exon	  junctions	  (Schwartz	  et	  al.,	  2009).	  Nucleosome	  positioning	  extends	  
beyond	  simply	  defining	  exons	  as	  chromatin	  architecture	  as	  alternative	  splicing	  is	  also	  
regulated	  by	  chromatin.	  This	  was	  demonstrated	  by	  the	  observation	  that:	  1)	  included	  
alternatively	  spliced	  exons	  have	  a	  higher	  nucleosome	  density	  when	  compared	  to	  the	  
nucleosome	  density	  observed	  in	  excluded	  alternatively	  spliced	  exons	  and	  2)	  weaker	  splice	  
sites	  have	  more	  well-­‐positioned	  nucleosomes	  (Spies	  et	  al.,	  2009;	  Tilgner	  et	  al.,	  2009).	  
Hypothetically,	  this	  enrichment	  of	  nucleosome	  density	  functions	  as	  a	  physical	  barrier	  to	  
slow	  the	  rate	  of	  RNAPII	  elongation,	  thus	  allowing	  time	  for	  splicing	  factors	  to	  be	  recruited	  
and	  enhancing	  the	  inclusion	  of	  particular	  exons	  in	  the	  final	  transcript	  product.	  Notably,	  
there	  is	  at	  least	  one	  instance	  where	  chromatin	  remodeling	  regulates	  alternative	  splicing	  
without	  affecting	  the	  elongation	  rate	  of	  RNAPII	  (Auboeuf	  et	  al.,	  2002).	  Therefore,	  it	  is	  
unlikely	  that	  the	  kinetic	  transcription	  model	  of	  splicing	  regulation	  is	  a	  completely	  accurate	  






5.3	  The	  role	  of	  histone	  post-­‐translational	  modifications	  in	  pre-­‐mRNA	  splicing	  
	   In	  addition	  to	  chromatin	  architecture	  marking	  intron/exon	  junctions,	  specific	  post-­‐
translational	  modifications	  of	  nucleosomal	  histones	  also	  play	  a	  role	  in	  exon	  definition.	  
Specifically,	  H3K36me3,	  H3K4me3,	  H3K27me2,	  and	  H3K27me3	  are	  elevated	  in	  exons,	  even	  
after	  normalization	  to	  nucleosome	  density,	  and	  enrichment	  of	  these	  marks	  is	  decreased	  in	  
alternatively	  spliced	  exons	  (when	  compared	  to	  constitutively	  included	  exons)	  (Andersson	  
et	  al.,	  2009;	  Dhami	  et	  al.,	  2010;	  Luco	  et	  al.,	  2010;	  Spies	  et	  al.,	  2009).	  In	  addition,	  ubH2B	  is	  
particularly	  elevated	  at	  intron/exon	  junctions	  in	  highly	  expressed	  exons	  in	  mammalian	  
cells	  (Jung	  et	  al.,	  2012).	  Conversely,	  some	  histone	  marks,	  such	  as	  H3K9me3	  are	  notably	  
absent	  from	  exon	  regions	  (Spies	  et	  al.,	  2009).	  	  
	   Because	  both	  active	  transcription	  (H3K36me3,	  H3K4me3,	  and	  ubH2B)	  and	  
repressive	  transcription	  (H3K27me2,	  H3K27me3,	  and	  ubH2B)	  marks	  regulate	  alternative	  
splicing,	  it	  is	  unlikely	  these	  histone	  PTMs	  regulate	  splicing	  using	  a	  mechanism	  by	  altering	  
RNAPII	  elongation	  rates	  to	  manipulate	  the	  inclusion	  or	  exclusion	  of	  exons.	  Rather,	  some	  
studies	  have	  found	  that	  certain	  histone	  modification-­‐binding	  proteins	  act	  as	  a	  bridge	  
between	  chromatin	  and	  specific	  splicing	  factors	  (Gunderson	  and	  Johnson,	  2009;	  Herissant	  
et	  al.,	  2014;	  Loomis	  et	  al.,	  2009;	  Luco	  et	  al.,	  2010;	  Piacentini	  et	  al.,	  2009;	  Sims	  et	  al.,	  2007).	  
For	  example,	  the	  chromatin	  remodeler,	  CHD1,	  binds	  both	  H3K4me3	  and	  the	  U2	  snRNP	  to	  
enhance	  pre-­‐mRNA	  splicing	  efficiency	  (Sims	  et	  al.,	  2007).	  	  	  
UbH2B,	  in	  particular,	  was	  reported	  to	  stimulate	  recruitment	  of	  U1	  and	  U2	  onto	  
nascent	  RNA	  (Herissant	  et	  al.,	  2014).	  In	  this	  study,	  nascent	  mRNPs	  were	  purified	  from	  wild-­‐
type	  or	  htbK123R	  yeast	  strains	  and	  bound	  proteins	  were	  detected	  using	  quantitative	  mass	  
spectrometry.	  Results	  showed	  that	  components	  of	  the	  U1	  and	  U2	  snRNPs	  were	  less	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abundant	  in	  the	  mRNPs	  isolated	  from	  the	  htbK123R	  strain,	  thus	  identifying	  a	  role	  for	  
ubH2B	  in	  recruitment	  of	  splicing	  factors.	  Whether	  any	  of	  the	  splicing	  factors	  directly	  
interact	  with	  ubH2B	  remains	  unclear.	  As	  ubH2B	  plays	  a	  critical	  role	  in	  transcription	  
elongation,	  another	  possibility	  is	  that	  ubH2B	  may	  affect	  alternative	  splicing	  through	  
modulation	  of	  RNAPII	  elongation	  rates.	  There	  is	  evidence	  that	  increasing	  global	  levels	  of	  
ubH2B	  in	  mammalian	  cells	  results	  in	  increased	  intron	  retention	  in	  the	  final	  pre-­‐mRNA	  
product	  (Zhang	  et	  al.,	  2013).	  In	  this	  study,	  depletion	  of	  the	  histone	  DUB,	  Usp49	  resulted	  in	  
increased	  ubH2B	  levels,	  increased	  exon	  skipping	  in	  alternatively	  spliced	  genes,	  and	  a	  
decrease	  in	  complete	  pre-­‐mRNA	  splicing.	  Under	  these	  circumstances,	  it’s	  possible	  that	  
elevated	  ubH2B	  levels	  increase	  the	  RNAPII	  elongation	  rate,	  thus	  disfavoring	  proper	  
temporal	  recruitment	  of	  splicing	  factors	  and	  cause	  inefficient	  splicing.	  	  
	   	  
5.4	  Future	  directions	  
	   As	  illustrated	  in	  our	  model	  (Figure	  3.17),	  our	  in	  vitro	  and	  in	  vivo	  data	  suggest	  Usp15	  
and	  SART3	  work	  together	  in	  a	  coordinated	  fashion	  to	  deubiquitinate	  evicted	  histones	  
during	  transcription	  prior	  to	  their	  reassembly	  onto	  DNA	  behind	  elongating	  RNAPII.	  
Deubiquitinating	  histones	  prior	  to	  reassembly	  would	  “reset”	  the	  chromatin	  template,	  
thereby	  allowing	  histone	  PTM	  patterning	  to	  be	  redefined	  for	  the	  next	  round	  of	  
transcription.	  Thus,	  deregulation	  of	  SART3	  could	  cause	  transcriptional	  and	  pre-­‐mRNA	  
processing	  aberrations.	  Based	  upon	  this	  model,	  we	  hope	  to	  answer	  three	  main	  questions:	  
1)	  Does	  SART3	  affect	  transcription	  and/or	  pre-­‐mRNA	  splicing?	  2)	  If	  so,	  how	  is	  SART3	  
affecting	  transcript	  levels?	  and	  3)	  Does	  Usp15	  play	  a	  role	  in	  SART3-­‐mediated	  regulation	  of	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transcript	  and	  ubH2B	  levels	  in	  vivo.	  Specific	  experiments	  designed	  to	  address	  these	  
questions	  are	  detailed	  below.	  
	  
5.4.1	  Does	  SART3	  affect	  transcription	  and/or	  pre-­‐mRNA	  splicing?	  
	   Upon	  SART3	  depletion,	  we	  identified	  many	  genes	  with	  increased	  transcript	  levels,	  
decreased	  transcript	  levels,	  or	  differentially	  spliced	  transcripts.	  Because	  these	  transcript	  
changes	  could	  be	  an	  indirect	  effect	  of	  SART3	  depletion,	  we	  hope	  to	  identify	  changes	  that	  are	  
directly	  mediated	  through	  the	  action	  of	  SART3.	  Thus,	  we	  plan	  to	  use	  the	  HeLa	  HA-­‐SART3	  
stable	  cell	  line	  utilized	  in	  Figure	  3.3	  to	  perform	  ChIP-­‐seq	  analysis	  (using	  anti-­‐HA	  for	  IP)	  to	  
define	  regions	  of	  the	  genome	  to	  which	  HA-­‐SART3	  is	  localized.	  Analysis	  of	  SART3	  ChIP-­‐seq	  
data	  will	  include	  a	  comparison	  with	  our	  RNA-­‐seq	  data	  to	  look	  for	  a	  correlation	  between	  
those	  genes	  whose	  transcription	  was	  affected	  by	  SART3	  depletion	  and	  genes	  at	  which	  
SART3	  is	  localized.	  If	  there	  is	  a	  high	  correlation	  between	  changes	  in	  transcript	  levels	  in	  
SART3	  depleted	  cells	  and	  SART3	  localization,	  we	  can	  be	  more	  confident	  the	  transcript	  
changes	  observed	  are	  a	  direct	  effect	  of	  SART3	  function.	  As	  was	  previously	  mentioned,	  we	  
have	  yet	  to	  identify	  a	  genomic	  region	  where	  SART3	  is	  absent.	  This	  ChIP-­‐seq	  analysis	  could	  
provide	  useful	  information	  in	  identifying	  SART3-­‐depleted	  regions	  of	  the	  genome.	  	  	  
	  
5.4.2	  How	  is	  SART3	  affecting	  transcript	  levels?	  
	   The	  changes	  in	  transcript	  abundance	  we	  observed	  in	  SART3-­‐depleted	  cells	  are	  most	  
likely	  caused	  by	  changes	  in	  either	  transcription	  or	  RNA	  stability.	  As	  SART3	  and	  ubH2B	  have	  
been	  implicated	  to	  play	  roles	  in	  the	  transcription	  pathway,	  we	  plan	  to	  first	  investigate	  the	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possibility	  that	  changes	  in	  transcription	  are	  responsible	  for	  the	  observed	  changes	  in	  
transcript	  levels.	  
	   First,	  we	  plan	  to	  examine	  RNAPII	  localization	  on	  a	  global	  level	  in	  SART3-­‐depleted	  
cells	  using	  ChIP-­‐seq.	  If	  changes	  in	  RNAPII	  levels	  are	  observed	  at	  genes	  affected	  by	  SART3	  
depletion,	  this	  would	  support	  the	  idea	  that	  transcript	  abundance	  changes	  in	  SART3-­‐
depleted	  cells	  are	  primarily	  caused	  by	  changes	  in	  transcription	  and	  not	  RNA	  stability.	  
Preliminary	  analysis	  of	  RNAPII	  occupancy	  at	  3	  genes	  revealed	  RNAPII	  levels	  are	  not	  
substantially	  affected	  by	  SART3	  depletion.	  Nonetheless,	  it	  is	  possible	  that,	  although	  RNAPII	  
localization	  is	  unaffected	  by	  SART3	  depletion,	  the	  phosphorylation	  status	  of	  the	  RNAPII	  
CTD	  may	  be	  affected,	  indicating	  changes	  in	  transcription	  are	  not	  due	  to	  defects	  in	  RNAPII	  
recruitment,	  but	  rather	  due	  to	  defects	  in	  transcription	  initiation	  or	  elongation.	  Thus,	  we	  
also	  plan	  to	  use	  ChIP	  to	  examine	  the	  Ser5P	  and	  Ser2P	  patterning	  of	  RNAPII	  at	  SART3-­‐
affected	  genes.	  
	   There	  is	  evidence	  supporting	  the	  model	  that	  RNAPII	  pauses	  at	  3’	  splice	  sites	  
(intron/exon	  junctions)	  to	  facilitate	  proper	  temporal	  recruitment	  of	  the	  splicing	  machinery	  
before	  transcription	  elongation	  is	  allowed	  to	  proceed	  (Alexander	  et	  al.,	  2010).	  Specifically,	  
studies	  in	  yeast	  using	  ChIP	  analysis	  showed	  the	  timing	  of	  splicing	  factor	  recruitment	  is	  
slightly	  delayed	  in	  relationship	  to	  the	  timing	  of	  RNAPII	  pausing	  at	  splice	  sites	  and	  inhibition	  
of	  splicing	  disrupts	  RNAPII	  pausing	  patterns	  (i.e.	  RNAPII	  no	  longer	  pauses	  at	  3’	  splice	  sites).	  
Furthermore,	  RNAPII	  pausing	  at	  the	  most	  5’	  intron/exon	  junction	  within	  a	  gene	  is	  required	  
for	  efficient	  Ser2	  phosphorylation	  of	  the	  RNAPII	  CTD.	  Based	  upon	  these	  studies,	  we	  expect	  




	   If	  the	  observed	  changes	  in	  transcript	  abundance	  in	  SART3	  depleted	  cells	  is	  a	  
consequence	  of	  deregulated	  transcription,	  it’s	  possible	  the	  mechanism	  of	  transcriptional	  
reprogramming	  is	  caused	  by	  changes	  in	  ubH2B	  levels	  or	  patterning.	  Because	  SART3	  
depletion	  resulted	  in	  a	  global	  increase	  in	  ubH2B	  levels,	  we	  are	  interested	  to	  learn	  if	  ubH2B	  
levels	  and	  patterning	  on	  SART3-­‐affected	  genes	  is	  changed	  upon	  SART3	  depletion.	  First,	  we	  
hope	  to	  analyze	  ubH2B	  localization	  using	  publicly	  available	  ChIP	  data	  to	  look	  for	  particular	  
ubH2B	  patterning	  in	  SART3-­‐affected	  genes,	  such	  as	  elevated	  levels	  within	  exons	  or	  at	  
intron/exon	  junctions.	  Secondly,	  we	  plan	  to	  monitor	  changes	  in	  ubH2B	  at	  SART3-­‐regulated	  
genes	  upon	  SART3	  depletion	  to	  assess	  a	  possible	  relationship	  between	  changes	  in	  
transcript	  levels	  and	  changes	  in	  ubH2B	  localization.	  Thirdly,	  we	  plan	  to	  analyze	  changes	  in	  
ubH2B	  levels	  and	  localization	  at	  genes	  with	  differential	  splicing	  patterns	  upon	  SART3	  
depletion	  to	  see	  if	  there	  is	  a	  correlation	  between	  ubH2B	  patterning	  and	  changes	  in	  
alternative	  splicing.	  UbH2B	  levels	  will	  be	  normalized	  to	  H2B	  ChIP	  signal	  to	  account	  for	  
changes	  in	  nucleosome	  density.	  
	   We	  observed	  that	  SART3	  has	  mild	  histone	  chaperone	  activity	  in	  vitro.	  We	  are	  
interested	  in	  investigating	  if	  the	  histone	  chaperone	  activity	  of	  SART3	  is	  required	  for	  the	  
regulation	  of	  global	  ubH2B	  levels	  and	  proper	  transcriptional	  control	  of	  SART3-­‐regulated	  
genes.	  To	  do	  this,	  we	  propose	  to	  use	  mutational	  dissection	  of	  SART3	  to	  disrupt	  SART3-­‐
histone	  binding	  as	  measured	  by	  in	  vitro	  histone	  binding	  and	  supercoiling	  assays.	  Secondly,	  
we	  propose	  to	  deplete	  SART3	  from	  HeLa	  cells	  and	  rescue	  the	  SART3	  depletion	  by	  
expressing	  wild-­‐type	  SART3,	  the	  SART3	  mutant	  defective	  for	  histone	  binding,	  or	  GFP	  as	  a	  
control.	  If	  the	  histone	  binding	  property	  of	  SART3	  is	  required	  for	  ubH2B	  and	  transcriptional	  
maintenance,	  we	  expect	  to	  see	  ubH2B	  and	  transcript	  levels	  restored	  in	  cells	  transfected	  
	  
	  141	  
with	  wild-­‐type	  SART3	  and	  not	  those	  rescued	  with	  the	  SART3	  mutant.	  Furthermore,	  ChIP	  
studies	  analyzing	  the	  localization	  of	  mutant	  SART3,	  RNAPII,	  and	  ubH2B	  could	  highlight	  
specific	  regulation	  steps	  at	  which	  the	  histone	  binding	  property	  of	  SART3	  is	  paramount.	  We	  
must	  also	  consider	  the	  possibility	  that	  mutating	  SART3	  residues	  could	  not	  only	  disrupt	  
histone	  binding,	  but	  could	  also	  disrupt	  interactions	  between	  SART3	  and	  other	  binding	  
partners.	  	  
	  
5.4.3	  Does	  Usp15	  play	  a	  role	  in	  SART3-­‐mediated	  regulation	  of	  transcript	  and	  ubH2B	  levels	  
in	  vivo?	  
	   Our	  model	  proposes	  that	  Usp15	  is	  recruited	  to	  sites	  of	  active	  transcription	  via	  
SART3	  and	  deubiquitinates	  histones	  prior	  to	  their	  re-­‐deposition	  onto	  DNA	  behind	  
elongating	  RNAPII	  (Figure	  3.14).	  We	  are	  interested	  to	  see	  if	  Usp15	  can	  also	  be	  detected	  at	  
SART3-­‐regulated	  genes	  using	  ChIP	  analysis.	  Furthermore,	  we	  plan	  to	  investigate	  whether	  
SART3	  and	  Usp15	  localization	  overlap,	  based	  upon	  ChIP	  analysis.	  Along	  these	  lines,	  it	  is	  
possible	  to	  deplete	  SART3	  from	  cells	  and	  rescue	  with	  a	  wild-­‐type	  or	  SART3	  N-­‐terminal	  
domain	  deletion	  mutant	  (which	  does	  not	  bind	  Usp15)	  and	  investigate	  changes	  in	  transcript	  
levels	  and	  ubH2B	  patterning	  at	  SART3-­‐affected	  genes.	  Again,	  these	  data	  must	  be	  analyzed	  
with	  the	  understanding	  that	  deletion	  of	  the	  SART3	  NTD	  could	  abrogate	  interactions	  
between	  SART3	  and	  other	  proteins.	  
Depletion	  of	  Usp15	  and	  its	  closest	  homologs,	  Usp4	  and	  Usp11,	  did	  not	  result	  in	  
global	  changes	  of	  ubH2B	  levels	  (Figure	  3.12B).	  Nevertheless,	  it	  is	  possible	  that	  Usp15	  may	  
deubiquitinate	  a	  subset	  of	  H2B	  and	  this	  small	  change	  may	  not	  be	  discernible	  in	  the	  context	  
of	  total	  cellular	  ubH2B.	  Therefore,	  if	  Usp15	  can	  be	  detected	  at	  particular	  genes	  using	  ChIP	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analysis,	  we	  plan	  to	  examine	  changes	  in	  ubH2B	  at	  these	  gene	  loci	  upon	  perturbation	  of	  
Usp15	  (either	  by	  depletion	  of	  Usp15	  or	  overexpression	  of	  the	  catalytically	  inactive	  mutant,	  
Usp15C269A).	  These	  data	  could	  provide	  further	  insight	  into	  the	  biological	  function	  of	  
Usp15	  in	  transcription	  and	  splicing.	  
	  
5.5	  Perspectives	  
	   Many	  questions	  remain	  unanswered	  in	  the	  field	  of	  co-­‐transcriptional	  splicing.	  For	  
example,	  an	  increase	  in	  ubH2B	  is	  observed	  at	  intron/exon	  junctions,	  but	  it	  is	  unclear	  how	  
this	  ubH2B	  patterning	  is	  achieved.	  Because	  RNAPII	  pauses	  at	  3’	  splice	  sites	  and	  because	  the	  
H2B	  E3	  ligase	  (RNF20/RNF40)	  associates	  with	  the	  elongating	  RNAPII	  complex,	  it’s	  possible	  
ubH2B	  levels	  are	  elevated	  at	  these	  RNAPII	  pause	  sites	  simply	  due	  to	  an	  increased	  residency	  
time	  of	  RNAPII	  at	  these	  intron/exon	  junctions	  (Alexander	  et	  al.,	  2010;	  Wood	  et	  al.,	  2003b).	  
Alternatively,	  it’s	  possible	  RNF20/RNF40	  non-­‐discriminately	  ubiquitinates	  H2B	  and,	  
rather,	  ubH2B	  patterning	  within	  genes	  is	  established	  through	  directed	  H2B	  
deubiquitination.	  
	   Not	  only	  is	  it	  not	  well	  understood	  why	  ubH2B	  levels	  are	  elevated	  at	  intron/exon	  
junctions,	  but	  the	  precise	  role	  of	  ubH2B	  in	  splicing	  not	  known.	  Herissant	  et	  al.	  showed	  
ubH2B	  is	  required	  for	  efficient	  recruitment	  of	  splicing	  factors	  onto	  nascent	  RNA,	  but	  the	  
mechanism	  of	  ubH2B-­‐mediated	  splicing	  factor	  recruitment	  has	  not	  been	  characterized	  
(Herissant	  et	  al.,	  2014).	  Although	  it	  is	  possible	  ubH2B	  directly	  recruits	  splicing	  factors	  to	  
splice	  sites,	  it’s	  also	  possible	  that	  an	  undefined	  factor	  acts	  as	  a	  bridging	  factor	  between	  
ubH2B	  and	  the	  splicing	  machinery.	  This	  bridging	  mechanism	  as	  a	  means	  of	  cross-­‐talk	  
between	  the	  chromatin	  and	  splicing	  machinery	  has	  been	  described	  in	  multiple	  cases	  (see	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Section	  5.3).	  Although	  SART3	  interacts	  with	  both	  histones	  and	  the	  splicing	  components,	  it’s	  
unlikely	  that	  SART3	  is	  acting	  as	  the	  primary	  bridging	  factor	  as	  our	  histone	  dimer	  pull-­‐down	  
assays	  indicate	  SART3	  non-­‐preferentially	  binds	  unmodified	  and	  ubiquitinated	  histone	  
dimers	  (Figure	  3.12A).	  Along	  these	  lines,	  it’s	  also	  possible	  ubH2B	  is	  not	  playing	  a	  direct	  role	  
in	  splicing,	  but	  rather	  regulates	  splicing	  via	  modulation	  of	  transcription	  elongation	  rates.	  	  
	   To	  achieve	  processive	  transcription	  elongation,	  it’s	  clear	  that	  both	  ubiquitination	  
and	  deubiquitination	  of	  H2B	  are	  required.	  What	  remains	  unclear	  is	  in	  which	  context	  (free	  
histones	  vs.	  nucleosomal	  histones)	  H2B	  is	  ubiquitinated	  or	  deubiquitinated,	  and	  how	  are	  
these	  processes	  regulated.	  According	  to	  our	  model,	  we	  propose	  RNF20/RNF40	  associated	  
with	  elongating	  RNAPII	  ubiquitinates	  nucleosomal	  H2B	  as	  ubiquitination	  after	  assembly	  
onto	  chromatin	  would	  be	  the	  most	  intuitive	  way	  to	  establish	  ubH2B	  patterning	  on	  genes.	  	  
	   Our	  work	  also	  sheds	  light	  on	  the	  mechanistic	  question	  concerning	  which	  histone	  
substrates	  are	  deubiquitinated,	  free	  histone	  or	  nucleosomal	  histones.	  Based	  upon	  our	  in	  
vitro	  deubiquitinating	  assay,	  we	  found	  that	  both	  free	  histones	  and	  nucleosomal	  histones	  
are	  deubiquitinated,	  but	  the	  different	  histone	  DUBs	  (namely	  SAGADUB	  and	  Usp15)	  exhibit	  
different	  degrees	  of	  substrate	  specificity	  (Figure	  3.4B-­‐C).	  These	  data	  indicate	  H2B	  
deubiquitination	  dynamics	  is	  regulated	  by	  multiple	  factors	  including	  histone	  DUBs	  and	  the	  
context	  in	  which	  the	  DUB	  encounters	  the	  histone	  substrate,	  thus	  increasing	  the	  complexity	  
of	  H2B	  deconjugation	  regulation.	  Further	  studies	  are	  needed	  to	  elucidate	  details	  
concerning	  histone	  DUB	  regulation	  during	  processes	  such	  as	  transcription,	  DNA	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APPENDIX	  I:	  REGULATION	  OF	  H2B	  DEUBIQUITINATION	  IS	  UNRELATED	  TO	  SAGADUB	  
EXPRESSION	  AND	  IS	  NOT	  CONTROLLED	  BY	  THE	  SPLICEOSOME	  
	  
A1.1	  The	  ubH2B	  increase	  observed	  in	  SART3-­‐depleted	  cells	  is	  not	  caused	  by	  a	  reduction	  in	  
SAGADUB	  transcript	  levels	  
Depletion	  of	  the	  U4/U6	  spliceosome	  recycling	  factor,	  SART3,	  caused	  a	  dramatic	  
increase	  in	  total	  ubH2B	  levels.	  Because	  splicing	  defects	  can	  affect	  transcription	  elongation	  
rates,	  we	  proposed	  that	  the	  ubH2B	  increase	  observed	  in	  SART3-­‐depleted	  cells	  could	  be	  a	  
result	  of	  decreased	  transcript	  levels	  of	  a	  histone	  DUB.	  Our	  primary	  suspect	  was	  SAGADUB	  as	  
this	  complex	  has	  been	  identified	  as	  a	  key	  regulator	  of	  Ub-­‐histone	  levels	  during	  
transcription	  (Lang	  et	  al.,	  2011).	  The	  human	  SAGADUB	  is	  comprised	  of	  4	  major	  proteins:	  
Ataxin7,	  Ataxin7L3,	  Eny2,	  and	  Usp22.	  Depletion	  of	  Ataxin7L3	  and	  Eny2	  results	  in	  an	  
increase	  in	  ubH2A	  and	  ubH2B	  levels	  (Figure	  A1.1A)	  (Lang	  et	  al.,	  2011).	  Notably,	  
transfection	  of	  Usp22-­‐targeted	  RNAi	  resulted	  in	  decreased	  Usp22	  transcript	  levels,	  but	  a	  
corresponding	  reduction	  in	  Usp22	  protein	  levels	  was	  not	  observed.	  These	  results	  suggest	  
the	  Usp22	  protein	  is	  has	  a	  long	  half-­‐life	  and	  the	  protein	  level	  is	  therefore	  unaffected	  after	  
72	  hours	  of	  RNAi	  treatment	  (Figure	  A1.1B-­‐C).	  Not	  surprisingly,	  transfection	  of	  Usp22	  RNAi	  
had	  no	  effect	  on	  global	  ubH2A	  or	  ubH2B	  levels	  (Figure	  A1.1C).	  	  
We	  observed	  that	  depletion	  of	  SART3	  using	  different	  siRNAs	  (#1	  and	  #2)	  at	  various	  
concentrations	  resulted	  in	  varying	  degrees	  of	  SART3	  depletion	  at	  both	  the	  RNA	  and	  protein	  
levels	  where	  SART3	  #2	  (high)	  >	  SART3	  #2	  (low)	  >	  SART3	  #1	  (high)	  (Figure	  3.12C	  and	  
Figure	  A1.1D).	  Changes	  in	  ubH2B	  levels	  also	  corresponded	  to	  the	  degree	  of	  SART3	  
knockdown	  in	  that	  more	  efficient	  depletion	  of	  SART3	  was	  accompanied	  by	  a	  greater	  





SART3	  knockdown,	  we	  used	  quantitative	  real-­‐time	  PCR	  to	  observe	  changes	  in	  transcript	  
levels	  of	  SAGADUB	  components.	  We	  proposed	  that	  if	  ubH2B	  levels	  are	  regulated	  by	  
components	  of	  SAGADUB	  in	  SART3-­‐depleted	  cells,	  then	  as	  SART3	  levels	  decrease,	  we	  would	  
observe	  a	  corresponding	  decrease	  in	  transcript	  levels	  of	  Ataxin7	  (ATXN7),	  Ataxin7L3	  
(ATXN7L3),	  and/or	  Eny2	  (ENY2).	  (Usp22	  was	  excluded	  from	  the	  analysis	  as	  a	  reduction	  in	  
Usp22	  transcript	  levels	  has	  no	  effect	  on	  ubH2B	  levels).	  Quantitative	  real-­‐time	  PCR	  revealed	  
the	  observed	  decrease	  transcript	  levels	  of	  SAGADUB	  components	  did	  not	  correspond	  to	  the	  
magnitude	  of	  SART3	  depletion	  (Figure	  A1.1E).	  This	  is	  most	  evident	  through	  a	  direct	  
comparison	  between	  the	  SART3	  #2	  low	  and	  high	  samples.	  These	  observations	  are	  in	  
accordance	  with	  another	  observation	  that	  SART3	  depletion	  only	  causes	  and	  an	  increase	  in	  
ubH2B	  levels	  while	  perturbation	  of	  SAGADUB	  affects	  both	  ubH2A	  and	  ubH2B	  levels	  (Figure	  
3.12A).	  	  	  
	  
A1.2	  SART3	  does	  not	  regulate	  ubH2B	  levels	  through	  perturbation	  of	  snRNP	  levels	  
	   Because	  SART3	  is	  a	  component	  of	  the	  spliceosome	  recycling	  machinery,	  we	  
suggested	  that	  depletion	  of	  other	  splicing	  components	  might	  also	  increase	  ubH2B	  levels.	  
We	  depleted	  several	  proteins	  associated	  with	  various	  snRNPs	  involved	  in	  spliceosome	  
assembly	  (Figure	  A1.2A).	  Due	  to	  lack	  of	  antibody	  availability,	  we	  assessed	  the	  efficiency	  of	  
depletion	  using	  quantitative	  real-­‐time	  PCR	  (Figure	  A1.2B).	  Notably,	  depletion	  of	  some	  
snRNP-­‐associated	  proteins	  resulted	  in	  an	  overall	  reduction	  in	  GAPDH	  transcript	  levels.	  As	  
GAPDH	  transcript	  levels	  were	  used	  for	  normalization,	  depletion	  efficiency	  of	  some	  proteins	  
may	  not	  be	  accurately	  represented	  due	  to	  changes	  in	  GAPDH	  transcription	  or	  transcript	  





PRPF19	  and	  Usp39	  increased	  ubH2B	  levels	  (Figure	  A1.2C).	  Unlike	  as	  was	  observed	  in	  
SART3-­‐depleted	  cells,	  this	  increase	  in	  ubH2B	  levels	  was	  also	  accompanied	  by	  an	  increase	  in	  
ubH2A	  levels.	  Uniquely,	  SF3A3	  depletion	  resulted	  in	  a	  mild	  increase	  in	  ubH2B	  levels,	  which	  
was	  not	  complimented	  by	  a	  change	  in	  ubH2A	  levels.	  Because	  depletion	  of	  PRPF19,	  Usp39,	  
and	  SF3A3	  caused	  ubH2B	  levels	  to	  increase,	  we	  analyzed	  changes	  in	  transcript	  levels	  of	  
these	  proteins	  in	  SART3	  depleted	  cells.	  Notably,	  transcript	  levels	  of	  snRNP-­‐associated	  
proteins	  were	  only	  marginally	  affected	  by	  SART3	  depletion	  (Figure	  A1.2D).	  These	  data	  
indicate	  the	  mechanism	  of	  SART3-­‐mediated	  regulation	  of	  ubH2B	  is	  predominantly	  
independent	  of	  other	  spliceosome	  factors.	  	  
	  
AI.3	  SART3	  depletion	  does	  not	  affect	  splicing	  of	  Usp49-­‐regulated	  genes	  
	   Recent	  work	  showed	  depletion	  of	  a	  H2B	  histone	  DUB,	  Usp49,	  resulted	  in	  increased	  
ubH2B	  levels	  and	  affected	  the	  splicing	  efficiency	  of	  a	  subset	  of	  genes	  (Zhang	  et	  al.,	  2013).	  
We	  were	  curious	  to	  see	  if	  these	  Usp49-­‐affected	  genes	  also	  displayed	  aberrant	  splicing	  
patterns	  in	  SART3-­‐depleted	  cells.	  We	  examined	  two	  genes	  RPS3	  and	  RPS6,	  which	  displayed	  
increased	  retention	  of	  the	  4th	  intron	  (5-­‐	  and	  7-­‐fold,	  respectively)	  in	  Usp49-­‐depleted	  cells.	  
We	  found	  a	  mild	  increase	  in	  RPS3	  intron	  levels	  and	  a	  slight	  decrease	  in	  RPS6	  intron	  levels	  
(2.53-­‐	  vs.	  0.82-­‐fold,	  respectively)	  in	  SART3-­‐depleted	  cells	  (Figure	  A1.3A).	  Additionally,	  we	  
used	  primers	  spanning	  exon-­‐exon	  junctions	  of	  exons	  2	  and	  3	  to	  monitor	  changes	  in	  the	  
spliced	  products	  and	  found	  splicing	  efficiency	  of	  these	  genes	  was	  unaffected	  upon	  SART3	  
depletion	  (Figure	  A1.3B).	  Although	  our	  RNA-­‐seq	  results	  revealed	  many	  differentially	  
spliced	  genes	  in	  SART3-­‐depleted	  cells,	  these	  data	  did	  not	  overlap	  with	  the	  splicing	  defects	  
observed	  in	  Usp49-­‐depleted	  cells.	  These	  data	  suggest	  the	  function	  of	  SART3	  and	  Usp49	  is	  






APPENDIX	  II:	  PRIMER	  SETS	  AND	  LENTIVIRUS	  PLASMIDS	  
	  
	  
Table	  A2.1.	  Primers	  used	  in	  qRT-­‐PCR	  analysis	  to	  measure	  knockdown	  efficiency	  of	  Usp15,	  
Usp4,	  Usp11,	  and	  SART3.	  Pertains	  to	  Chapter	  3.	  
Gene	   Forward	   Reverse	   Primer	  #	  
Usp15	   CGACGCTGCTCAAAACCTC	   TCCCATCTGGTATTTGTCCCAA	   485,	  486	  
Usp4	   TGACAGCCGGTGGTTCAAG	   GGTAGGGACCAATACATAGTCCA	   487,	  488	  
Usp11	   TATAAGCAGTGGGAGGCATACG	   ATGACCTTGCGTTCAATGGGT	   967,	  968	  
SART3	   TGAGGTTAAGGCGGCTAGGA	   CATGGCGTACTCATCCCCATC	   848,	  849	  
	  
Table	  A2.2.	  Lentivirus	  packaging	  vectors	  and	  shSART3	  plasmids.	  Pertains	  to	  Chapter	  4.	  
Plasmid	  number	   Description	   TRC	  number	   Identification	  number	  
-­‐	   non-­‐targeting	  shRNA	   -­‐	   -­‐	  
-­‐	   GFP	   -­‐	   -­‐	  
pPAX	   Gag-­‐Pol	   -­‐	   -­‐	  
PMD2.G	   VSV-­‐G	   -­‐	   -­‐	  
1	   shSART3	   148744	   5326	  
2	   shSART3	   148806	   5327	  
3	   shSART3	   128080	   5329	  
4	   shSART3	   147508	   5330	  
5	   shSART3	   127760	   5328	  
6	   shSART3	   146268	   5331	  
7	   shSART3	   129569	   5332	  
8	   shSART3	   149271	   5333	  
9	   shSART3	   344340	   5334	  
10	   shSART3	   344260	   5335	  
11	   shSART3	   344338	   5336	  
















Table	  A2.3.	  Primers	  used	  in	  qRT-­‐PCR	  analysis	  to	  measure	  transcript	  levels	  of	  genes	  
reported	  to	  have	  transcript	  changes	  in	  RNA-­‐seq	  analysis.	  Pertains	  to	  Chapter	  4.	  
Gene	   Forward	   Reverse	   Primer	  #	  
Unspliced	  
GAPDH	   CTCTCCAGAACATCATCCCTG	   TGGCAGGTTTTTCTAGACGG	  
1045,	  
1046	  
USP18	   TTTTGGAGTGATCACGAATGAGC	   CATGAGGGTAGTCCCAGGC	  
1245,	  
1247	  
CTR9	   GTGCCCTTTCAGCCTATGGA	   CTTAGCCTCCCCTAGGTTTCC	   1248,	  1249	  
F11R	   TCCATCCAAGCCTACAGTTAACAT	   AGCTCTCCTGTTGTGGGATT	  
1250,	  
1251	  
PDGFB	   GTGAGAAAGATCGAGATTGTGCG	   CTCGCTGCTCCTGGGAAC	  
1252,	  
1253	  
SPINT1	   ACTGCGTGGACCTGCCAG	   TGGAGATGCCGCGACAAGA	   1254,	  1255	  
LAMP3	   ATGGCAGTCAAATGAGAGCAA	   CTGTTTGAAAGGTGATATGACCATC	  
1260,	  
1261	  
MFAP5	   AAGGTGCTGCTGTTTCTTGC	   TAGGATCTTCTGTGAATGTTTCTGGA	  
1262,	  
1263	  
GRAMD1B	   GCCAAAACGGAGAGCACTTAT	   CTGCCACATGTTTGATCCTGT	   1264,	  1265	  
CDKN1A	   AACTTCGACTTTGTCACCGAG	   AGAGTCTCCAGGTCCACCT	   1268,	  1269	  





















Table	  A2.4.	  Primers	  used	  in	  ChIP	  analysis	  to	  assay	  genomic	  localization	  of	  SART3	  and	  
RNAPII.	  Pertains	  to	  Chapter	  4.	  	  
Gene	   Forward	   Reverse	   Primer	  #	  
CTR9	  (1)	   AGAAGCCAGAGCTCCAGCG	   GCTCTGGTCTTGACTGCCG	   1384,	  1385	  





F11R	  (1)	   AAAGGCGCAAGTCGAGAGG	   ACAACAGGATCGCCAATATGAAGAG	  
1392,	  
1393	  
F11R	  (2)	   CACTCCTGACAGGGCCCA	   AATGCCAGGGAGCCTAAGGAG	   1396,	  1397	  










FAT3	  (3)	   CAGTAACACTTCTCTTTTTTGTCTCAGG	   GAATGTCTGCGGCAGTGATGA	  
1412,	  
1413	  




























Table	  A2.5.	  Primers	  used	  in	  qRT-­‐PCR	  analysis	  to	  measure	  changes	  in	  transcript	  levels	  of	  
SAGADUB	  subunits,	  spliceosome	  components,	  and	  RPS3/RPS6	  intronic	  and	  spliced	  products.	  
Pertains	  to	  Appendix	  I.	  	  
Gene	   Forward	   Reverse	   Primer	  #	  
ATXN7L3	   CCAGGCCCTGATCAGCC	   TGGCTTCTTCTTCTTGTTGGAA	   1017,	  1018	  
USP22	   CCATTGATCTGATGTACGGAGG	   TCCTTGGCGATTATTTCCATGTC	   534,	  535	  





ATXN7	   CAAAGGTTGCCAAAGTGC	   TCGTGGAGTCCAGAGTGC	   1005,	  1006	  
PRPF3	   CACGACAAATCGAGGAGAGGA	   GGCTGAATAGTGTTGCCAATAGG	  
902,	  
903	  
PRPF31	   CTTTCCGGGGATTCAGTCAAG	   CAGCTCGTTTTCGATCTCCAC	   963,	  964	  
USP39	   CACTTACCTGCCGGGTATTGT	   CCTGGAGGACGTTTGATGTTCT	   965,	  966	  
SF3A3	   GTCATGGCTAAAGAGATGCTCAC	   TCCTCCTTTCGTAATCCATCCTT	  
971,	  
972	  
PRPF6	   CCGTTGGGGACCAGATGAAG	   GGCGTTCCATACGATATTTCTCT	   973,	  974	  
PRPF19	   CGAGAACTACATTGCGGAGAAT	   GCTGGTACAGAGCGTGTGAC	   1138,	  1139	  
RPS3	  












spliced	   GCAGAATCCGCAAACTTTTC	   TTTTCTTGGTACGCTGCTTC	  
1179,	  
1180	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
